<chapter label="CHAPTER 3" id="ch0003"><title><emphasis role="strong">Respiratory</emphasis></title>
<sect1 id="ch0003s0069"><title><emphasis role="strong">CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Chronic obstructive pulmonary disease (COPD): Chronic obstructive bronchitis and emphysema</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Chronic airflow limitations (CAL): Caused by a mixture of small airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema)</para></listitem>
<listitem><para>Airway inflammation: Causes structural changes, narrowing of lumina, and loss of elastic recoil in parenchyma</para>
</listitem></orderedlist></listitem>
<listitem><para>Asthma (also called chronic reactive airway disease)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Chronic inflammatory disorder&mdash;episodic exacerbations of reversible inflammation and hyperreactivity and variable constriction of bronchial smooth muscle, hypersecretion of mucus, and edema</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Spirometric Classification of Severity of COPD (airflow limitation based on postbronchodilator FEV<subscript>1</subscript>&mdash;Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2017 report</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>GOLD 1 (mild COPD)&mdash;mild airflow limitation (FVC &lt; 0.70; FEV<subscript>1</subscript> &ge; to 80% predicted)</para></listitem>
<listitem><para>GOLD 2 (moderate COPD)&mdash;worsening airflow limitation (FVC &lt; 0.70; 50% &le; FEV<subscript>1</subscript> &lt; 80% predicted); shortness of breath on exertion, and chronic cough and sputum production may be present</para></listitem>
<listitem><para>GOLD 3 (severe COPD)&mdash;continued worsening of airflow limitation (FVC &lt; 0.70; 30% &le; FEV<subscript>1</subscript> &lt; 50% predicted); increasing shortness of breath, reduced exercise capacity, fatigue, and repeated exacerbations</para></listitem>
<listitem><para>GOLD 4 (very severe COPD)&mdash;severe airflow limitation (FVC &lt; 0.70; FEV<subscript>1</subscript> &lt; 30% predicted)</para></listitem>
<listitem><para>Symptom evaluation: Although spirometry is necessary for making the diagnosis of COPD, assessment goals should focus on symptoms, risk for exacerbations, and determining effect of disease on client&rsquo;s overall health. Updated COPD guidelines include groups A, B, C, and D that guide therapy (Haelle, 2017).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>COPD</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Risk factors: Smoking (primary irritant), indoor/outdoor air pollution, secondhand smoke (e.g., smoke from cooking or heating fuels); history of childhood respiratory infections, heredity&mdash;a<subscript>1</subscript>-antitrypsin deficiency; occupational dusts, vapors, fumes, gases, and other chemicals.</para></listitem>
<listitem><para>Acute exacerbations usually due to pulmonary infections.</para>
</listitem></orderedlist></listitem>
<listitem><para>Asthma</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Tends to be acute and intermittent or episodic.</para></listitem>
<listitem><para>The severity is classified as (1) intermittent, (2) mild persistent, (3) moderate persistent, or (4) severe persistent. This classification is based on the impairment and risk related to disease, which is measured by (a) frequency and severity of symptoms, including nocturnal symptoms; (b) characteristics of acute episodes; (c) pulmonary function; and (d) exacerbations (Sharma &amp; Gupta, 2016).</para></listitem>
<listitem><para>Environmental and other factors (not a complete listing): Household substances (such as dust mites, pets, cockroaches, mold), pollen, foods, latex, emotional upheaval, air pollution, cold weather, exercise, chemicals, medications, and viral infections are known to contribute to development of asthma.</para></listitem>
<listitem><para>Genetics: Although allergies and environmental exposure factors are known risk factors in the development of asthma, both twin and family studies point to a strong genetic component. To date, linkage studies have identified more than a dozen genomic regions linked to asthma (Barnes, 2016). According to a Centers for Disease Control and Prevention (CDC) report, if a person has a parent with asthma, he or she is three to six times more likely to develop asthma than someone who does not have a parent with asthma (Benaroch, 2016).</para></listitem>
<listitem><para>In most children, asthma develops before age 5 years, and in more than half, asthma develops before age 3 years. Multiple triggers or precipitants as above plus upper respiratory infections (most commonly viral), including respiratory syncytial virus (RSV) bronchiolitis in infancy, irritants such as tobacco smoke, sports and games requiring continuous activity or that are played in cold weather, and changes in atmospheric or barometric pressure (Sharma &amp; Gupta, 2016).</para></listitem>
<listitem><para>The Severe Asthma Research Program of the National Heart, Lung, and Blood Institute identified five phenotypes of asthma (Moore et al, 2010):</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Group 1 clients have early onset asthma with normal lung function treated with two or fewer controller medications and minimal healthcare utilization.</para></listitem>
<listitem><para>Group 2 clients have early onset asthma and preserved lung function but increased medication requirements (three or more medications) and healthcare utilization.</para></listitem>
<listitem><para>Group 3 comprises mostly older obese women with late-onset asthma, moderate reductions in pulmonary function, and frequent oral corticosteroid use to manage exacerbations.</para></listitem>
<listitem><para>Group 4 and 5 clients have severe airflow obstruction with bronchodilator responsiveness but differ in their ability to attain normal lung function, age of asthma onset, atopic status, and use of oral corticosteroids.</para>
</listitem></orderedlist></listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>COPD</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: Over 9 million Americans (3.8%) reported that they had been diagnosed with COPD in that year (2015) (CDC: National Center for Health Statistics, 2017a)</para></listitem>
<listitem><para>Mortality: In 2014, death due to chronic lower respiratory diseases was the fifth leading cause of death (23,894) in age group 45 to 64 and the third leading cause of death (124,693) in age group 65 and older (CDC, 2015a).</para></listitem>
<listitem><para>Cost: In 2010, total national costs attributable to COPD and its sequelae were estimated at $32.1 billion (Ford et al, 2015).</para>
</listitem></orderedlist></listitem>
<listitem><para>Asthma</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: In 2015, over 18 million Americans were reported to have asthma, including 6.2 million children under 18 (CDC, National Center for Health Statistics, 2017b).</para></listitem>
<listitem><para>Mortality: In 2015, there were 3651 deaths attributed to asthma.</para></listitem>
<listitem><para>Cost: Annual direct healthcare cost is approximately $50.1 billion; indirect costs (e.g., lost productivity) are $5.9 billion, totaling $56.0 billion (Asthma &amp; Allergy Foundation of America [AAFA], 2015).</para>
</listitem></orderedlist></listitem></orderedlist></listitem></orderedlist>
<note id="ch0003s0069note0112"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Asthma:</emphasis> Chronic, reversible inflammation of the airways caused by a reaction of the airways to various stimuli.</para>
<para><emphasis role="strong">Bronchiectasis:</emphasis> Condition in which damage to the airways causes them to widen and become flabby and scarred. Bronchiectasis is usually the result of infection or other condition that injures airway walls and causes loss of ability to clear mucus.</para>
<para><emphasis role="strong">CAT (COPD Assessment Test) Score:</emphasis> Range from 0 to 40. Represents disease impact; score less than 10 equals low impact; greater than 10 equals high impact. A change of score of two or more points is considered clinically significant.</para>
<para><emphasis role="strong">Chronic bronchitis:</emphasis> Inflammation and scarring of the lining of the bronchi.</para>
<para><emphasis role="strong">Chronic obstructive pulmonary disease (COPD):</emphasis> Disease state characterized by an airflow limitation that is not fully reversible. It is usually progressive and associated with an abnormal inflammatory response to noxious particles or gases.</para>
<para><emphasis role="strong">Dyspnea:</emphasis> Shortness of breath that may be persistent, worse with activity, and progressive over time.</para>
<para><emphasis role="strong">Emphysema:</emphasis> Destruction of the alveoli, which leads to overdistention of the air spaces. Damage is irreversible.</para>
<para><emphasis role="strong">FEV<subscript>1</subscript>:</emphasis> Forced expired volume in 1 second.</para>
<para><emphasis role="strong">FVC:</emphasis> Forced vital capacity.</para>
<para><emphasis role="strong">Hypercapnia:</emphasis> Condition in which there is increased level of carbon dioxide in blood. This condition is closely associated with hypoxemia (low level of oxygen), which causes breathing difficulty and breathing/respiratory failure.</para>
</note>
<sect2 id="ch0003s0070"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Primarily community level; however, severe exacerbations may necessitate emergency or inpatient hospital stay.</para>
</sect2>
<sect2 id="ch0003s0071"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0002s0027">Heart failure: chronic</link></para>
<para><link linkend="ch0014s0384">Pediatric considerations</link></para>
<para><link linkend="ch0003s0074">Pneumonia</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0014s0348">Surgical intervention</link></para>
<para><link linkend="ch0003s0094">Respiratory failure: ventilatory assistance</link></para>
<table frame="top" id="ch0003s0069ta0064"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION
<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Fatigue, exhaustion, malaise</para></listitem>
<listitem><para>Inability to perform basic activities of daily living (ADLs) because of breathlessness</para></listitem>
<listitem><para>Inability to sleep, need to sleep sitting up</para></listitem>
<listitem><para>Dyspnea at rest or in response to activity or exercise</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Fatigue</para></listitem>
<listitem><para>Restlessness, insomnia</para></listitem>
<listitem><para>General debilitation or loss of muscle mass</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Swelling of lower extremities</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Elevated blood pressure (BP)</para></listitem>
<listitem><para>Elevated heart rate or severe tachycardia, dysrhythmias</para></listitem>
<listitem><para>Distended neck veins, with advanced disease</para></listitem>
<listitem><para>Dependent edema, which may not be related to heart disease</para></listitem>
<listitem><para>Faint heart sounds due to increased anteroposterior (AP) chest diameter</para></listitem>
<listitem><para>Skin color and mucous membranes may be pale or bluish and cyanotic, clubbing of nails and peripheral cyanosis, pallor (can indicate anemia)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Increased stress factors</para></listitem>
<listitem><para>Changes in lifestyle</para></listitem>
<listitem><para>Feelings of hopelessness, loss of interest in life</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Anxious, fearful, irritable behavior, emotional distress</para></listitem>
<listitem><para>Apathy, change in alertness, dull affect, withdrawal</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Nausea&mdash;side effect of medication or mucus production</para></listitem>
<listitem><para>Poor appetite, anorexia (emphysema)</para></listitem>
<listitem><para>Altered taste due to medications</para></listitem>
<listitem><para>Inability to eat because of respiratory distress</para></listitem>
<listitem><para>Persistent weight loss, decreased muscle mass or subcutaneous fat (emphysema)</para></listitem>
<listitem><para>Weight gain reflecting edema (bronchitis, prednisone use)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Poor skin turgor</para></listitem>
<listitem><para>Dependent edema</para></listitem>
<listitem><para>Diaphoresis</para></listitem>
<listitem><para>Abdominal palpation may reveal hepatomegaly</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">HYGIENE</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Decreased ability and increased need for assistance with ADLs</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Poor hygiene</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Chest tightness (asthma)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Variable levels of dyspnea, with insidious and progressive onset (predominant symptom in emphysema), especially on exertion</para></listitem>
<listitem><para>Seasonal or episodic occurrence of breathlessness (asthma); inability to breathe (asthma); chronic &ldquo;air hunger&rdquo; (COPD)</para></listitem>
<listitem><para>Use of oxygen at night or continuously</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Respirations:</emphasis></para>
<itemizedlist mark="&bull;">
<listitem><para>Usually rapid and may be shallow</para></listitem>
<listitem><para>Prolonged expiratory phase with grunting, pursed-lip breathing (emphysema)</para></listitem>
<listitem><para>Assumption of three-point (&ldquo;tripod&rdquo;) position for breathing&mdash;especially with acute exacerbation of chronic bronchitis</para></listitem>
<listitem><para>Use of accessory muscles for respiration, such as elevated shoulder girdle, retraction of supraclavicular fossae, flaring of nares</para></listitem>
<listitem><para>Chest may appear hyperinflated with increased AP diameter (barrel-shaped), minimal diaphragmatic movement</para></listitem></itemizedlist></listitem>
<listitem><para><emphasis role="bi">Breath sounds:</emphasis></para>
<itemizedlist mark="&bull;">
<listitem><para>May be faint with expiratory wheezes (emphysema)</para></listitem>
<listitem><para>Scattered, fine, or coarse moist crackles (bronchitis)</para></listitem></itemizedlist></listitem>
<listitem><para>Rhonchi, wheezing throughout lung fields on expiration and possibly during inspiration, progressing to diminished or absent breath sounds. Wheezing of COPD can vary from day to day or time of day. Widespread wheezing may be heard on inspiration or expiration. Laryngeal-level wheezing can be present without other abnormal breath sounds (asthma).</para></listitem>
<listitem><para><emphasis role="bi">Percussion:</emphasis> May reveal hyperresonance over lung fields (air-trapping with emphysema) or dullness over lung fields (consolidation, fluid, mucus)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Coughing:</emphasis></para></listitem>
<listitem><para>Intermittent cough episodes (note chronic cough is often first symptom of COPD)</para></listitem>
<listitem><para>Paroxysms of cough (asthma)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Cough may be productive or nonproductive.</para></listitem>
<listitem><para>Persistent cough with sputum production (gray, white, or yellow), which may be copious (chronic bronchitis).</para>
<itemizedlist mark="&bull;">
<listitem><para>Sputum production may be small, large, or intermittent.</para></listitem>
<listitem><para>Large volumes of sputum can accompany underlying bronchiectasis or bacterial exacerbations.</para></listitem></itemizedlist></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Skin color</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>May be normal despite abnormal gas exchange and rapid respiratory rate (moderate emphysema, known as &ldquo;pink puffers&rdquo;)</para></listitem>
<listitem><para>Pallor, with cyanosis of lips, nailbeds; overall duskiness; ruddy color (chronic bronchitis, sometimes called &ldquo;blue bloater&rdquo;)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Voice</emphasis></para></listitem>
<listitem><para>History of recurrent respiratory infections (asthma) (particularly during childhood)</para></listitem>
<listitem><para>Long-term exposure to indoor or outdoor air pollution or respiratory irritants (asthma)</para></listitem>
<listitem><para>Occupational or environmental exposures to smoke, dust, particulates, and fumes (e.g., chemical agents, coal burning and coal dust; biomass fuels [from organic materials such as wood and sawdust, animal dung, crop residues]) (asthma)</para></listitem>
<listitem><para>Smoking (cigarette, pipe, cigar, water pipe) (cigarette smoking is the most commonly occurring risk factor for COPD)</para></listitem>
<listitem><para>Concomitant chronic diseases frequently include cardiovascular disease, skeletal muscle dysfunction, metabolic syndrome, osteoporosis, depression, anxiety, and lung cancer</para></listitem>
<listitem><para>Familial and hereditary factors, that is, deficiency of a<subscript>1</subscript>-antitrypsin (emphysema)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Difficulty speaking sentences of more than four or five words at one time, loss of voice</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">SAFETY</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>History of allergic reactions or sensitivity to substances or environmental factors</para></listitem>
<listitem><para>Recent or recurrent infections</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Flushing, perspiration (asthma)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Decreased libido</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">SOCIAL INTERACTION</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Dependent relationship(s)</para></listitem>
<listitem><para>Insufficient support from or to partner or significant other (SO), lack of support systems</para></listitem>
<listitem><para>Prolonged disease or disability progression</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Inability to converse or maintain voice because of respiratory distress</para></listitem>
<listitem><para>Limited physical mobility</para></listitem>
<listitem><para>Neglectful relationships with other family members</para></listitem>
<listitem><para>Inability to perform or inattention to employment responsibilities, absenteeism, confirmed disability</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Use or misuse of respiratory drugs</para></listitem>
<listitem><para>Use of herbal supplements, such as astragalus, coleus, echinacea</para></listitem>
<listitem><para>Smoking or difficulty stopping smoking, chronic exposure to secondhand smoke, smoking substances other than tobacco</para></listitem>
<listitem><para>Regular use of alcohol</para></listitem>
<listitem><para>Failure to improve over long period of time</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Episodic or long-term assistance with shopping, transportation, self-care needs, homemaker or home maintenance tasks</para></listitem>
<listitem><para>Changes in medication and therapeutic treatments, use of supplemental oxygen, ventilator support; end-of-life issues</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0003s0069ta0065"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="4">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<colspec colnum="4" colname="4" align="left" colsep="0"/>
<spanspec spanname="1-3" namest="1" nameend="3"/>
<spanspec spanname="2-3" namest="2" nameend="3"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-3">
<para><emphasis role="strong">TEST
<?lb?>WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para><emphasis role="bi">Pulmonary function tests (PFTs)</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="6" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para>Numerous specific tests are included as part of the comprehensive PFT and fall within three categories: airway flow rates, lung volumes and capacities, and gas exchange.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Used to establish baseline lung function, evaluate dyspnea, detect pulmonary disease, and monitor effects of therapies used to treat respiratory disease. <emphasis>Note:</emphasis> The spirometer is also used as an exercise tool for improving lung function, for example, after surgery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Total lung capacity (TLC):</emphasis> Maximum amount of air that lungs can hold, measured at the top of an inhalation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased in obstructive lung disease.</para><para>Decreased in restrictive lung disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Residual volume (RV):</emphasis> Air remaining in the lungs after maximum exhalation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased in obstructive lung disease. Decreased in restrictive lung disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Vital capacity (VC):</emphasis> Maximum amount of air that can be exhaled during a normal or slow exhalation after fullest possible inhalation. Important measurement in assessing the client&rsquo;s ability to cough and protect airway.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Normal or decreased in obstructive lung disease.</para>
<para>Decreased in restrictive lung disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Spirometry testing, including FVC and FEV<subscript>1</subscript>:</emphasis> Measures the amount of air taken in (volume) and exhaled as a function of time (e.g., after deepest possible inhalation), which is also known as forced vital capacity (FVC).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased in obstructive lung disease. <emphasis>Note:</emphasis> Spirometry is required to make the diagnosis of COPD; presence of a postbronchodilator FEV<subscript>1</subscript>/FVC &lt;0.70 confirms presence of persistent airflow limitation. <emphasis>Note:</emphasis> Spirometry may be done at the same time as body plethysmography using the same equipment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Peak expiratory flow:</emphasis> Measures the speed of exhaling and lung constriction.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>People with asthma often use this test routinely to monitor their asthma control.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Plethysmography:</emphasis> Test that takes lung volume measurements (inhaling and exhaling). The test involves sitting in an airtight booth and blowing into a mouthpiece while a computer records measurements.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps diagnose respiratory diseases with similar symptoms, including asthma, pulmonary fibrosis, and chronic obstructive pulmonary disease (COPD).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para><emphasis role="bi">Bronchial provocation tests</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="1" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Exercise challenge:</emphasis> Baseline spirometry followed by exercise on a treadmill or bicycle to heart rate greater than 60% of predicted maximum, with monitoring of the ECG and oxyhemoglobin saturation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The diagnosis of asthma can be confirmed with the exercise challenge in a patient with history of exercise-induced symptoms (e.g., cough, wheeze, chest tightness or pain) (Sharma &amp; Gupta, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Inhalation challenge test:</emphasis> Measures how much and how quickly client can breathe air in and out before and after taking medicine.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determines whether bronchial tubes overreact to environmental factors (e.g., breathing cold air, highly humid air) or to inhaling certain substances (e.g., methacholine, histamine, or respiratory inhalers). This may support a diagnosis of asthma.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para><emphasis role="bi">Other diagnostic studies</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="1" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Chest x-ray:</emphasis> Evaluates organs or structures within the chest.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May reveal hyperinflation of lungs with increased AP diameter, flattened diaphragm, increased retrosternal air space, decreased vascular markings/bullae (emphysema), increased bronchovascular markings (bronchitis), and normal findings during periods of remission (asthma).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Pulse oximetry:</emphasis> Reflects oxygen saturation through measurement of the portion of light transmitted by oxygenated hemoglobin using a sensor attached to fingers/earlobes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Noninvasive measure of arterial blood oxygen and diffusion. Abnormally low levels (&lt;88%) indicate impaired gas exchange. ABG analysis is recommended when SaO<subscript>2</subscript> &lt; 80% (Kee et al, 2010).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para><emphasis role="bi">Arterial blood gases (ABGs):</emphasis> Measures oxygen and carbon dioxide levels to assess and monitor gas exchange.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Gas exchange abnormalities result in hypoxemia and hypercapnia. Gas transfer for oxygen and carbon dioxide worsens as disease progresses. Reduced ventilation may also be due to reduced ventilatory drive or increased dead space (Elbehairy et al, 2015). Most often PaO<subscript>2</subscript> is decreased and PaCO<subscript>2</subscript> is normal or increased in chronic bronchitis and emphysema but is often decreased in asthma; pH normal or acidotic, mild respiratory alkalosis secondary to hyperventilation (moderate emphysema or asthma) (Kee et al, 2010).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para><emphasis role="bi">Complete blood count (CBC) and differential:</emphasis> Provides baseline data about the hematologic system and yields information related to oxygen-carrying capacity and infection.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Findings are variable and can include increased hemoglobin (advanced emphysema) and increased eosinophils (asthma); elevated white blood cells (WBCs) in severe respiratory infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para><emphasis role="bi">Alpha-1 antitrypsin (AAT):</emphasis> A deficiency in AAT is a genetic trait considered to be a risk factor for the development of COPD. Performed when COPD develops in patients &lt; 45 years old, of Caucasian descent, with strong family history of COPD (Kee et al, 2010).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased levels are seen in early onset emphysema in adults; increased levels are present in acute and chronic inflammatory disorders.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para><emphasis role="bi">Allergy testing</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can identify allergic factors that may significantly contribute to asthma.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="2-3">
<para><emphasis role="bi">Histologic evaluation of airways</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Typically reveal infiltration with inflammatory cells, narrowing of airway lumina, bronchial and bronchiolar epithelial denudation, and mucus plugs (Sharma &amp; Gupta, 2016).</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0003s0072"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Maintain airway patency.</para></listitem>
<listitem><para>Assist with measures to facilitate gas exchange.</para></listitem>
<listitem><para>Enhance nutritional intake.</para></listitem>
<listitem><para>Prevent complications and slow progression of condition.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment regimen.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0003s0073"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Ventilation/oxygenation adequate to meet self-care needs.</para></listitem>
<listitem><para>Nutritional intake meeting caloric needs.</para></listitem>
<listitem><para>Infection treated or prevented.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0003s0069note0113"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Airway Clearance</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Obstructed airway: Chronic obstructive pulmonary disease; airway spasm; excessive mucus; retained secretions, exudate in the alveoli</para>
<para>Physiological factors: Asthma; infection</para>
<para>Environmental factors: Smoking, exposure to smoke; secondhand smoke</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Dyspnea, difficulty verbalizing</para>
<para>Alteration in respiratory rate or pattern</para>
<para>Diminished/adventitious breath [rales, crackles; wheezes, rhonchi]</para>
<para>Ineffective cough</para>
<para>Restlessness, cyanosis</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Airway Patency</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain patent airway with breath sounds clear or clearing.</para>
<para>Demonstrate behaviors to improve airway clearance.</para>
</note>
<note role="none" id="ch0003s0069note0114">
<table frame="top" id="ch0003s0069ta0066"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Airway Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate breath sounds. Note adventitious breath sounds such as wheezes, crackles, or rhonchi.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Some degree of bronchospasm is present with obstructions in airway and may or may not be manifested in adventitious breath sounds, such as scattered, moist crackles (bronchitis); faint sounds, with expiratory wheezes (emphysema); or absent breath sounds (severe asthma).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess and monitor respiratory rate. Note inspiratory-to-expiratory ratio.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachypnea is usually present to some degree and may be pronounced on admission, during stress, or during concurrent acute infectious process. Respirations may be shallow and rapid, with prolonged expiration in comparison to inspiration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note presence and degree of dyspnea, for example, reports of &ldquo;air hunger,&rdquo; restlessness, anxiety, respiratory distress, and use of accessory muscles. Use a 0 to 10 scale or American Thoracic Society&rsquo;s Grade of Breathlessness Scale to rate breathing difficulty. Ascertain precipitating factors when possible. Differentiate acute episode from exacerbation of chronic dyspnea.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Respiratory dysfunction is variable depending on the underlying process, for example, infection, allergic reaction, and the stage of chronicity in a client with established COPD. <emphasis>Note:</emphasis> Using a scale to rate dyspnea aids in quantifying and tracking changes in respiratory distress.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Check peak expiratory flow rate (PEFR) before and after treatments using peak flow meter (PFM).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitors effectiveness of drug therapy; identifies need for change in regimen in children age 5 and older. <emphasis>Note:</emphasis> Although peak flow monitoring in the emergency room (ER) may prove helpful for assessment of lung function and response to treatment, it&rsquo;s usually possible only if client is familiar with the technique because he or she already uses it at home (Volpe et al, 2011).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist client to maintain a comfortable position to facilitate breathing by elevating the head of bed, leaning on over-bed table, or sitting on edge of bed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevation of the head of the bed facilitates respiratory function using gravity; however, client in severe distress will seek the position that most eases breathing. Supporting arms and legs with table, pillows, and so on helps reduce muscle fatigue and can aid chest expansion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage and assist client with COPD to practice abdominal or pursed-lip breathing exercises.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides client with some means to cope with and control dyspnea and reduce air-trapping.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for persistent, hacking, or moist cough. Assist with measures to improve effectiveness of cough effort.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cough can be persistent but ineffective, especially if client is elderly, acutely ill, or debilitated. Coughing is most effective in an upright or in a head-down position after chest percussion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Increase fluid intake to 3000 mL/d within cardiac tolerance. Provide warm or tepid liquids. Recommend intake of fluids between, instead of during, meals.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hydration helps decrease the viscosity of secretions, facilitating expectoration. Using warm liquids may decrease bronchospasm. Fluids during meals can increase gastric distention and pressure on the diaphragm.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Avoid iced liquids, especially in children.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May trigger bronchospasm.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Limit exposure to environmental pollutants such as dust, smoke, and feather pillows according to individual situation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Precipitators of allergic type of respiratory reactions that can trigger or exacerbate onset of acute episode.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Use a spacer when administering metered-dose inhaler (MDI) and spacer with mask as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Most effective way of delivering maximum amount of medication. Mask should be used in child too young to seal lips around mouthpiece. <emphasis>Note:</emphasis> Spacer is not to be used with dry-powder inhalers.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The goal of <emphasis role="strong">pharmacologic management of COPD</emphasis> is to (1) reduce shortness of breath, (2) control coughing and wheezing, and (3) prevent exacerbations. Drug classes to accomplish this include short- and long-acting bronchodilators, corticosteroids, and phosphodiesterase-4 (PDE4) inhibitors.</para>
<para>The goal of <emphasis role="strong">pharmacologic management of asthma in teens and adults</emphasis> is to (1) prevent long-term symptoms that interfere with daily living, (2) maintain lung function, (3) allow the person to participate in all desired activities of daily living, (4) treat asthma attacks as they occur, and (5) prevent repeated asthma attacks. Treatment choices include long-term (controller) medicines used daily for persistent asthma and quick-relief medicines used as needed to provide rapid relief of symptoms during asthma attacks. Drug classes to accomplish these goals include inhaled, oral, or injected corticosteroids; short-acting and long-acting beta2-agonists; anticholinergics; leukotriene pathway modifiers; and (less commonly) mast cell stabilizers.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Short-acting bronchodilators including short-acting beta2-agonists (in inhaled, pill, liquid, and injectable forms) such as albuterol (Proventil, Ventolin), levalbuterol (Xopenex), and metaproterenol (Alupent)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These agents are first-line therapies for rapid symptomatic improvement of bronchoconstriction (often called &ldquo;rescue drugs&rdquo;). They relax smooth muscles and reduce local congestion, reducing airway spasm, wheezing, and mucus production. Inhalation by metered-dose inhaler (MDI) with a spacer is recommended, but medications may be nebulized in the event client has severe coughing or is too dyspneic to puff effectively.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Long-acting bronchodilators, including beta2-agonists (such as formoterol [Fordil] and salmeterol [Serevent]), anticholinergics (such as ipratropium [Atrovent], tiotropium [Spiriva]), or combination drugs (e.g., beta2-agonist and corticosteroid)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Long-acting bronchodilators are used to provide control&mdash;not quick relief&mdash;of asthma. They are often used in conjunction with inhaled steroids. <emphasis>Note:</emphasis> Inhaled anticholinergic agents are considered first-line drugs for clients with stable COPD because they have a longer duration of action with less toxicity potential while still providing the effective relief of the beta-agonists.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Methylxanthines, such as theophyllines (Elixophyllin:Theo-24, Uniphyl)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This class of bronchodilator can be used as a long-term controller for both asthma and COPD. It decreases the lungs&rsquo; response to irritants, improves breathing by increasing the strength of the diaphragm, stimulates the breathing control centers in the brain; it must be used regularly to prevent wheezing and shortness of breath. <emphasis>Note:</emphasis> Theophylline products are used with less frequency now and are not recommended as first-line drugs in older clients with COPD because of their potentially adverse cardiovascular effects.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anti-inflammatory drugs: <emphasis role="strong">oral or intravenous</emphasis> (IV) <emphasis role="strong">steroids,</emphasis> such as prednisone (Cordrol, Deltasone, Pred-Pak, Liquid Pred), methylprednisolone (Medrol), and dexa-methasone (Decadron), and <emphasis role="strong">inhaled steroids,</emphasis> such as fluticasone (Flovent HFA), budesonide (Pulmicort Flexhaler), beclomethasone (Qvar), ciclesonide (Alvesco), and mometasone (Asmanex)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Corticosteroids reduce local airway inflammation and edema by inhibiting effects of histamine and other mediators. <emphasis>Note:</emphasis> Anti-inflammatory drugs (particularly inhaled steroids) are the most important treatment for most people with asthma (Sharma &amp; Gupta, 2016). The aim of inhaled corticosteroids in COPD is to reduce exacerbation rates and slow decline in health status. Studies have shown benefits of systemic steroids in the management of COPD exacerbations, but these must be weighed against potential harmful side effects (e.g., thrush, hoarseness, and risk of pneumonia) (Yang et al, 2012).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Leukotriene antagonists, such as montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduce leukotriene activity to limit inflammatory response. In mild to moderate asthma, reduces need for inhaled beta2-agonists and systemic corticosteroids. Not effective in acute exacerbations because there is no bronchodilator effect.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Phosphodiesterase type 4 enzyme inhibitors, such as roflumilast (Daliresp)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases exacerbations in clients with severe COPD associated with chronic bronchitis; acts as an NSAID to decrease number of neutrophils and eosinophils in airway.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Mast cell stabilizers such as cromolyn (Intal) and nedocromil (Tilade)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These agents work to prevent allergy cells (mast cells) from breaking open and releasing chemicals that help cause inflammation. They make the airways less sensitive to many asthma triggers.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antimicrobials</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Various antimicrobials may be indicated for control of bacterial exacerbations of COPD, such as pneumonia. (Refer to CP: <link linkend="ch0003s0074">Pneumonia</link>.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Analgesics, cough suppressants, or antitussives, such as codeine and dextromethorphan products (Benylin DM, Comtrex, Novahistine)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Persistent, exhausting cough may need to be suppressed to conserve energy and permit client to rest. <emphasis>Note:</emphasis> Regular use of antitussives is not recommended for COPD clients as cough can have a significant protective effect.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide supplemental humidification, such as ultrasonic nebulizer and aerosol room humidifier.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Humidity helps reduce viscosity of secretions, facilitating expectoration, and may reduce or prevent formation of thick mucus plugs in bronchioles.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with respiratory treatments, such as spirometry and chest physiotherapy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Breathing exercises help enhance diffusion; aerosol or nebulizer medications can reduce bronchospasm and stimulate expectoration. Postural drainage and percussion enhance removal of excessive and sticky secretions and improve ventilation of lung segments in the setting of COPD (Leader, 2016a). <emphasis>Note:</emphasis> Chest physiotherapy may aggravate bronchospasm in asthmatics.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor and graph serial ABGs, pulse oximetry, and chest x-ray.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Establishes baseline for monitoring progression or regression of disease process and complications. <emphasis>Note:</emphasis> Pulse oximetry readings detect changes in saturation as they are happening, helping to identify trends possibly before client is symptomatic. However, the accuracy of pulse oximetry may be questioned if client has severe peripheral vasoconstriction.</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0069note0115"><title><emphasis role="strong">NURSING DIAGNOSIS: impaired Gas Exchange</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Ventilation-perfusion imbalance [retained secretions, bronchospasm, air-trapping]</para>
<para>Alveolar-capillary membrane changes [e.g., obstructive lung disease]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Dyspnea</para>
<para>Confusion, restlessness</para>
<para>Abnormal breathing (e.g., rate, rhythm, depth); tachycardia</para>
<para>Abnormal ABGs&mdash;hypoxia, hypercapnia</para>
<para>Nasal flaring; abnormal skin color (e.g., pale, dusky, cyanosis)</para>
<para>Reduced tolerance for activity</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Gas Exchange</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate improved ventilation and adequate oxygenation of tissues by ABGs within client&rsquo;s normal range and be free of symptoms of respiratory distress.</para>
<para>Participate in treatment regimen within level of ability and situation.</para>
</note>
<note role="none" id="ch0003s0069note0116">
<table frame="top" id="ch0003s0069ta0067"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Acid-Base Management: Respiratory Acidosis</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess respiratory rate and depth. Note use of accessory muscles, pursed-lip breathing, and inability to speak or converse.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in evaluating the degree of respiratory distress and chronicity of the disease process.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevate head of bed and assist client to assume position to ease work of breathing. Include periods of time in prone position as tolerated. Encourage deep, slow, or pursed-lip breathing as individually needed and tolerated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Oxygen delivery may be improved by upright position and breathing exercises to decrease airway collapse, dyspnea, and work of breathing. <emphasis>Note:</emphasis> Recent research supports use of prone position to increase PaO<subscript>2</subscript>.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess and routinely monitor skin and mucous membrane color.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cyanosis may be peripheral (noted in nailbeds) or central (noted around lips or earlobes). Duskiness and central cyanosis indicate advanced hypoxemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage expectoration of sputum; suction when indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Thick, tenacious, copious secretions are a major source of impaired gas exchange in small airways with COPD. Deep suctioning may be required when cough is ineffective for expectoration of secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate breath sounds, noting areas of decreased airflow and adventitious sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Breath sounds may be faint because of decreased airflow or areas of consolidation. Presence of wheezes may indicate bronchospasm or retained secretions. Scattered, moist crackles may indicate interstitial fluid or cardiac decompensation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Palpate chest for fremitus.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decrease of vibratory tremors suggests fluid collection or air-trapping.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor level of consciousness and mental status. Investigate changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Restlessness and anxiety are common manifestations of hypoxia. Worsening ABGs accompanied by confusion and somnolence are indicative of cerebral dysfunction due to hypoxemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate level of activity tolerance. Provide calm, quiet environment. Limit client&rsquo;s activity or encourage bedrest or chair rest during acute phase. Have client resume activity gradually and increase as individually tolerated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>During severe, acute, or refractory respiratory distress, client may be totally unable to perform basic self-care activities because of hypoxemia and dyspnea. Rest interspersed with care activities remains an important part of treatment regimen. An exercise program is aimed at improving aerobic capacity and functional performance, increasing endurance and strength without causing severe dyspnea (Corbridge &amp; Nyenhuis, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate sleep patterns; note reports of difficulties and whether client feels well rested. Provide quiet environment and group care and monitoring activities to allow periods of uninterrupted sleep. Limit stimulants such as caffeine. Encourage position of comfort.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Multiple external stimuli and presence of dyspnea and hypoxemia may prevent relaxation and inhibit sleep. Sleeping difficulties due to hypoxia related to apnea and nocturnal hypopnea may require referral to sleep specialist.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs and cardiac rhythm.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia, dysrhythmias, and changes in BP can reflect effect of systemic hypoxemia on cardiac function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor and graph serial ABGs and pulse oximetry.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>PaCO<subscript>2</subscript> is usually elevated in bronchitis and emphysema, and PaO<subscript>2</subscript> is generally decreased, so that hypoxia is present in a greater or lesser degree. <emphasis>Note:</emphasis> A &ldquo;normal&rdquo; or increased PaCO<subscript>2</subscript> signals impending respiratory failure for asthmatics.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer supplemental oxygen judiciously via nasal cannula, mask/nonrebreathing mask, high-flow oxygen systems, or mechanical ventilator. Titrate as indicated by ABG results and client tolerance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Used to correct and prevent worsening of hypoxemia, improve survival and quality of life. Supplemental oxygen can be provided during exacerbations only or as a long-term therapy. <emphasis>Note:</emphasis> High-flow oxygen therapy (providing flow rates of up to 60 L/min, high molecular humidity, and precise oxygen delivery) has been found to decrease the work of breathing and improve gas exchange. This can reduce the need for noninvasive ventilation and intubation in selected patient populations (Frat et al, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer antianxiety, sedative, or opioid agents, such as morphine, with caution.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used to reduce dyspnea by controlling anxiety and restlessness, which increases oxygen consumption and demand, exacerbating dyspnea. Must be monitored closely because depressive effect may lead to respiratory failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist with noninvasive (nasal or oronasal) intermittent positive-pressure ventilation (NIPPV) or intubation and institution of mechanical ventilation, as indicated; transfer to critical care unit depending on client directives.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Development of or impending respiratory failure requires prompt life-saving measures. NIPPV provides ventilatory support by means of positive pressure, typically through a nasal mask. It may be useful in the home setting as well to treat chronic respiratory failure or limit acute exacerbations in clients who can maintain spontaneous respiratory effort due to hypercapnia. NIPPV remains the standard of care for decreasing morbidity and mortality in patients hospitalized with exacerbation of COPD and acute respiratory failure (Elliot &amp; Nava, 2012).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prepare for additional referrals and interventions, such as to a pulmonary specialist, pulmonary rehabilitation program, or for surgical intervention, as appropriate.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be indicated to confirm diagnosis and optimize appropriate treatment. A multidisciplinary approach including education and exercise training may be helpful in improving client function and quality of life. Screened candidates&mdash;those with severe dyspnea or end-stage emphysema with FEV<subscript>1</subscript> less than 35% of the predicted value despite maximal medical therapy and with the ability to complete preoperative pulmonary rehabilitation programs&mdash;may benefit from lung volume reduction surgery (LVRS). This procedure removes ineffective lung tissue, allowing for better lung expansion, enhanced blood flow to healthy tissues (correction of ventilation-perfusion mismatch), and improved respiratory muscle efficiency.</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0069note0117"><title><emphasis role="strong">NURSING DIAGNOSIS: imbalanced Nutrition: less than body requirements</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Biological factors&mdash;dyspnea; medication side effects; anorexia, nausea or vomiting; fatigue</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Body weight 20% or more under ideal weight range; poor muscle tone</para>
<para>Reported altered taste sensation, aversion to eating, lack of interest in food</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Nutritional Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Display progressive weight gain toward goal as appropriate.</para>
<para>Demonstrate behaviors and lifestyle changes to regain and maintain appropriate weight.</para>
</note>
<note role="none" id="ch0003s0069note0118">
<table frame="top" id="ch0003s0069ta0068"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Nutrition Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess dietary habits, recent food intake. Note degree of difficulty with eating. Evaluate weight and body size or mass.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client in acute respiratory distress is often anorectic because of dyspnea, sputum production, and medication effects. In addition, many COPD clients habitually eat poorly even though respiratory insufficiency creates a hypermetabolic state with increased caloric needs. As a result, client often is admitted with some degree of malnutrition. People who have emphysema are often thin, with wasted musculature.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate bowel sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diminished or hypoactive bowel sounds may reflect decreased gastric motility and constipation (common complication) related to limited fluid intake, poor food choices, decreased activity, and hypoxemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Give frequent oral care, remove expectorated secretions promptly, and provide specific container for disposal of secretions and tissues.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Noxious tastes, smells, and sights are prime deterrents to appetite and can produce nausea and vomiting with increased respiratory difficulty.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage a rest period of 1 hour before and after meals. Provide frequent small feedings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps reduce fatigue during mealtime and provides opportunity to increase total caloric intake.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid gas-producing foods and carbonated beverages.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can produce abdominal distention, which hampers abdominal breathing and diaphragmatic movement and can increase dyspnea.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid very hot or very cold foods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Extremes in temperature can precipitate or aggravate coughing spasms.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Weigh, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in determining caloric needs, setting weight goal, and evaluating adequacy of nutritional plan. <emphasis>Note:</emphasis> Weight loss may continue in the client with COPD, despite adequate intake, as edema is resolving.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Consult dietitian or nutritional support team to provide easily digested, nutritionally balanced meals by mouth, supplemental or tube feedings, and parenteral nutrition. (Refer to CP: <link linkend="ch0006s0219">Total Nutritional Support: Parenteral/Enteral Feeding</link>.)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Method of feeding and caloric requirements are based on individual situation and specific needs to provide maximal nutrients with minimal client effort and energy expenditure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review serum albumin or prealbumin, transferrin, amino acid profile, iron, nitrogen balance studies, glucose, liver function studies, and electrolyte laboratory values as ordered.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determines deficits and monitors effectiveness of nutritional therapy.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer supplemental oxygen during meals, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Decreases dyspnea and increases energy for eating, enhancing intake.</para></entry></row></tbody></tgroup></table>
</note>

<note id="ch0003s0069note0119"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient knowledge of therapeutic regimen; complexity of therapeutic regimen</para>
<para>Perceived seriousness of condition, susceptibility, benefit</para>
<para>Economically disadvantaged; excessive demands</para>
<para>Family pattern of healthcare</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports difficulty with prescribed regimen</para>
<para>Failure to include treatment regimen in daily living or to take action to reduce risk factors</para>
<para>Unexpected acceleration of illness symptoms</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Management: Chronic Obstructive Pulmonary Disease/Asthma Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition and disease process and treatment.</para>
<para>Identify relationship of current signs and symptoms to the disease process and correlate these with causative factors.</para>
<para>Participate in problem-solving of factors interfering with integration of therapeutic regimen.</para>
<para>Initiate necessary lifestyle changes and participate in treatment regimen.</para>
</note>

<note role="none" id="ch0003s0069note0120"><table frame="top" id="ch0003s0069ta0069"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
</entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Teaching: Disease Process/Asthma Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Explain and reinforce explanations of individual disease process, including factors that lead to exacerbation episodes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding decreases anxiety and can lead to improved participation in treatment plan.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Review possible disease course as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>For children with asthma, symptoms may disappear during their teen years but may return in adulthood.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss respiratory medications, side effects, drug interactions, and adverse reactions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Frequently, these clients are on several respiratory drugs simultaneously that have similar side effects and potential drug interactions. It is important that the client/SO understand the difference between nuisance side effects (medication continued) and untoward or adverse side effects (medication possibly discontinued or dosage changed).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Demonstrate correct technique for using an MDI, such as how to hold it, pausing 2 to 5 minutes between puffs, and cleaning the inhaler.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Proper administration of drug enhances delivery and effectiveness. <emphasis>Note:</emphasis> When administering MDI, client begins inhalation and then presses canister. If MDI is used with a spacer, canister is pressed first then client takes two breaths.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Devise system for recording prescribed intermittent drug and inhaler usage.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of improper use or overdosage of pen (as necessary) medications, especially during acute exacerbations, when cognition may be impaired.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss dietary concerns such as food allergies or intolerances in client with asthma.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although rare, asthma can be triggered by foods. Person with both food allergies and asthma symptoms should be aware of how asthma might affect allergies and vice versa. Studies have found that the following foods and food additives can trigger an asthma attack: milk, eggs, peanuts, tree nuts, soy, wheat, fish, shellfish, and turkey (Groce, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review eating plan and ways to manage allergic responses (e.g., keeping rescue medication for asthma close at hand, along with epinephrine to treat inadvertent allergic reactions).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Having food allergy and asthma places people at greater risk for morbidity and mortality. With heightened awareness of the relationship between these two entities, management of food allergy and asthma and recognition of food-triggered asthma exacerbations may improve treatment and prevent severe reaction. Particular attention should be given to patients with both food allergies and asthma as these patients have been found to have a higher incidence of fatal or near-fatal anaphylaxis (Bird &amp; Burks, 2009; Wang &amp; Liu, 2011).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss use of herbals, especially when client is on multiple respiratory medications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Many interactions can occur between herbals and medications used to treat respiratory disorders. Although most herbals do not usually have dangerous side effects, effects can become dangerous or lethal if combined with other substances or when taken in larger doses. For example, herbs, such as ephedra, should be used only in very small doses and for a short time and could be dangerous when used with rescue medications (similarity of action in some ingredients).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Recommend avoidance of sedative antianxiety agents unless specifically prescribed and approved by physician treating respiratory condition.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although client may be nervous and feel the need for sedatives, these can depress respiratory drive and protective cough mechanisms. <emphasis>Note:</emphasis> These drugs may be used prophylactically when client is unable to avoid situations known to increase stress and trigger respiratory response.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Instruct asthmatic client/parent in use of peak flow meter (PMF) as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Peak flow level can drop before client exhibits any signs and symptoms of asthma after the &ldquo;first time&rdquo; the client is exposed to a trigger. Regular use of the peak flow meter may reduce the severity of the attack because of earlier intervention. However, trying to learn to use the PFM during an attack may not be possible.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage client to monitor own status with use of CAT (or similar numeric value grading score) to evaluate cough, mucus production, chest tightness, ability to rest, activity limitations, confidence, and energy levels) and to relay the information to healthcare providers.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This self-administered questionnaire helps the client monitor own respiratory status and changes that may be indicative of improvement or need for prompt medical evaluation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Recommend client/parent keep a daily or periodic diary of asthma symptoms as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helpful in determining effectiveness of treatment plan and need for adjustment as child ages. <emphasis>Note:</emphasis> Symptoms at night are an indication of nocturnal asthma or poor control even if condition appears stable during the day (Sawicki &amp; Haver, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Discuss self-management plan</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Avoidance of triggers and ways to control these factors in and around the home and school/work setting.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoiding triggers (e.g., known allergens, excessively dry or cold air, wind, temperature extremes, chemical products and fumes, tobacco smoking, and secondhand smoke) is important in the self-management of asthma and in the prevention of acute exacerbations.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Use of asthma symptom zones, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Zones may be divided into green (peak expiratory flow rate [PEFR] 80% to 100% and no breathing difficulty); yellow (PEFR 50% to 80% of baseline and some difficulty breathing, with wheezing and coughing), indicating need for a short-term change or increase in medication; and red (PEFR less than 50% baseline and does not respond to inhaled bronchodilators), which should be evaluated by care provider (Sawicki &amp; Haver, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review of breathing exercises, coughing effectively, and general conditioning exercises.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pursed-lip and abdominal or diaphragmatic breathing exercises strengthen muscles of respiration, help minimize collapse of small airways, and provide the individual with means to control dyspnea. Conditioning exercises, carried out regularly and soon after taking medications, can increase activity tolerance, muscle strength, and quality of life.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Importance of regular oral care and dental hygiene.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases bacterial growth in the mouth, which can lead to pulmonary infections.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Importance of avoiding people with active respiratory infections. Emphasize need for routine influenza and pneumococcal vaccinations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases exposure to and incidence of acquired acute upper respiratory infections (URIs). <emphasis>Note:</emphasis> The Global Initiative for Obstructive Lung Disease (GOLD) advises that getting vaccinated against the flu and pneumonia viruses helps reduce the risk of acute COPD exacerbation (Leader, 2016b).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Discuss and encourage family to form a detailed rescue plan for an acute asthmatic episode, including how to identify signs of an acute attack, how to use and monitor effects of rescue medications, and how, when, and where to obtain emergent care.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Child (if of age to self-manage) and/or caregiver must have the knowledge and capability of helping child in emergent asthma attack, including medications to use and contact numbers to obtain rapid assistance. Relief medications include short-acting bronchodilators, systemic corticosteroids, and ipratropium (Atrovent) to bring about relaxation of bronchi (Sawicki &amp; Haver, 2016; Sharma &amp; Gupta, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Recommend client wear medical identification device at all times.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides important information during emergency situations regarding client&rsquo;s condition, allergies, usual medications, emergency contacts, and provider information.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review the harmful effects of smoking in regard to client&rsquo;s particular condition. Strongly advise cessation of smoking by client and SO. Assess client&rsquo;s willingness and rationale for client&rsquo;s stated desire to quit. Assist client in devising a quit plan with information on QUITLINES, support groups, nicotine substitutes, and other resources that aid in smoking cessation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cessation of smoking may slow or halt progression of COPD. Even when client wants to stop smoking, support groups and medical monitoring may be needed. <emphasis>Note:</emphasis> Research studies suggest that side stream or secondhand smoke can be as detrimental as actually smoking.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide information about benefits of regular exercise while addressing individual activity limitations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Encourage preventive therapy for strenuous play or sports.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Having this knowledge can enable client and SO to make informed choices and decisions to reduce client&rsquo;s dyspnea, maximize functional level, perform most desired activities, and prevent complications. This may include alternating activities with rest periods to prevent fatigue, conserving energy during activities by pulling instead of pushing articles, sitting instead of standing while performing tasks, using pursed-lip breathing, side-lying position, and possible need for supplemental oxygen during sexual activity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss importance of regular medical follow-up care, when to notify healthcare professional of changes in condition, and periodic spirometry testing, chest x-rays, and sputum cultures.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use of a reliever (short-acting) inhaler 10 to 15 minutes before engaging in activities and repeating medication after 2 hours of continuous exercise or conclusion of activity as well as warm-up exercises and appropriate cool-down activities can prevent asthma symptoms.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Recommend obtaining vaccines as indicated (e.g., influenza, pneumonia).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can reduce serious illnesses of lower respiratory tract infections that can exacerbate COPD condition and increase risk of death (Wongsurakiat et al, 2004).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review oxygen requirements and dosage for client who is discharged on supplemental oxygen. Discuss safe use of oxygen and refer to supplier as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitoring disease process allows for alterations in therapeutic regimen to meet changing needs and may help prevent complications. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> It is recommended that children with asthma see their primary provider every 1 to 6 months, as the choice of medications varies depending on age of child (Sawicki &amp; Haver, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct client and SO in use of NIPPV as appropriate. Problem-solve possible side effects, and identify adverse signs and symptoms such as increased dyspnea, fatigue, daytime drowsiness, or headaches on awakening.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of misuse&mdash;too little or too much&mdash;and resultant complications. Promotes environmental and physical safety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide information and encourage participation in support groups sponsored by the American Lung Association and public health department.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>NIPPV may be used at night and periodically during day to decrease CO<subscript>2</subscript> level, improve quality of sleep, and enhance functional level during the day. Signs of increasing CO<subscript>2</subscript> level indicate need for more aggressive therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Refer for evaluation of home care if indicated. Provide a detailed plan of care and baseline physical assessment to home-care nurse as needed on discharge from acute care.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These clients and their SOs may experience anxiety, depression, and other reactions as they deal with a chronic disease that has an impact on their desired lifestyle. Support groups may be desired or needed to provide assistance, emotional support, and respite care.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist client and SO in making arrangements for access to emergency assistance, such as a buddy system for getting help quickly, special phone numbers, and &ldquo;panic button.&rdquo;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides for continuity of care. May help reduce frequency of hospitalization.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Facilitate discussion about healthcare directives and end-of-life wishes as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Client with chronic respiratory condition should have access to prompt assistance when needed. This is both necessary and psychologically comforting for self-management. Although many clients have an interest in discussing living wills, their wishes may be unspoken. In client with severe pulmonary disease, it is helpful to discuss preferences regarding aggressive treatment, home care only, hospitalization for comfort care, and full life support. It is useful also to discuss the goals of care, such as functional independence or continuation of life support in an extended-care nursing facility.</para></entry></row>
</tbody></tgroup></table>
</note>

<note id="ch0003s0069note0121">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Self-Care deficit, [specify]</emphasis>&mdash;fatigue, weakness, severe anxiety</para></listitem>
<listitem><para><emphasis role="bi">impaired Home Maintenance</emphasis>&mdash;condition impacting ability to maintain home; insufficient support system or finances; insufficient knowledge of neighborhood resources</para></listitem>
<listitem><para><emphasis role="bi">risk for Infection</emphasis>&mdash;chronic illness, inadequate vaccination; inadequate primary defenses (e.g., decrease in ciliary action, smoking); increased environmental exposure to pathogens</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0003s0074"><title><emphasis role="strong">PNEUMONIA</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Inflammation of the lung parenchyma associated with alveolar edema and congestion that impairs gas exchange</para></listitem>
<listitem><para>Common pathogens</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Viruses (CDC, 2016a)</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Common causative organisms include respiratory syncytial virus (RSV) (most common virus causing pneumonia in children): Influenza (most common virus causing pneumonia in adults) and human parainfluenza viruses (HPIVs); human metapneumovirus (HMV).</para></listitem>
<listitem><para>Viruses account for approximately half of all cases of community-acquired pneumonia (CAP).</para>
</listitem></orderedlist></listitem>
<listitem><para>Bacteria</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Divided into typical and atypical types.</para></listitem>
<listitem><para>Gram-positive <emphasis>Streptococcus pneumoniae, Haemophilus,</emphasis> and <emphasis>Staphylococcus</emphasis> most common typical bacterial causes.</para></listitem>
<listitem><para>Atypical bacterial causes include <emphasis>Legionella, mycoplasma,</emphasis> and <emphasis>chlamydia</emphasis> (National Heart, Lung, and Blood Institute [NHLB], 2016).</para>
</listitem></orderedlist></listitem>
<listitem><para>Fungus</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Most common causes <emphasis>Histoplasma capsulatum</emphasis> and <emphasis>Coccidioides immitis.</emphasis></para></listitem>
<listitem><para><emphasis>Pneumocystis jirovecii (formerly carinii)</emphasis> and cytomegalovirus (CMV) often occur in immunocompromised persons.</para>
</listitem></orderedlist></listitem>
<listitem><para>Chemical: Inflammation of lung tissue is from poisons or toxins. Many substances can cause chemical pneumonia, including liquids, gases, and small particles, such as dust or fumes. <emphasis>Note:</emphasis> Aspiration pneumonia is a type of chemical pneumonia.</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Types (NHLB, 2016)</emphasis></para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Community-acquired pneumonia (CAP): Commonly caused by <emphasis>S. pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae,</emphasis> RSV, and occasionally atypical pathogens.</para></listitem>
<listitem><para>Hospital-acquired pneumonia (HAP): Pneumonia that occurs 48 hours or more after hospital admission and that was not present at the time of admission.</para></listitem>
<listitem><para>Ventilator-assisted pneumonia (VAP): Often caused by <emphasis>Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus,</emphasis> and both methicillin-sensitive and methicillin-resistant <emphasis>S. aureus</emphasis> (MRSA).</para></listitem>
<listitem><para>Aspiration pneumonia: Caused by inhaling food, drink, vomit, or saliva from the mouth into the lungs. Aspiration may occur when something disturbs the normal gag reflex, such as a brain injury, swallowing problem, or excessive use of alcohol or drugs.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Primary pneumonia is caused by the client&rsquo;s inhalation or aspiration of a pathogen (microaspiration).</para></listitem>
<listitem><para>Secondary pneumonia ensues from lung damage caused by the spread of an infectious agent&mdash;bacterial, viral, or fungal&mdash;from another site in the body or from various chemical irritants (including gastric reflux and aspiration, smoke inhalation) or radiation therapy.</para></listitem>
<listitem><para>Risk factors: Comorbidities, such as heart or lung disease, compromised immune system, diabetes mellitus, liver or renal failure, malnutrition, smoking, previous antibiotic therapy, abdominal or thoracic surgical procedures, endotracheal intubation with mechanical ventilation.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: Hospital discharges in the United States attributed to pneumonia in 2013 were 674,000 (CDC, 2017a). Pneumonia accounts for 13% of all infectious illnesses in infants younger than 2 years. However, deaths occur almost exclusively in children with underlying conditions, such as chronic lung disease of prematurity, congenital heart disease, and immunosuppression (Bennett &amp; Domachowske, 2017).</para>
<para>Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections (ALRIs) in children. Studies conducted using molecular diagnostic assays confirmed that RSV accounts for over 50% of bronchiolitis (see <link linkend="ch0003s0074note0122">Glossary</link>) in young children requiring hospitalization</para>
</listitem>
<listitem><para>Mortality: In the United States, deaths attributed to pneumonia in 2014 were over 55,000 and listed as the eighth leading cause of death (Kochanek et al, 2016). Globally, pneumonia killed more than 900,000 children younger than age 5 years in 2015 and is the leading cause of death of infectious diseases in children worldwide (World Health Organization [WHO], 2016).</para></listitem>
<listitem><para>Cost:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>A study published in 2015 with data gleaned from 2007&mdash;2011 reported that pneumonia-related medical costs in the post-Prevnar-13 period (2011) showed a 22% decrease compared with the pre-Prevnar-13 period (2007&mdash;2009), although these differences were not statistically significant (Park et al, 2015).</para></listitem>
<listitem><para><emphasis role="strong">CAP:</emphasis> In the United States, annual healthcare costs associated with CAP range from $10.6 to $17 billion and are expected to grow as the proportion of older persons increases. Inpatient care accounts for more than 90% of pneumonia-related health expenditures (Kaysen &amp; Viera, 2016).</para>
</listitem></orderedlist></listitem></orderedlist></listitem></orderedlist>
<note id="ch0003s0074note0122"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Adventitious breath sounds:</emphasis> Abnormal breath sounds heard when listening to the chest. Adventitious sounds may include crackles or rales, rhonchi or wheezes, or pleural friction rubs.</para>
<para><emphasis role="strong">Bronchial breath sounds:</emphasis> A harsh or blowing quality, made by air moving in the large bronchi and barely, if at all, modified by the intervening lung; may be heard over a consolidated lung.</para>
<para><emphasis role="strong">Bronchiolitis <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject>:</emphasis> Involves inflammation of small airways, which is a common condition in children. Patients with bronchiolitis present with features close to pneumonia. Cough, sputum, fever, and pleuritic-type chest pain are some of the clinical features of bronchiolitis. Most of the cases have a mixture of features of pneumonia and obstructive airway disease. <emphasis>Note:</emphasis> It is not common for pneumonia to progress into bronchiolitis while the reverse is very common.</para>
<para><emphasis role="strong">Community-acquired pneumonia (CAP):</emphasis> Acquired outside healthcare organizations, including hospitals, nursing homes, and other long-term care facilities; includes the first 2 days of hospitalization.</para>
<para><emphasis role="strong">Crackles:</emphasis> An adventitious breath sound produced by air passing over airway secretions; a discontinuous sound, as opposed to a wheeze, which is continuous. Crackles are classified as &ldquo;fine&rdquo; or &ldquo;coarse&rdquo; and are also known as rales.</para>
<para><emphasis role="strong">Empyema:</emphasis> A condition in which pus and fluid from infected tissue collect in a body cavity; most often used to refer to collections of pus in the space around the lungs (pleural cavity).</para>
<para><emphasis role="strong">Fremitus:</emphasis> A palpable vibration, as felt by the hand placed on the chest during coughing or speaking.</para>
<para><emphasis role="strong">Healthcare-associated pneumonia (HCAP) (also may be called hospital-acquired pneumonia [HAP] or nosocomial pneumonia):</emphasis> Occurs 48 hours or longer after admission to a facility.</para>
<para><emphasis role="strong">Percussion:</emphasis> An assessment method in which the surface of the body is struck with the fingertips to obtain sounds that can be heard or vibrations that can be felt. It can determine the position, size, and consistency of an internal organ. It is done over the chest to determine the presence of normal air content in the lungs.</para>
<para><emphasis role="strong">Pleural effusion:</emphasis> Accumulation of fluid in the space between the membrane encasing the lung and lining the thoracic cavity.</para>
<para><emphasis role="strong">Pleural friction rub:</emphasis> An abrasive sound that is synchronous with the respiratory movements, made by the rubbing together of two acutely inflamed serous surfaces, as in acute pleurisy.</para>
<para><emphasis role="strong">Respiratory syncytial virus (RSV):</emphasis> A highly contagious virus and the leading cause of lower respiratory disease (e.g., bronchiolitis and pneumonia) in children ages 2 and under. RSV infection is primarily a disease of winter or early spring, with waves of illness sweeping through a community. There is currently no vaccine against RSV.</para>
</note>
<sect2 id="ch0003s0075"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Most clients are treated as outpatients in community settings.</para>
<para>Persons at higher risk (such as children under 5, those older than 65, and persons with other chronic conditions such as chronic obstructive pulmonary disease [COPD], diabetes, cancer, and congestive heart failure) are treated in the hospital, as are those already hospitalized for other reasons and who have developed healthcare-acquired pneumonia.</para>
</sect2>
<sect2 id="ch0003s0076"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0003s0089">Acute lung injury/acute respiratory distress syndrome</link></para>
<para><link linkend="ch0013s0328">Acquired immunodeficiency syndrome (AIDS)</link></para>
<para><link linkend="ch0003s0069">Chronic obstructive pulmonary disease (COPD) and asthma</link></para>
<para><link linkend="ch0014s0384">Pediatric considerations</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0003s0094">Respiratory failure/ventilatory assistance</link></para>
<para><link linkend="ch0013s0318">Sepsis/septic shock</link></para>
<table frame="top" id="ch0003s0074ta0070"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION
<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Fatigue, weakness</para></listitem>
<listitem><para>Insomnia</para></listitem>
<listitem><para>Prolonged immobility and bedrest</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Lethargy</para></listitem>
<listitem><para>Decreased tolerance to activity</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>History of recent or chronic heart failure (HF)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Tachycardia</para></listitem>
<listitem><para>Flushed appearance, pallor, central cyanosis</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Loss of appetite</para></listitem>
<listitem><para>Nausea, vomiting</para></listitem>
<listitem><para>May be receiving intestinal, gastric feedings</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Cachectic appearance (malnutrition)</para></listitem>
<listitem><para>Distended abdomen</para></listitem>
<listitem><para>Hyperactive bowel sounds</para></listitem>
<listitem><para>Dry skin with poor turgor</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Changes in mentation, such as confusion, somnolence</para></listitem>
<listitem><para>Changes in behavior, such as irritability, restlessness, lethargy</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Headache</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Substernal chest pain (influenza)</para></listitem>
<listitem><para>Chest, rib and/or back pain (pleuritic) aggravated by cough</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Splinting, guarding over affected area</para></listitem>
<listitem><para>Position&mdash;commonly lies on affected side to restrict movement</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Progressive or sudden shortness of breath</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Respirations:</emphasis> Tachypnea, shallow grunting respirations</para></listitem>
<listitem><para>Use of accessory muscles, nasal flaring</para></listitem>
<listitem><para><emphasis role="bi">Breath sounds</emphasis> are diminished or absent over involved area</para>
<itemizedlist mark="&bull;">
<listitem><para>Bronchial breath sounds over area(s) of consolidation</para></listitem>
<listitem><para>Coarse inspiratory crackles</para></listitem>
<listitem><para>Pleural friction rub</para></listitem></itemizedlist></listitem>
<listitem><para><emphasis role="bi">Color:</emphasis> Pallor or cyanosis of lips or nailbeds</para></listitem>
<listitem><para><emphasis role="bi">Percussion:</emphasis> Dull over consolidated areas</para></listitem>
<listitem><para><emphasis role="bi">Fremitus:</emphasis> Tactile and vocal, gradually increases with consolidation</para></listitem>
<listitem><para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Signs of respiratory distress (Bradley et al, 2011)</para>
<itemizedlist mark="&bull;">
<listitem><para>Tachypnea&mdash;respiratory rate, breaths/min</para>
<itemizedlist mark="&bull;">
<listitem><para>Age 0 to 2 months: &gt;60</para></listitem>
<listitem><para>Age 2 to 12 months: &gt;50</para></listitem>
<listitem><para>Age 1 to 5 years: &gt;40</para></listitem>
<listitem><para>Age 5 years: &gt;20</para></listitem></itemizedlist></listitem>
<listitem><para>Dyspnea</para></listitem>
<listitem><para>Retractions (suprasternal, intercostal, or subcostal); nasal flaring</para></listitem>
<listitem><para>Grunting</para></listitem>
<listitem><para>Apnea</para></listitem></itemizedlist></listitem>
<listitem><para>Altered mental status</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Cough: dry and hacking (initially), progressing to productive cough</para></listitem>
<listitem><para>Presence of tracheostomy, endotracheal tube; current treatment with mechanical ventilator</para></listitem>
<listitem><para>History of recurrent or chronic upper respiratory infections (URIs), tuberculosis, COPD, cigarette smoking</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Sputum: Scanty or copious; pink, rusty, or purulent (green, yellow, or white)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Recurrent chills</para></listitem>
<listitem><para>History of altered immune system, such as systemic lupus erythematosus (SLE), AIDS, active malignancies, neurological disease, HF, diabetes, steroid or chemotherapy use; institutionalization, general debilitation</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Diaphoresis</para></listitem>
<listitem><para>Shaking</para></listitem>
<listitem><para>Fever</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Recent surgery, chronic alcohol use or long history of alcoholism, intravenous (IV) drug therapy or abuse, chemotherapy or other immunosuppressive therapy</para></listitem>
<listitem><para>Use of herbal supplements, such as garlic, ginkgo, licorice, onion, turmeric, horehound, marshmallow, mullein, wild cherry bark, astragalus, echinacea, elderberry, goldenseal, Oregon grape root</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Assistance with self-care, homemaker tasks</para></listitem>
<listitem><para>Supplemental oxygen, especially if recovery is prolonged or other predisposing condition exists</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0003s0074ta0071"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST
<?lb?>WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry>
</row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Evaluates organs and structures within the chest. Confirms the diagnosis of pneumonia.</para></listitem>
<listitem><para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Chest x-rays are not routinely done for children but should be obtained in child with suspected or documented hypoxemia or significant respiratory distress.</para></listitem>
<listitem><para><emphasis role="bi">Ultrasonography:</emphasis> Uses ultrasonic waves to visualize internal organs for possible pathology.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para>Confirms diagnosis of pneumonia. Identifies structural distribution of pneumonia, such as lobar or bronchial. May show scattered or localized infiltration (bacterial) or diffuse and extensive nodular infiltrates (more often viral). In <emphasis>Mycoplasma pneumoniae,</emphasis> chest x-ray may be clear.</para>
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Recent studies have found that point-of-care ultrasound imaging can diagnose pneumonia in children and young adults with higher specificity than x-ray (Shah et al, 2013).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Complete blood count (CBC):</emphasis> Battery of screening tests that typically includes hemoglobin (Hgb); hematocrit (Hct); red blood cell (RBC) count, morphology, indices, and distribution width index; platelet count and size; white blood cell (WBC) count and differential. Provides baseline data about the hematologic system and yields information related to oxygen-carrying capacity and infection.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Leukocytosis with a left shift is usually present in bacterial pneumonia, although a low WBC count may be present in viral infection, immunosuppressed conditions such as AIDS, and overwhelming bacterial pneumonia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject>&nbsp;<emphasis role="bi">Blood cultures:</emphasis> Determines presence of infection.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identification of specific organism useful in choice of therapy for child requiring hospitalization for presumed bacterial pneumonia or in outpatient setting for children receiving antibiotic therapy who demonstrate progressive deterioration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ASSOCIATED TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Sputum studies:</emphasis> Often necessary to determine the etiology of pneumonia, type of infecting organisms, and sensitivity to antibiotics. Serial sputum studies may be necessary to determine response to treatment.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>More than one type of organism may be present. Fifty percent of pneumonia cases are believed to be caused by viruses and tend to result in less severe illness than pneumonias triggered by bacteria. Mycoplasma pneumonia is one of the most common causes of atypical pneumonia. Opportunistic pneumonias (organisms causing disease in a host whose resistance to fight infection is diminished) consist of <emphasis>Pneumocystis carinii,</emphasis> cytomegalovirus, and tuberculosis (TB) (Benito et al, 2012). <emphasis>Note:</emphasis> Sputum cultures may not identify all offending organisms. Blood cultures may show transient bacteremia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="none"><listitem><para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject>&nbsp;<emphasis role="bi">RSV washing</emphasis>: Detects virus that is being shed in the respiratory/nasal secretions of an infected child usually between age 6 months to 2 years.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rapid results help guide treatment options and possible need for further testing if results are negative in a symptomatic child.</para></entry>
</row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Serologic studies (viral or Legionella titers, cold agglutinins):</emphasis> Assist in differential diagnosis of specific organism.</para></listitem>
<listitem><para><emphasis role="bi">Arterial blood gases (ABGs):</emphasis> Measure oxygen and carbon dioxide levels to rule out hypoxemia or hypercapnia.</para></listitem>
<listitem><para><emphasis role="bi">Pulse oximetry:</emphasis> Noninvasive measure of arterial blood oxygen diffusion and saturation.</para></listitem>
<listitem><para><emphasis role="bi">Bronchoscopy:</emphasis> Insertion of a flexible scope into the airways allows direct visualization of tracheobronchial tree for abnormalities and to obtain sputum for cytological examination.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provide information on the specific organism causing the pneumonia or can rule out other diseases.</para>
<para>Abnormalities may be present, depending on extent of lung involvement and underlying lung disease.</para>
<para>The percentage expressed is the ratio of oxygen to Hgb. Pulse oximetry less than 90% indicates hypoxia. Abnormally low levels (&lt;88%) indicate impaired gas exchange and impending respiratory failure.</para>
<para>May be both diagnostic (qualitative cultures) and therapeutic (reexpansion of lung segment).</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0003s0077"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Maintain or improve respiratory function.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Support recuperative process.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0003s0078"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Ventilation and oxygenation adequate for individual needs.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Lifestyle changes identified and initiated to prevent recurrence.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0003s0074note0123"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Airway Clearance</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Infection&mdash;[tracheal bronchial inflammation, edema formation]; underlying chronic obstructive pulmonary disease</para>
<para>Exudate in alveoli</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Changes in respiratory rate</para>
<para>Diminished/adventitious breath sounds</para>
<para>Dyspnea, cyanosis</para>
<para>Ineffective cough</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Airway Patency</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify and demonstrate behaviors to achieve airway clearance.</para>
<para>Display patent airway with breath sounds clearing and absence of dyspnea and cyanosis.</para>
</note>

<note role="none" id="ch0003s0074note0124">
<table frame="top" id="ch0003s0074ta0072"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Airway Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess rate and depth of respirations and chest movement.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachypnea, shallow respirations, and asymmetric chest movement are frequently present because of discomfort of moving chest wall or fluid in lung.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate lung fields, noting areas of decreased or absent airflow and adventitious breath sounds, such as crackles and wheezes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased airflow occurs in areas consolidated with fluid. Bronchial breath sounds (normal over bronchus) can also occur in consolidated areas. Crackles, rhonchi, and wheezes are heard on inspiration and expiration in response to fluid accumulation, thick secretions, and airway spasm or obstruction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor for signs of respiratory failure, for example, cyanosis and severe tachypnea.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>When pneumonia is severe, the client may require endotracheal intubation and mechanical ventilation to keep airways clear.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevate head of bed; change position frequently.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keeping the head elevated lowers diaphragm, promoting chest expansion, aeration of lung segments, and mobilization of secretions to keep the airway clear.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client with frequent deep-breathing exercises. Demonstrate and help client, as needed; learn to perform activity, such as splinting chest and effective coughing while in upright position.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Deep breathing facilitates maximum expansion of the lungs and smaller airways. Coughing is a natural self-cleaning mechanism, assisting the cilia to maintain patent airways. Splinting reduces chest discomfort, and an upright position favors deeper, more forceful cough effort. <emphasis>Note:</emphasis> Cough associated with pneumonias may last days, weeks, or even months.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Perform treatments between meals and limit fluids when appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Coordination of treatments, schedules, and oral intake reduces likelihood of vomiting with coughing and expectorations.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suction, only as needed, for example, oxygen desaturation related to airway secretions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stimulates cough or mechanically clears airway in client who is unable to do so because of ineffective cough or decreased level of consciousness.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Force fluids to at least 2500 mL per day, unless contraindicated, as in HF. Offer warm, rather than cold, fluids.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluids, especially warm liquids, aid in mobilization and expectoration of secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist with and monitor effects of nebulizer treatments and other respiratory physiotherapy, such as incentive spirometer, intermittent positive-pressure breathing (IPPB), percussion, and postural drainage.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Facilitates liquefaction and removal of secretions. <emphasis>Note:</emphasis> Postural drainage may not be effective in interstitial pneumonias or those causing alveolar exudates or destruction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer medications, as indicated, for example, expectorants, bronchodilators, and analgesics.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in reduction of bronchospasm and mobilization of secretions. Analgesics are given to improve cough effort by reducing discomfort but should be used cautiously because they can decrease cough effort and depress respirations.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide supplemental fluids such as IV, humidified oxygen, and room humidification.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluids are required to replace losses, including insensible losses, and aid in mobilization of secretions. <emphasis>Note:</emphasis> Some studies indicate that room humidification has been found to provide minimal benefit and is thought to increase the risk of transmitting infection.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Monitor serial chest x-rays, ABGs, and pulse oximetry readings. (Refer to ND: <link linkend="ch0003s0074note0125">impaired Gas Exchange</link>, following.)</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Follows progress and effects of disease process and therapeutic regimen and facilitates necessary alterations in therapy.</para></entry></row></tbody></tgroup></table>
</note>

<note id="ch0003s0074note0125"><title><emphasis role="strong">NURSING DIAGNOSIS: impaired Gas Exchange</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Alveolar-capillary membrane changes [such as in acute respiratory distress]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Abnormal breathing pattern (e.g., rate, rhythm, depth); nasal flaring</para>
<para>Dyspnea, abnormal skin color (e.g., pale, dusky)</para>
<para>Tachycardia; dysrhythmias</para>
<para>Restlessness; confusion; irritability</para>
<para>Abnormal arterial blood gases (ABGs)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Gas Exchange</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate improved ventilation and oxygenation of tissues by ABGs within client&rsquo;s acceptable range and absence of symptoms of respiratory distress.</para>
<para>Participate in treatment regimen (e.g., breathing exercises, effective coughing, use of oxygen) within level of ability or situation.</para>
</note>
<note role="none" id="ch0003s0074note0126">
<table frame="top" id="ch0003s0074ta0073"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Respiratory Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess respiratory rate, depth, and ease.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Manifestations of respiratory distress are dependent on, and indicative of, the degree of lung involvement and underlying general health status.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe color of skin, mucous membranes, and nailbeds, noting presence of peripheral cyanosis (nailbeds) or central cyanosis (circumoral).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cyanosis of nailbeds may represent vasoconstriction or the body&rsquo;s response to fever or chills; however, cyanosis of earlobes, mucous membranes, and skin around the mouth (&ldquo;warm membranes&rdquo;) is indicative of systemic hypoxemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess mental status.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Restlessness, irritation, confusion, and somnolence may reflect hypoxemia or decreased cerebral oxygenation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor heart rate and rhythm.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia is usually present because of fever and dehydration but may represent a response to hypoxemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor body temperature, as indicated. Assist with comfort measures to reduce fever and chills, such as addition or removal of bedcovers, comfortable room temperature, and tepid or cool water sponge bath.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>High fever (common in bacterial pneumonia and influenza) greatly increases metabolic demands and oxygen consumption and alters cellular oxygenation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain bedrest. Encourage use of relaxation techniques and diversional activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces exhaustion (as well as oxygen consumption and demands) to facilitate resolution of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevate head and encourage frequent position changes, deep breathing, and effective coughing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These measures promote maximal inspiration and enhance expectoration of secretions to improve ventilation. (Refer to ND: <link linkend="ch0003s0074note0123">ineffective Airway Clearance</link>.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess level of anxiety. Encourage verbalization of concerns and feelings. Answer questions honestly. Visit frequently and arrange for significant other (SO) and visitors to stay with client as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anxiety is a manifestation of psychological concerns and physiological responses to hypoxia. Providing reassurance and enhancing sense of security can reduce the psychological component, thereby decreasing oxygen demand and adverse physiological responses.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for deterioration in condition, noting hypotension, copious amounts of pink or bloody sputum, pallor, cyanosis, change in level of consciousness, severe dyspnea, and restlessness.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Shock and pulmonary edema are the most common causes of death in pneumonia and require immediate medical intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor ABGs and pulse oximetry.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies problems, such as ventilatory failure; follows progress of disease process or improvement; and facilitates alterations in pulmonary therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Oxygen Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer oxygen therapy by appropriate means, for example, nasal prongs, mask.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The purpose of oxygen therapy is to maintain PaO<subscript>2</subscript> above 60 mm Hg, or greater than 90% O<subscript>2</subscript> saturation. Oxygen is administered by the method that provides appropriate delivery within the client&rsquo;s tolerance.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prepare for and transfer to critical care unit if indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Intubation and mechanical ventilation may be required in the event of severe respiratory insufficiency. (Refer to CP: <link linkend="ch0003s0094">Respiratory Failure/Ventilatory Assistance</link>.)</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0074note0127"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for Infection [spread]</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Inadequate primary defenses&mdash;decreased ciliary action, stasis of body fluids [respiratory secretions]</para>
<para>Inadequate secondary defenses&mdash;[presence of existing infection], immunosuppression; chronic disease, malnutrition; inadequate vaccination</para>
<para>[Exposure to multiple healthcare workers]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Infection Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Achieve timely resolution of current infection without complications.</para>
<para><emphasis role="strong">Risk Control: Infectious Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify interventions to prevent and reduce risk and spread of a secondary infection.</para>
</note>
<note role="none" id="ch0003s0074note0128"><table frame="top" id="ch0003s0074ta0074"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Infection Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs closely, especially during initiation of therapy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>During this period, potentially fatal complications, such as hypotension or shock, may develop.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct client concerning the disposition of secretions (e.g., raising and expectorating versus swallowing) and reporting changes in color, amount, and odor of secretions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although client may find expectoration offensive and attempt to limit or avoid it, it is essential that sputum be disposed of in a safe manner. Changes in characteristics of sputum reflect resolution of pneumonia or development of secondary infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Demonstrate and encourage good hand-washing technique.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Effective means of reducing spread or acquisition of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Change position frequently and provide good pulmonary toilet.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes expectoration, clearing of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Perform proper suctioning technique for ventilated clients as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Secretions that accumulate below and above the endotracheal (ET) tube cuff are an ideal growth medium for pathogens. Numerous studies are currently being carried out to determine what factors influence the incidence of VAP. Results are inconclusive, but efforts are continuing to find a way to reduce infections and improve patient outcomes. This includes actions regarding suctioning (e.g., timing and type of suctioning [closed or open] and types of ET tubes). It also involves specific care interventions (e.g., raising or lowering the head of bed, subglottic suctioning, use of special mouthwashes and antibiotics) (Damas et al, 2015; Klompas, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Limit visitors as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces likelihood of exposure to other infectious pathogens.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Institute isolation precautions as individually appropriate (e.g., masks and gloves, possibly gowns) during client contact.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Depending on type of infection, response to antibiotics, client&rsquo;s general health, and development of complications, isolation techniques may be instituted to prevent spread and protect client from other infectious processes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> RSV (which is highly contagious) and certain other infective agents that cause pneumonia in children require that caregivers, family, and visitors be protected.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage adequate rest balanced with moderate activity. Promote adequate nutritional intake.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Facilitates healing process and enhances natural resistance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor effectiveness of antimicrobial therapy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Signs of improvement in condition should occur within 24 to 48 hours.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate sudden changes or deterioration in condition, such as increasing chest pain, extra heart sounds, altered sensorium, recurring fever, and changes in sputum characteristics.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Delayed recovery or increase in severity of symptoms suggests resistance to antibiotics or secondary infection. Complications affecting any organ system include lung abscess, empyema, bacteremia, pericarditis, endocarditis, meningitis, encephalitis, and superinfections.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer antimicrobials, as indicated, by results of sputum and blood cultures, for example, <emphasis role="bi">macrolides</emphasis> such as azithromycin (Zithromax), clarithromycin (Biaxin), and erythromycin (E-Mycin); <emphasis role="bi">penicillin combinations,</emphasis> for example, amoxicillin (Amoxil) and clavulanate (Augmentin); <emphasis role="bi">tetracyclines,</emphasis> for example, doxycycline (Doryx, Bio-Tab) and minocycline (Minocin); <emphasis role="bi">cephalosporins,</emphasis> for example, cefepime (Maxipime) and cefuroxime (Kefurox, Zinacef); <emphasis role="bi">ketolides,</emphasis> for example, telithromycin (KETEK); and <emphasis role="bi">oxazolidinones,</emphasis> for example, linezolid (Zyvox).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These drugs are used to combat most of the microbial pneumonias. Combinations of drugs can be used when the pneumonia is a result of mixed organisms.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Provide influenza antiviral therapy (e.g., oseltamivir [Tamiflu]), as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Should be administered as soon as possible to child with moderate to severe CAP consistent with influenza virus infection during widespread local circulation of influenza viruses (Bradley et al, 2011).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prepare for and assist with additional diagnostic studies, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Fiberoptic bronchoscopy may be done for clients who do not respond in a reasonable amount of time to antimicrobial therapy to clarify diagnosis and therapeutic needs.</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0074note0129"><title><emphasis role="strong">NURSING DIAGNOSIS: Activity Intolerance</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Imbalance between oxygen supply and demand</para>
<para>General weakness</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Report of weakness, fatigue, exertional dyspnea</para>
<para>Tachypnea</para>
<para>Abnormal heart rate response to activity</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Activity Tolerance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report and demonstrate a measurable increase in tolerance to activity with absence of dyspnea and excessive fatigue, with vital signs within client&rsquo;s acceptable range.</para>
</note>
<note role="none" id="ch0003s0074note0130"><table frame="top" id="ch0003s0074ta0075"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Energy Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate client&rsquo;s response to activity. Note reports of dyspnea, increased weakness and fatigue; changes in oxygen saturation (O<subscript>2</subscript> sat, per pulse oximetry) and vital signs during and after activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establishes client&rsquo;s capabilities and needs and facilitates choice of interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide a quiet environment and limit visitors during acute phase, as indicated. Encourage use of stress management and diversional activities as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces stress and excess stimulation, promoting rest.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain importance of rest in treatment plan and necessity for balancing activities with rest.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bed and chair rest is maintained during acute phase to decrease metabolic demands, thus conserving energy for healing. Activity restrictions thereafter are determined by individual client response to activity and resolution of respiratory insufficiency.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client to assume comfortable position for rest and sleep.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may be comfortable with head of bed elevated, sleeping in a chair, or leaning forward on over-bed table with pillow support.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist with self-care activities as necessary. Provide for progressive increase in activities during recovery phase. Reduce intensity level or postpone activities that cause undesired physiological changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Minimizes exhaustion and helps balance oxygen supply and demand.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide and monitor response to supplemental oxygen, when indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>If oxygen saturation (per pulse oximetry) drops with client activity during acute or early recovery phase, oxygen may be needed during activities.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to physical/occupational therapy, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be needed/desired to develop individually appropriate exercise/progressive activity plans.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0074note0131"><title><emphasis role="strong">NURSING DIAGNOSIS: acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Biological injury agent (e.g., infection; [inflammation of lung parenchyma, cellular reactions to circulating toxins]); [persistent coughing]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Verbal/coded report [pleuritic chest pain, headache, muscle or joint pain]</para>
<para>Guarding behavior; positioning to ease pain</para>
<para>Expressive behavior&mdash;restlessness</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize relief or control of pain.</para>
<para>Demonstrate relaxed manner, resting, sleeping, and engaging in activity appropriately.</para>
</note>
<note role="none" id="ch0003s0074note0132"><table frame="top" id="ch0003s0074ta0076"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine pain characteristics, such as sharp, constant, and stabbing. Investigate changes in character, location, and intensity of pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Chest pain, usually present to some degree with pneumonia, may also herald the onset of complications of pneumonia, such as pericarditis and endocarditis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in heart rate or blood pressure (BP) may indicate that client is experiencing pain, especially when other reasons for changes in vital signs have been ruled out.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide comfort measures, such as back rubs, change of position, and quiet music or conversation. Encourage use of relaxation and breathing exercises.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nonanalgesic measures administered with a gentle touch can lessen discomfort and augment therapeutic effects of analgesics. Client involvement in pain control measures promotes independence and enhances sense of well-being.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Offer frequent oral hygiene.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Mouth breathing and oxygen therapy can irritate and dry out mucous membranes, potentiating general discomfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct and assist client in chest-splinting techniques during coughing episodes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in control of chest discomfort while enhancing effectiveness of cough effort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top"/></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer analgesics and antitussives, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>These medications may be used to suppress body discomforts (e.g., headache, chest/rib pain) and paroxysmal cough, thus enhancing general comfort and rest.</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0074note0133"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for deficient Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Excessive losses through normal routes [e.g., fever, profuse diaphoresis, mouth breathing, hyperventilation]</para>
<para>Factors influencing fluid needs [e.g., hypermetabolic state]; extremes of age or weight; deviations affecting intake of fluids</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Balance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate fluid balance evidenced by individually appropriate parameters, such as moist mucous membranes, good skin turgor, prompt capillary refill, and stable vital signs.</para>
</note>
<note role="none" id="ch0003s0074note0134"><table frame="top" id="ch0003s0074ta0077"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Fluid Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess vital sign changes, such as increased temperature, prolonged fever, tachycardia, and orthostatic hypotension.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated temperature or prolonged fever increases metabolic rate and fluid loss through evaporation. Orthostatic BP changes and increasing tachycardia may indicate systemic fluid deficit.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess skin turgor, moisture of mucous membranes&mdash;lips and tongue.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indirect indicators of adequacy of fluid volume, although oral mucous membranes may be dry because of mouth breathing and supplemental oxygen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note reports of nausea and vomiting.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Presence of these symptoms reduces oral intake.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor intake and output (I&amp;O), noting color and character of urine. Calculate fluid balance. Be aware of insensible losses. Weigh as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about adequacy of fluid volume and replacement needs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Force fluids to at least 3000 mL per day or as individually appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Meets basic fluid needs, reducing risk of dehydration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Ensure child is receiving daily maintenance fluids, in addition to covering fluid losses caused by current conditions (e.g., fever, inability to take oral fluids, vomiting).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Basic fluid needs are determined by child&rsquo;s weight&mdash;up to 10 kg: 100 mL/kg/24 hr; 10 to 20 kg: 50 mL/kg/24 hr; more than 20 kg: 20 mL/24 hr. Note that the smaller the child, the greater the percentage of weight is water.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer medications, as indicated, such as antipyretics, antiemetics.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in reducing fluid losses.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provide supplemental IV fluids as necessary.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>In the presence of reduced intake or excessive loss, use of parenteral route may correct or prevent deficiency.</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0074note0135"><title><emphasis role="strong">NURSING DIAGNOSIS: deficient Knowledge regarding condition, treatment, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information; insufficient knowledge of resources</para>
<para>Alteration in cognitive functioning or memory</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports the problem</para>
<para>Inaccurate follow-through of instructions</para>
<para>Development of preventable complication</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Pneumonia Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition, disease process, and prognosis.</para>
<para>Verbalize understanding of therapeutic regimen.</para>
<para>Initiate necessary lifestyle changes.</para>
<para>Participate in treatment program.</para>
</note>
<note role="none" id="ch0003s0074note0136"><table frame="top" id="ch0003s0074ta0078"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review normal lung function and pathology of condition, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes understanding of current situation and importance of cooperating with treatment regimen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss debilitating aspects of disease, length of convalescence, and recovery expectations. Identify self-care and homemaker needs and resources.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Information can enhance coping and help reduce anxiety and excessive concern. Respiratory symptoms may be slow to resolve, and fatigue and weakness can persist for an extended period. These factors may be associated with depression and the need for various forms of support and assistance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide information in verbal, written, and/or audiovisual forms.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fatigue and depression can affect ability to assimilate information and follow medical regimen. Having written instructions for later referral may help client/SO in following previous verbal instructions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of continuing effective coughing and deep-breathing exercises.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Continuing respiratory exercises may be necessary for an extended period of time while chest is congested and secretions are difficult to manage.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize necessity of continuing antimicrobial therapy for prescribed length of time.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early discontinuation of antibiotics may result in failure to completely resolve infectious process.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review importance of cessation of smoking. Refer to smoking cessation program or physician as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Smoking destroys tracheobronchial ciliary action, irritates bronchial mucosa, and inhibits alveolar macrophages, compromising body&rsquo;s natural defense against infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Outline steps to enhance general health and well-being, such as balanced rest and activity, well-rounded diet, program of aerobic exercise or strength training (particularly elderly individuals), and avoidance of crowds during cold and flu season and of persons with upper respiratory infections.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recent research suggests elderly people with moderate physical limitations can significantly improve immunological defenses through exercise that increases levels of salivary IgA&mdash;immunoglobulin that aids in blocking infectious agents entering through mucous membranes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of continuing medical follow-up and obtaining vaccinations and immunizations as appropriate for both children and adults.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May prevent recurrence of pneumonia and related complications. <emphasis>Note:</emphasis> In the United States, there are several vaccines that can help protect against infections caused by bacteria or viruses. These vaccines include pneumococcal, <emphasis>Haemophilus influenzae</emphasis> type b (Hib), pertussis (whooping cough), varicella (chickenpox), measles, and influenza (flu) vaccine (CDC, 2016a). <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject>&nbsp;<emphasis>Note:</emphasis> RSV lower respiratory tract infection has been found to be a risk factor for asthma and wheezing later in childhood (Bass, 2017).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Identify signs and symptoms requiring notification of healthcare provider, such as increasing dyspnea, chest pain, prolonged fatigue, weight loss, fever or chills, persistence of productive cough, and changes in mentation.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prompt evaluation and timely intervention may prevent or minimize complications.</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0074note0137">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Fatigue</emphasis>&mdash;disease states, stress</para></listitem>
<listitem><para><emphasis role="bi">risk for Infection</emphasis>&mdash;inadequate secondary response (e.g., leukopenia, suppressed inflammatory response), chronic disease, malnutrition, [current use of antibiotics]</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, economic difficulties, perceived seriousness and susceptibility</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0003s0079"><title><emphasis role="strong">LUNG CANCER: POSTOPERATIVE CARE</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Usually develops within the wall or epithelium of the bronchial tree</para></listitem>
<listitem><para>Exposure to environmental and occupational carcinogens and an individual&rsquo;s susceptibility to these carcinogens are thought to increase the risk for developing lung cancer. Smoking continues to be the leading cause of lung cancer, accounting for 80% of cases.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Classification:</emphasis> Cancers of the lung are divided into two major subdivisions (American Cancer Society [ACS], 2017; Cancer Treatment Centers of America, n.d.):</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Small cell lung carcinomas (SCLCs) and non&ndash;small cell lung carcinomas (NSCLCs)</para></listitem>
<listitem><para>SCLC (also called oat cell cancer) accounts for 20% of lung cancers, while NSCLC accounts for approximately 80% of lung cancers. There are three main types of NSCLC: adenocarcinomas, squamous cell carcinomas, and large cell carcinomas.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Staging:</emphasis> Small cell lung cancer is staged in two ways: (1) limited (confined to one lung, including nearby lymph cells) and (2) extensive (cancer has spread to the other lung, the pleura, or to other organs in the body).</para>
<para>The TNM (tumor-node-metastasis) system, developed by the American Joint Commission for Staging and End Results Reporting, is used to stage non&ndash;small cell lung cancer:</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>T describes the size of the original tumor and extent of invasion of the cancer into the epithelium.</para></listitem>
<listitem><para>N describes involvement of the lymph nodes.</para></listitem>
<listitem><para>M describes the extent of metastasis (usually liver, bones, or brain).</para></listitem>
<listitem><para>Once the T, N, and M categories have been assigned, the information is combined to assign an overall stage of 0, I, II, III, or IV. Some stages are subdivided into A and B, which have important treatment and prognosis implications (ACS, 2016).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology (ACS, 2017)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>While tobacco smoking is believed to account for 80% of lung cancer cases, not all smokers develop lung cancer, and some patients with lung cancer have never smoked. Studies published by the U.S. Surgeon General in 2006 concluded that living with a smoker increases a nonsmoker&rsquo;s chances of developing lung cancer by 20% to 30% (National Center for Biotechnology Information [NCBI], Office on Smoking and Health, 2006).</para></listitem>
<listitem><para>While genetic predisposition can be attributed to all populations, certain other factors, either in conjunction with smoking or independent of smoking, are population specific, including chronic viral exposure; exposure to arsenic, radon gas, asbestos; and other environmental carcinogens.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity (ACS, 2017)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Lung cancer is the most common cause of cancer worldwide. In the United States, lung cancer is the second most common cancer in women and second only to prostate cancer in men. Lung cancer is more common in men than women, particularly in blacks and non-Hispanic whites (National Institutes of Health [NIH], National Cancer Institute, SEER, 2009&ndash;2013).</para></listitem>
<listitem><para>The probability of developing lung cancer increases after age 40 in both sexes and peaks around age 70, especially in men. In 2013, 83% of those living with lung cancer were 60 years of age or older (NIH, 2013).</para>
</listitem></orderedlist></listitem>
<listitem><para>Mortality</para>
<itemizedlist mark="none">
<listitem><para>Lung cancer is the leading cause of cancer death in both men and women in the United States. It is estimated that in 2017, approximately 156,000 lung cancer deaths occurred (one in four cancer deaths) (ACS, 2017).</para>
</listitem></itemizedlist></listitem>
<listitem><para>Cost&mdash;In 2016, the NIH estimated lung cancer care cost in the United States at $13.6 billion (NIH, 2017).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Treatment Options</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Depends upon staging&mdash;generally the lower the stage, the more favorable the prognosis</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Surgery is primary treatment for NSCLC stage I and stage II tumors.</para></listitem>
<listitem><para>Selected stage III carcinomas may be operable if the tumor is resectable.</para>
</listitem></orderedlist></listitem>
<listitem><para>Surgical procedures for operable tumors of the lung include:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Pneumonectomy&mdash;performed for lesions originating in the mainstem bronchus or lobar bronchus</para></listitem>
<listitem><para>Lobectomy&mdash;preferred for peripheral carcinoma localized in a lobe</para></listitem>
<listitem><para>Wedge or segmental resection&mdash;performed for lesions that are small and well contained within one segment</para></listitem>
<listitem><para>Endoscopic laser resection&mdash;may be done on peripheral tumors to reduce the necessity of cutting through ribs</para></listitem>
<listitem><para>Photodynamic therapy&mdash;reduces symptoms such as bleeding or may be used to treat small tumors</para></listitem>
<listitem><para>Cryotherapy&mdash;instrument is used to freeze and destroy the tumor</para></listitem>
<listitem><para>Electrotherapy&mdash;electrical current is used to cauterize (burn) and destroy the tumor</para>
</listitem></orderedlist></listitem>
<listitem><para>Medical treatments may include radiation, chemotherapy, and targeted drug therapy.</para>
</listitem></orderedlist></listitem></orderedlist>
<para>*****<emphasis role="strong">This care plan addresses only surgical treatments.</emphasis></para>
<note id="ch0003s0079note0138"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Adenocarcinomas:</emphasis> Are the most common type of NSCLC in the United States and comprise up to 40% of <emphasis role="strong">lung cancer</emphasis> cases. While adenocarcinomas are associated with <emphasis role="strong">smoking</emphasis> like other lung cancers, this type is also seen in nonsmokers&mdash;especially women&mdash;who develop <emphasis role="strong">lung cancer</emphasis> (Ratini, 2016).</para>
<para><emphasis role="strong">Cryosurgery:</emphasis> Freezing of tumor in its original location (in situ). Sometimes used for NSCLC patients who can&rsquo;t tolerate surgery.</para>
<para><emphasis role="strong">Hemoptysis:</emphasis> Expectoration of blood or of blood-stained sputum.</para>
<para><emphasis role="strong">Lobectomy:</emphasis> Removal of one lobe.</para>
<para><emphasis role="strong">Pneumonectomy:</emphasis> Removal of an entire lung.</para>
<para><emphasis role="strong">Staging:</emphasis> Classification as to the extent of disease, based on pathology report from tissue obtained during bronchoscopy, needle (or other) biopsy, bloodwork, and imaging studies to rule out distant metastases.</para>
<para><emphasis role="strong">Video-assisted thoracoscopic surgery (VATS):</emphasis> Less invasive type of surgery used when possible for treatment of early stage NSCLC.</para>
<para><emphasis role="strong">Wedge or segmental resection:</emphasis> Removal of the tumor and a small part of the lung.</para>
</note>
<sect2 id="ch0003s0080"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Primary Health Care Settings&mdash;aimed at health education, prevention (Stop Smoking and Clean Air Campaigns), early diagnosis, and follow-up care</para>
<para>Secondary Health Care Settings&mdash;referral to specialists in pulmonology, thoracic surgery, oncology, radiology, nutrition, occupational therapy, outpatient/ambulatory surgery, hospice, and home care</para>
<para>Tertiary Health Care Settings&mdash;inpatient medical-surgical unit, ICU</para>
</sect2>
<sect2 id="ch0003s0081"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0014s0370">Cancer, general considerations</link></para>
<para><link linkend="ch0003s0084">Pneumothorax/hemothorax</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para>Radical neck surgery: laryngectomy (postoperative care), see Davis<emphasis>Plus</emphasis></para>
<para><link linkend="ch0014s0348">Surgical intervention</link></para>
<table frame="top" id="ch0003s0079ta0079"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE (PREOPERATIVE)</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Findings depend on type, duration of cancer, and extent of metastasis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION
<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Fatigue, inability to maintain usual routine</para></listitem>
<listitem><para>Dyspnea with activity</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Lassitude&mdash;usually in advanced stage</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Swelling of extremities</para></listitem>
<listitem><para>Swelling in neck lymph nodes</para></listitem>
<listitem><para>Fast heart rate</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Jugular vein distention (JVD), with vena caval obstruction</para></listitem>
<listitem><para>Swelling of face</para></listitem>
<listitem><para>Swollen lymph nodes above collarbone</para></listitem>
<listitem><para>Expanded veins in arms, chest, or neck</para></listitem>
<listitem><para>Tachycardia and dysrhythmias</para></listitem>
<listitem><para>Pericardial rub, indicating effusion</para></listitem>
<listitem><para>Clubbing of fingers</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Frightened feelings, fear of outcome of surgery</para></listitem>
<listitem><para>Denial of severity of condition and potential for malignancy</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Restlessness</para></listitem>
<listitem><para>Repetitive questioning</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Intermittent diarrhea, due to hormonal imbalance, small cell lung cancer (SCLC)</para></listitem>
<listitem><para>Increased frequency and amount of urine, due to hormonal imbalance (epidermoid tumor)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Weight loss</para></listitem>
<listitem><para>Poor appetite, decreased food intake</para></listitem>
<listitem><para>Difficulty swallowing (late symptom)</para></listitem>
<listitem><para>Thirst, increased fluid intake</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Thin, emaciated, or wasted appearance in late stages</para></listitem>
<listitem><para>Edema of face or neck, chest, back, due to vena caval obstruction; facial or periorbital edema, due to hormonal imbalance (SCLC)</para></listitem>
<listitem><para>Glucose in urine, due to hormonal imbalance (epidermoid tumor)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Chest pain&mdash;not usually present in early stages and not always present in advanced stages. When present, pain may be described as dull, aching, persistent</para></listitem>
<listitem><para>Shoulder or arm pain, particularly with large cell carcinoma or adenocarcinoma</para></listitem>
<listitem><para>Bone and joint pain&mdash;cartilage erosion secondary to increased growth hormones (large cell carcinoma or adenocarcinoma)</para></listitem>
<listitem><para>Intermittent abdominal pain</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Guarding and protective actions</para></listitem>
<listitem><para>Distraction behaviors, such as restlessness, withdrawal</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>History of smoking; occupational exposure to pollutants, industrial dusts, such as asbestos, iron oxides, coal dust, or to radioactive materials</para></listitem>
<listitem><para>Mild cough or change in usual cough pattern, sputum production</para></listitem>
<listitem><para>Shortness of breath</para></listitem>
<listitem><para>Weak breathing</para></listitem>
<listitem><para>Hoarseness or change in voice (late symptom)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Dyspnea, aggravated by exertion</para></listitem>
<listitem><para>Increased tactile fremitus, indicating consolidation</para></listitem>
<listitem><para>Dullness when chest is tapped</para></listitem>
<listitem><para>Brief crackles or wheezes on inspiration or expiration</para></listitem>
<listitem><para>Persistent crackles or wheezes; tracheal shift (space-occupying lesion)</para></listitem>
<listitem><para>Hemoptysis</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Fever may be present, with large cell carcinoma or adenocarcinoma</para></listitem>
<listitem><para>Bruising, discoloration of skin, due to hormonal imbalance (SCLC)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Gynecomastia, due to neoplastic hormonal changes (large cell carcinoma)</para></listitem>
<listitem><para>Amenorrhea, impotence, due to hormonal imbalance (SCLC)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Familial risk factors&mdash;cancer, especially lung, tuberculosis</para></listitem>
<listitem><para>Failure to improve</para></listitem>
<listitem><para>Use of vitamins or herbal supplements, such as vitamins A, C, E; riboflavin; folic acid; ashwagandha; birch; yellow doc; milk thistle; turmeric; ginger; red clover; echinacea; astragalus; reishi and shiitake mushrooms; zedoary</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Assistance with transportation, medications, treatments, self-care, homemaker and maintenance tasks</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0003s0079ta0080"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-3" namest="1" nameend="3"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para><emphasis>Note:</emphasis> These tests may be done preoperatively (not necessarily a comprehensive listing)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Carcinoembryonic antigen (CEA, also called carcinogenic antigen):</emphasis> A cancer-specific immune system protein that is present in many adenocarcinomas, including lung adenocarcinoma.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased preoperative levels of CEA usually suggest a poor prognosis. A CEA level greater than 50 may indicate advanced-stage lung cancer.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Parathyroid protein-related hormone (PTHrP):</emphasis> Measures the release of a protein&mdash;similar to parathyroid hormone&mdash;produced by some cancers, including all lung cancers.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Blood levels of PTHrP may help to distinguish lung cancer from cancer of the pleura or other diseases, is responsible for the clinical syndrome of hypercalcemia of malignancy, may stimulate proliferation of cancer cells, and is a factor in development of bone metastasis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Lymphocyte count:</emphasis> Determines number of white blood cells present.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Lymphocytopenia or decreased level of cells can occur with surgical procedures and is associated with shorter survival times for clients with advanced lung cancer.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Sputum cytology:</emphasis> Examines a sample of sputum (mucus) under a microscope to determine whether abnormal cells are present.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sputum is produced in the lungs and in the airways leading to the lungs. Sputum cytology may be done when lung cancer is suspected.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Chest x-ray, posteroanterior (PA) and lateral:</emphasis> Evaluates organs or structures within the chest.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Lung cancer is often discovered on chest x-ray. Size and location of mass can be determined. Peripheral nodules and hilar and mediastinal changes may suggest lymphadenopathy. Pleural effusions and endobronchial obstruction may be seen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Thoracic CT:</emphasis> An imaging method that uses x-rays to create cross-sectional pictures of the chest and upper abdomen.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A CT scan is frequently the second step either to follow up on an abnormal chest x-ray finding or to evaluate troublesome symptoms in those with a normal chest x-ray.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Positron emission tomography (PET) scan:</emphasis> Nuclear imaging scan used to evaluate and stage lung cancer.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies occult metastatic disease in the mediastinum and distant sites. More sensitive and specific than CT scan and may be used in combination with, or instead of, CT to determine tumor size and location and for staging.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Magnetic resonance imaging (MRI) scan:</emphasis> Uses magnetic fields to produce two- or three-dimensional images of organs inside the body.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Used to confirm abnormalities seen on chest x-ray, to detect early (&lt;1 cm) lesions not visible on chest x-ray, and to assess spread to the mediastinum. Outlines shape, size, and location of lesion. May reveal erosion of ribs or vertebrae.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Pulmonary function studies, including total lung capacity (TLC), functional residual capacity (FRC), and residual volume (RV):</emphasis> Provide information on the extent of the pulmonary abnormality and if there is air-trapping in the lungs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Volumes may be increased, indicating air-trapping, especially advanced disease. If airways are blocked by tumor, an obstructive pattern of pulmonary disease may lead to changes in FRC.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Biopsy:</emphasis> May be performed using forceps or needle, or may be via open surgical incision. Allows for direct and microscopic examination of tissue for presence of malignant cells.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Needle biopsy may be performed on scalene nodes, hilar lymph nodes, or pleura to establish diagnosis. Tissue biopsy of metastatic sites is used to stage disease and determine prognosis and treatment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Bronchoscopy:</emphasis> Procedure used to look inside the lungs&rsquo; airways, or bronchi and bronchioles, by means of a thin tube inserted through the mouth or nose.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Samples may be taken from fluid (bronchoalveolar lavage), tissue (transbronchial biopsy), or lymph nodes (transbronchial needle aspiration) to diagnose or stage certain cancers.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Thoracentesis:</emphasis> Procedure in which a needle is used to remove excess fluid in the pleural space (space between the lungs and the chest wall).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>If fluid is present in the lining of the lung, removal of the fluid may help diagnose cancer, as well as improve breathing symptoms.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Endoscopic ultrasound:</emphasis> Minimally invasive procedure to assess gastrointestinal and lung diseases. It uses high-frequency sound waves to produce detailed images of the lining and walls of digestive tract and chest, as well as nearby organs. May be combined with fine-needle aspiration (FNA) of tissue or fluids.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be done to stage cancer, if present, or determine if cancer has metastasized to lymph nodes or other organs. Also done to provide precise information about NSCLC, to guide treatment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">TESTS THAT MAY BE DONE POSTOPERATIVELY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Arterial blood gases (ABGs):</emphasis> Measures arterial oxygen (PaO<subscript>2</subscript>), carbon dioxide tension (PaCO<subscript>2</subscript>), and acidity (pH).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Done to evaluate ventilation and acid-base status to determine treatment needs and response to therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Pulse oximetry:</emphasis> Noninvasive method of continuously measuring arterial oxyhemoglobin saturation (SaO<subscript>2</subscript>) via sensor placed on fingertip or earlobe.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be particularly useful in the care patients with advanced lung cancer, allowing for early detection of hypoxemia.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>&bull;</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Complete blood count (CBC):</emphasis> Measures the levels of components in blood, including hemoglobin and hematocrit (Hgb/Hct), red blood cells (RBCs), white blood cells (WBCs) and their components (differential), and platelets.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Identifies presence of anemia (low Hgb/Hct, RBCs) and potential or presence of infection (changes in numbers of WBCs and differential). Altered platelets can cause/exacerbate bleeding and bruising.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0003s0082"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Maintain or improve respiratory function.</para></listitem>
<listitem><para>Control or alleviate pain.</para></listitem>
<listitem><para>Support efforts to cope with diagnosis and situation.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and therapeutic regimen.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0003s0083"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Oxygenation and ventilation adequate to meet individual activity needs.</para></listitem>
<listitem><para>Pain controlled.</para></listitem>
<listitem><para>Anxiety and fear decreased to manageable level.</para></listitem>
<listitem><para>Free of preventable complications.</para></listitem>
<listitem><para>Disease process, prognosis, and planned therapies understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0003s0079note0139"><title><emphasis role="strong">NURSING DIAGNOSIS: impaired Gas Exchange</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Ventilation-perfusion imbalance [removal of lung tissue, hypoventilation, hypovolemia]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Abnormal breathing pattern (e.g., rate, rhythm, depth); nasal flaring</para>
<para>Dyspnea, abnormal skin color (e.g., pale, dusky)</para>
<para>Restlessness; confusion; irritability</para>
<para>Abnormal arterial blood gases (ABGs)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Gas Exchange</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate improved ventilation and oxygenation of tissues by ABGs within client&rsquo;s acceptable range and absence of symptoms of respiratory distress.</para>
</note>
<note role="none" id="ch0003s0079note0140"><table frame="top" id="ch0003s0079ta0081"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Respiratory Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note respiratory rate, depth, and ease of respirations. Observe for use of accessory muscles, pursed-lip breathing, or changes in skin or mucous membrane color, such as pallor and cyanosis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Respirations may be increased because of pain or as an initial compensatory mechanism to accommodate for loss of lung tissue. However, increased work of breathing and cyanosis may indicate increasing oxygen consumption and energy expenditures or reduced respiratory reserve, for example, in an elderly client or a client with coexisting COPD.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate lungs for air movement and abnormal breath sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Consolidation and lack of air movement on operative side are normal in the client who has had a pneumonectomy; however, a client who has had a lobectomy should demonstrate normal airflow in remaining lobes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate restlessness and changes in mentation and level of consciousness.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May indicate increased hypoxia or complications such as mediastinal shift in a client who has had a pneumonectomy when accompanied by tachypnea, tachycardia, and tracheal deviation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess client response to activity. Encourage rest periods, limiting activities to client tolerance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased oxygen consumption and demand and stress of surgery may result in increased dyspnea and changes in vital signs with activity; however, early mobilization is desired to help prevent pulmonary complications and to obtain and maintain respiratory and circulatory efficiency.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note development of fever.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fever within the first 24 hours after surgery is frequently due to atelectasis. Temperature elevation within postoperative days 5 to 10 usually indicates an infection, such as wound or systemic.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Airway Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain patent airway by positioning, suctioning, and use of airway adjuncts.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Airway obstruction impedes ventilation, impairing gas exchange. (Refer to ND: <link linkend="ch0003s0074note0123">ineffective Airway Clearance</link>.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reposition frequently, placing client in sitting and supine to side positions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maximizes lung expansion and drainage of secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid positioning client with a pneumonectomy on the operative side; instead, favor the &ldquo;good lung down&rdquo; position.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Research shows that positioning clients following lung surgery with their &ldquo;good lung down&rdquo; maximizes oxygenation by using gravity to enhance blood flow to the healthy lung, thus creating the best possible match between ventilation and perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage and assist with deep-breathing exercises and pursed-lip breathing, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes maximal ventilation and oxygenation and reduces or prevents atelectasis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Tube Care: Chest</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain patency of chest drainage system following lobectomy and segmental wedge resection procedures.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Drains fluid from pleural cavity to promote reexpansion of remaining lung segments.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note changes in amount or type of chest tube drainage.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bloody drainage should decrease in amount and change to a more serous composition as recovery progresses. A sudden increase in amount of bloody drainage or return to frank bleeding suggests thoracic bleeding or a hemothorax; sudden cessation suggests blockage of tube, requiring further evaluation and intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for presence of bubbling in water-seal chamber.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Air leaks appearing immediately postoperatively are not uncommon, especially following lobectomy or segmental resection; however, this should diminish as healing progresses. Prolonged or new leaks require evaluation to identify problems in client versus a problem in the drainage system. (Refer to CP: <link linkend="ch0003s0084">Pneumothorax/Hemothorax</link> for more information regarding chest tubes.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Airway Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer supplemental oxygen via nasal cannula, partial rebreathing mask, or high-humidity face mask, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maximizes available oxygen, especially while ventilation is reduced because of anesthetic, depression, or pain, and during period of compensatory physiological shift of circulation to remaining functional alveolar units.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist with and encourage use of incentive spirometer.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents or reduces atelectasis and promotes reexpansion of small airways.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor and document ABGs and pulse oximetry readings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreasing PaO<subscript>2</subscript> or increasing PaCO<subscript>2</subscript> may indicate need for ventilatory support.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Note hemoglobin (Hgb) levels.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Significant blood loss results in decreased oxygen-carrying capacity, reducing PaO<subscript>2</subscript>.</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0079note0141"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Airway Clearance</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Excessive mucus; retained secretions </para>
<para>[Restricted chest movement&mdash;pain, weakness]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Dyspnea</para>
<para>Changes in respiratory rate</para>
<para>Adventitious breath sounds</para>
<para>Ineffective cough</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Airway Patency</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate patent airway, with fluid secretions easily expectorated, clear breath sounds, and noiseless respirations.</para>
</note>
<note role="none" id="ch0003s0079note0142"><table frame="top" id="ch0003s0079ta0082"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Airway Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate chest for character of breath sounds and presence of secretions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Noisy respirations, rhonchi, and wheezes are indicative of retained secretions or airway obstruction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client with and provide instruction in effective deep breathing, coughing in upright position (sitting), and splinting of incision.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Upright position favors maximal lung expansion, and splinting improves force of cough effort to mobilize and remove secretions. Splinting may be done by nurse placing hands anteriorly and posteriorly over chest wall and by client, with pillows, as strength improves.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe amount and character of sputum and aspirated secretions. Investigate changes, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased amounts of colorless (or blood-streaked) or watery secretions are normal initially and should decrease as recovery progresses. Presence of thick, tenacious, bloody, or purulent sputum suggests development of secondary problems&mdash;for example, dehydration, pulmonary edema, local hemorrhage, or infection&mdash;that require correction or treatment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suction if cough is weak or breath sounds not cleared by cough effort. Avoid deep endotracheal and nasotracheal suctioning in client who has had pneumonectomy, if possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&ldquo;Routine&rdquo; suctioning increases risk of hypoxemia and mucosal damage. Deep endotracheal suctioning is generally contraindicated following pneumonectomy to reduce the risk of rupture of the bronchial stump suture line. If suctioning is unavoidable, it should be done gently and only to induce effective coughing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage oral fluid intake, at least 2500 mL/d, within cardiac tolerance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adequate hydration aids in keeping secretions loose and enhances expectoration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess for pain and discomfort and medicate on a routine basis and before breathing exercises.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourages client to move, cough more effectively, and breathe more deeply to prevent respiratory insufficiency.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide and assist client with incentive spirometer and postural drainage and percussion, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improves lung expansion and ventilation and facilitates removal of secretions. <emphasis>Note:</emphasis> Postural drainage may be contraindicated in some clients and, in any event, must be performed cautiously to prevent respiratory embarrassment and incisional discomfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use humidified oxygen and ultrasonic nebulizer. Provide additional fluids intravenously (IV), as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Providing maximal hydration helps loosen and liquefy secretions to promote expectoration. Impaired oral intake necessitates IV supplementation to maintain hydration.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer bronchodilators, expectorants, and analgesics, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Relieves bronchospasm to improve airflow. Expectorants increase mucus production and liquefy and reduce viscosity of secretions, facilitating removal. Alleviation of chest discomfort promotes cooperation with breathing exercises and enhances effectiveness of respiratory therapies.</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0079note0143"><title><emphasis role="strong">NURSING DIAGNOSIS: acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Injuring agents&mdash;(biological [cancer invasion of pleura, chest wall]; physical [surgical incision, tissue trauma, presence of chest tube])</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Verbal/coded report</para>
<para>Guarded behavior</para>
<para>Expressive behavior&ndash;restlessness</para>
<para>Narrowed focus</para>
<para>Changes in blood pressure (BP), heart, or respiratory rate</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report pain relieved or controlled.</para>
<para>Appear relaxed and sleep or rest appropriately.</para>
<para>Participate in desired as well as needed activities.</para>
</note>
<note role="none" id="ch0003s0079note0144"><table frame="top" id="ch0003s0079ta0083"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ask client about pain. Determine pain location and characteristics, for example, continuous, aching, stabbing, or burning. Have client rate intensity on a scale (e.g., numeric, faces, etc.).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helpful in evaluating cancer-related pain symptoms, which may involve viscera, nerve, or bone tissue. Use of rating scale aids client in assessing level of pain and provides tool for evaluating effectiveness of analgesics, enhancing client control of pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess client&rsquo;s verbal and nonverbal pain cues.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discrepancy between verbal and nonverbal cues may provide clues to degree of pain and need for and effectiveness of interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note possible psychological as well as pathophysiological causes of pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fear, distress, anxiety, and grief over confirmed diagnosis of cancer can impair ability to cope. In addition, a posterolateral incision is more uncomfortable for client than an anterolateral incision. The presence of chest tubes can greatly increase discomfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate effectiveness of pain control. Encourage sufficient medication to manage pain; change medication or time span as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pain perception and pain relief are subjective. If client is unable to provide input, the nurse should observe physiological and nonverbal signs of pain and administer medications on a regular basis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage verbalization of feelings about the pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fears and concerns can increase muscle tension and lower threshold of pain perception. (Refer to ND: <link linkend="ch0003s0079note0145">Anxiety [specify level]</link>, following.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide comfort measures such as frequent changes of position, back rubs, and support with pillows. Encourage use of relaxation techniques, including visualization, guided imagery, and appropriate diversional activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes relaxation and redirects attention. Relieves discomfort and augments therapeutic effects of analgesia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Schedule rest periods; provide quiet environment.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases fatigue and conserves energy, enhancing coping abilities.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist with self-care activities, breathing and arm exercises, and ambulation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents undue fatigue and incisional strain. Encouragement and physical assistance and support may be needed for some time before client is able or confident enough to perform these activities because of pain or fear of pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Assist with patient-controlled analgesia (PCA) or analgesia through epidural catheter. Administer intermittent analgesics routinely, as indicated, especially 45 to 60 minutes before respiratory treatments and deep-breathing and coughing exercises.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Maintaining a constant drug level avoids cyclic periods of pain, aids in muscle healing, and improves respiratory function and emotional comfort and coping.</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0079note0145"><title><emphasis role="strong">NURSING DIAGNOSIS: Anxiety [specify level]</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Major change (e.g., health status; threat to current status); situational crises</para>
<para>Threat of death</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports apprehensive; worried, distressed</para>
<para>Poor eye contact; self-focused; alteration in attention and concentration; decreased ability to learn or problem solve</para>
<para>Increased pulse, respiration, blood pressure</para>
<para>Insomnia</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Anxiety Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate appropriate range of feelings and appear relaxed and resting appropriately.</para>
<para><emphasis role="strong">Anxiety Self-Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Acknowledge and discuss fears and concerns.</para>
<para>Verbalize accurate knowledge of situation.</para>
<para>Report beginning use of individually effective coping strategies.</para>
</note>
<note role="none" id="ch0003s0079note0146"><table frame="top" id="ch0003s0079ta0084"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Anxiety Reduction</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate client and significant other (SO) level of understanding of diagnosis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client and SO are hearing and assimilating new information that includes changes in self-image and lifestyle. Understanding perceptions of those involved sets the tone for individualizing care and provides information necessary for choosing appropriate interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Acknowledge reality of client&rsquo;s fears and concerns and encourage expression of feelings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Support may enable client to begin exploring and dealing with the reality of cancer and its treatment. Client may need time to identify feelings and even more time to begin to express them.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide opportunity for questions and answer them honestly. Be sure that client and care providers have the same understanding of terms used.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establishes trust and reduces misperceptions or misinterpretation of information.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Accept, but avoid reinforcing, client&rsquo;s denial of the situation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>When extreme denial or anxiety is interfering with progress of recovery, the issues facing client need to be explained and resolutions explored.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note comments and behaviors indicative of beginning acceptance or use of effective strategies to deal with situation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fear and anxiety will diminish as client begins to accept and deal positively with reality. Indicator of client&rsquo;s readiness to accept responsibility for participation in recovery and to &ldquo;resume life.&rdquo;</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Involve client and SO in care planning. Provide time to prepare for events and treatments.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May help restore some feeling of control and independence to client who feels powerless in dealing with diagnosis and treatment.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provide for client&rsquo;s physical comfort.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>It is difficult to deal with emotional issues when experiencing extreme or persistent physical discomfort.</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0079note0147"><title><emphasis role="strong">NURSING DIAGNOSIS: deficient Knowledge regarding condition, treatment, prognosis, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Lack of exposure, unfamiliarity with resources</para>
<para>Information misinterpretation</para>
<para>Lack of recall</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports the problem</para>
<para>Inadequate follow-through of instruction</para>
<para>Inappropriate or exaggerated behaviors&mdash;agitated, apathetic</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Cancer Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of ramifications of diagnosis, prognosis, and possible complications.</para>
<para>Participate in learning process.</para>
<para>Verbalize understanding of therapeutic regimen.</para>
<para>Correctly perform necessary procedures and explain reasons for the actions.</para>
<para>Initiate necessary lifestyle changes.</para>
</note>
<note role="none" id="ch0003s0079note0148">
<table frame="top" id="ch0003s0079ta0085"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss diagnosis, current and planned therapies, and expected outcomes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides individually specific information, creating knowledge base for subsequent learning regarding home management. Radiation and/or chemotherapy may follow surgical intervention, and information is essential to enable the client and SO to make informed decisions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reinforce surgeon&rsquo;s explanation of surgical procedure, providing diagram as appropriate. Incorporate this information into discussion about short- and long-term recovery expectations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Length of rehabilitation and prognosis depend on type of surgical procedure, preoperative physical condition, and duration and degree of complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss necessity of planning for follow-up care before discharge.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Follow-up assessment of respiratory status and general health is imperative to ensure optimal recovery. Also provides opportunity to readdress concerns or questions at a less stressful time.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify signs and symptoms requiring medical evaluations, such as changes in appearance of incision, development of respiratory difficulty, fever, increased chest pain, and changes in appearance of sputum.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early detection and timely intervention may prevent or minimize complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of avoiding exposure to smoke, air pollution, and contact with individuals with upper respiratory infections (URIs).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Protects lung(s) from irritation and reduces risk of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review nutritional and fluid needs. Suggest increasing protein and use of high-calorie snacks as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Meeting cellular energy requirements and maintaining good circulating volume for tissue perfusion facilitate tissue regeneration and healing process.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify individually appropriate community resources, such as American Cancer Society, visiting nurse, social services, and home care.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Agencies such as these offer a broad range of services that can be tailored to provide support and meet individual needs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Prescribed Activity/Exercise</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Help client determine activity tolerance and set goals.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Weakness and fatigue should decrease as lung heals and respiratory function improves during recovery period, especially if cancer was completely removed. If cancer is advanced, it is emotionally helpful for client to be able to set realistic activity goals to achieve optimal independence.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate availability and adequacy of support system(s) and necessity for assistance in self-care and home management.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>General weakness and activity limitations may reduce individual&rsquo;s ability to meet own needs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage alternating rest periods with activity and light tasks with heavy tasks. Emphasize avoidance of heavy lifting and isometric or strenuous upper body exercise. Reinforce physician&rsquo;s time limitations about lifting.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Generalized weakness and fatigue are usual in the early recovery period but should diminish as respiratory function improves and healing progresses. Rest and sleep enhance coping abilities, reduce nervousness (common in this phase), and promote healing. <emphasis>Note:</emphasis> Strenuous use of arms can place undue stress on incision because chest muscles may be weaker than normal for 3 to 6 months following surgery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend stopping any activity that causes undue fatigue or increased shortness of breath.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Exhaustion aggravates respiratory insufficiency.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct and provide rationale for arm and shoulder exercises. Have client or SO demonstrate exercises. Encourage following graded increase in number and intensity of routine repetitions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Simple arm circles and lifting arms over the head or out to the affected side are initiated on the first or second postoperative day to restore normal range of motion (ROM) of shoulder and to prevent ankylosis of the affected shoulder.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Incision Site Care</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage inspection of incisions. Review expectations for healing with client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Healing begins immediately, but complete healing takes time. As healing progresses, incision lines may appear dry with crusty scabs. Underlying tissue may look bruised and feel tense, warm, and lumpy (resolving hematoma).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct client and SO to watch for and report places in incision that do not heal or reopening of healed incision, any drainage (bloody or purulent), and localized area of swelling with redness or increased pain that is hot to touch.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Signs and symptoms indicating failure to heal, development of complications requiring further medical evaluation and intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggest wearing soft cotton shirts and loose-fitting clothing; cover portion of incision with pad, as indicated, and leave incision open to air as much as possible, unless compression garment is used.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces suture line irritation and pressure from clothing. Leaving incisions open to air promotes healing process and may reduce risk of infection.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Shower in warm water, washing incision gently. Avoid tub baths until approved by physician.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Keeps incision clean and promotes circulation and healing. <emphasis>Note:</emphasis> &ldquo;Climbing&rdquo; out of tub requires use of arms and pectoral muscles, which can put undue stress on incision.</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0079note0149">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">ineffective Airway Clearance</emphasis>&mdash;excessive mucus, retained secretions, [pain, fatigue]</para></listitem>
<listitem><para><emphasis role="bi">acute Pain</emphasis>&mdash;physical&mdash;surgical incision, tissue trauma, disruption of intercostal nerves, anxiety</para></listitem>
<listitem><para><emphasis role="bi">Self-Care deficit</emphasis>&mdash;fatigue, pain/discomfort, weakness</para></listitem></itemizedlist>
<para>Refer to CP: <link linkend="ch0014s0370">Cancer-General Considerations</link> for additional interventions.</para>
</note>
</sect2></sect1>
<sect1 id="ch0003s0084"><title><emphasis role="strong">PNEUMOTHORAX/HEMOTHORAX</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis> (Daley et al, 2016; Schiffman, 2016)</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Partial or complete collapse of lung due to accumulation of air (pneumothorax), blood (hemothorax), or other fluid (pleural effusion) in the pleural space.</para></listitem>
<listitem><para>Intrathoracic pressure changes are induced by increased pleural space volumes and reduced lung capacity, causing respiratory distress and gas exchange problems. This produces tension on mediastinal structures that can impede cardiac and systemic circulation.</para></listitem>
<listitem><para>Complications include hypoxemia, respiratory failure, and cardiac arrest.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Classification</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Primary spontaneous pneumothorax</para></listitem>
<listitem><para>Secondary spontaneous pneumothorax</para></listitem>
<listitem><para>Iatrogenic pneumothorax</para></listitem>
<listitem><para>Traumatic pneumothorax</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology (Daley et al, 2016)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Primary spontaneous: Rupture of pleural blebs typically occurs in young people without parenchymal lung disease or occurs in the absence of traumatic injury to the chest or lungs.</para></listitem>
<listitem><para>Secondary spontaneous: Occurs in the presence of lung disease (primarily emphysema) but can also occur with tuberculosis (TB), sarcoidosis, cystic fibrosis, malignancy, and pulmonary fibrosis.</para></listitem>
<listitem><para>Iatrogenic: Complication of medical or surgical procedures, such as therapeutic thoracentesis, tracheostomy, transthoracic needle aspiration biopsy of pulmonary nodules (most common cause), transbronchial or pleural biopsy, central venous catheter insertion (usually subclavian or internal jugular); acute respiratory distress syndrome (ARDS) and positive-pressure mechanical ventilation (tension pneumothorax); inadvertent intubation of right mainstem bronchus.</para></listitem>
<listitem><para>Traumatic: Most common form of pneumothorax and hemothorax, caused by open or closed chest or abdominal trauma related to blunt or penetrating injuries (e.g., chest injury from car crash; gunshot or stab wounds) and high-risk occupation (e.g., diving, flying).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Indications for Thoracostomy</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Pneumothorax: Open or closed; simple or tension</para></listitem>
<listitem><para>Bleeding into pleural space (hemothorax)</para></listitem>
<listitem><para>Lymphatic fluid leaking into pleural space (chylothorax)</para></listitem>
<listitem><para>Pus and infected tissue fluid in pleural space (empyema)</para></listitem>
<listitem><para>Abnormal amount of fluid in pleural space resulting from either excess fluid production or decreased fluid absorption (pleural effusion): Often associated with an underlying malignancy but may result from several other conditions (e.g., TB, cirrhosis with ascites, chronic pancreatitis, nephrotic syndrome, medication-associated effusion).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Patient presentation and possible treatment options (Baumann et al, 2001; Daley et al, 2016)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Client has no symptoms and the pneumothorax finding is incidental (usually on an x-ray performed for an unrelated reason). Treatment decisions may be based on the likelihood of recurrence.</para></listitem>
<listitem><para>Client is symptomatic but clinically stable: Treatment with small-bore catheter or chest tube placement is recommended.</para></listitem>
<listitem><para>Client has life-threatening pneumothorax that causes hemodynamic instability. This condition is treated immediately with tube thoracostomy and treatment of underlying conditions.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics (Schiffman, 2016)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: Primary spontaneous pneumothorax affects approximately 9000 persons per year in the United States and is more common in men between 20 and 40 years of age.</para></listitem>
<listitem><para>Recurrence rate is about 40% for both primary and secondary spontaneous pneumothorax, occurring in intervals of 1.5 to 2 years.</para></listitem>
<listitem><para>Mortality: Rate is 15% for those with secondary pneumothorax associated with underlying lung disease.</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0003s0084note0150"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Blunt-force chest trauma:</emphasis> Closed trauma to the chest may result in laceration of lung tissue or an artery by a rib, causing blood to collect in the pleural space.</para>
<para><emphasis role="strong">Chest tube drainage unit (CDU):</emphasis> Drainage system that is connected to a chest tube to remove air and/or fluids from the chest cavity or pleural space. The device consists of a water seal and collection chambers and a suction-control chamber or a one-way mechanical valve, depending on the amount of drainage anticipated and the client&rsquo;s level of mobility.</para>
<para><emphasis role="strong">Crepitation:</emphasis> A dry, crackling sound or sensation on auscultation or palpation of the skin, indicating the presence of subcutaneous emphysema, or air trapped in the tissues, associated with a pneumothorax.</para>
<para><emphasis role="strong">Empyema:</emphasis> Pus from an infection, such as pneumonia, in the pleural space.</para>
<para><emphasis role="strong">Fremitus:</emphasis> Vibratory sensation or tremors felt through the chest wall during coughing or speaking.</para>
<para><emphasis role="strong">Hamman sign:</emphasis> Crunching sound heard in chest auscultation, which correlates with heartbeat, reflecting air in mediastinum.</para>
<para><emphasis role="strong">Hemopneumothorax:</emphasis> Both air and blood in the pleural space.</para>
<para><emphasis role="strong">Hemothorax:</emphasis> Collection of blood in the pleural space, which can exert pressure on the lung, causing it to collapse.</para>
<para><emphasis role="strong">Hypercapnia:</emphasis> Increased level of carbon dioxide in the blood.</para>
<para><emphasis role="strong">Hypoxemia:</emphasis> Decreased level of oxygen in the blood.</para>
<para><emphasis role="strong">Penetrating chest trauma:</emphasis> Chest trauma in which a weapon, such as a knife, bullet, or needle, lacerates the lung.</para>
<para><emphasis role="strong">Pleural effusion:</emphasis> Excessive fluid in the pleural space.</para>
<para><emphasis role="strong">Pleural space:</emphasis> Area between the parietal pleura (membrane lining the chest cavity) and the visceral pleura, which surrounds the lungs. Normally, this potential space holds about 50 mL of lubricating fluid that prevents friction between the pleurae as they move during inhalation and exhalation.</para>
<para><emphasis role="strong">Pneumothorax:</emphasis> Buildup of air in the pleural space, exerting pressure against the lung and causing it to collapse.</para>
<para><emphasis role="strong">Tachypnea:</emphasis> Abnormally rapid respirations.</para>
<para><emphasis role="strong">Tension pneumothorax:</emphasis> Accumulation of air into the intrapleural space that shifts the mediastinum to the unaffected side, thus impairing ventilation and compromising cardiac function and venous return.</para>
<para><emphasis role="strong">Thoracentesis:</emphasis> Use of a needle to rapidly remove fluid from the pleural space.</para>
<para><emphasis role="strong">Thoracostomy:</emphasis> Minimally invasive procedure in which a thin plastic tube is inserted into the pleural space&mdash;the area between the chest wall and lungs&mdash;to remove excess fluid or air (may be attached to a suction device).</para>
</note>
<sect2 id="ch0003s0085"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>This care plan addresses the patient who has chest tube placement and is treated in an inpatient medical or surgical unit.</para>
</sect2>
<sect2 id="ch0003s0086"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0002s0053">Cardiac surgery</link></para>
<para><link linkend="ch0003s0069">Chronic obstructive pulmonary disease (COPD) and asthma</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0003s0099">Pulmonary tuberculosis (TB)</link></para>
<para><link linkend="ch0003s0094">Respiratory failure/ventilatory assistance (mechanical)</link></para>
<table frame="top" id="ch0003s0084ta0086"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Findings vary depending on the amount of air and/or fluid accumulation, rate of accumulation, and underlying lung function.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION
<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Shortness of breath</para></listitem>
<listitem><para>Fatigue</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Dyspnea with activity or even at rest</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Tachycardia; irregular rate, dysrhythmias</para></listitem>
<listitem><para>S<subscript>3</subscript> or S<subscript>4</subscript> or gallop heart rhythm&mdash;heart failure (HF) secondary to effusion</para></listitem>
<listitem><para>Apical pulse reveals point of maximal impulse (PMI) displaced in presence of mediastinal shift with tension pneumothorax</para></listitem>
<listitem><para>Homans&rsquo; sign&mdash;crunching sound correlating with heartbeat, reflecting air in mediastinum</para></listitem>
<listitem><para><emphasis role="bi">Blood pressure (BP):</emphasis> Hypertension or hypotension. <emphasis>Note:</emphasis> Hypotension is an inconsistent finding, although is a key sign in tension pneumothorax.</para></listitem>
<listitem><para>Jugular vein distention (JVD), especially with tension pneumothorax</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Anxiety, apprehension</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Restlessness, irritability</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Unilateral chest pain, aggravated by breathing, coughing, and movement; or</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Facial grimacing</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Sudden onset of symptoms while coughing or straining&mdash;spontaneous pneumothorax; or</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Guarding affected area</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Sharp, stabbing chest pain aggravated by deep breathing, possibly radiating to neck, shoulders, abdomen&mdash;pleural effusion</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Distraction behaviors</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Difficulty breathing, &ldquo;air hunger&rdquo;</para></listitem>
<listitem><para>Coughing, which may be presenting symptom</para></listitem>
<listitem><para>Use of positive-pressure mechanical ventilation or positive end-expiratory pressure (PEEP) therapy</para></listitem>
<listitem><para>History of recent chest surgery or trauma; chronic lung disease, lung inflammation, or infection (empyema or effusion); diffuse interstitial disease (sarcoidosis); malignancies (e.g., obstructive tumor)</para></listitem>
<listitem><para>Previous spontaneous pneumothorax; spontaneous rupture of emphysematous bulla, subpleural bleb in COPD</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Respirations:</emphasis></para></listitem>
<listitem><para>Tachypnea. <emphasis>Note:</emphasis> In tension pneumothorax, pulse may exceed 130 bpm.</para></listitem>
<listitem><para>Labored breathing, use of accessory muscles in chest, neck; intercostal retractions; forced abdominal expiration</para></listitem>
<listitem><para>Respiratory distress/respiratory arrest</para></listitem>
<listitem><para><emphasis role="bi">Chest observation and auscultation:</emphasis></para></listitem>
<listitem><para>Unequal or paradoxical chest movement (if trauma, flail), reduced thoracic excursion on affected side</para></listitem>
<listitem><para>Breath sounds distant or absent on involved side</para></listitem>
<listitem><para>Ipsilateral (same side) crackles, wheezes</para></listitem>
<listitem><para><emphasis role="bi">Chest percussion:</emphasis></para></listitem>
<listitem><para>Hyperresonance over air-filled area&mdash;pneumothorax; dullness over fluid-filled area&mdash;hemothorax</para></listitem>
<listitem><para>Fremitus decreased on involved site</para></listitem>
<listitem><para><emphasis role="bi">Skin:</emphasis> Pallor, cyanosis, diaphoresis, subcutaneous crepitation</para></listitem>
<listitem><para><emphasis role="bi">Mentation:</emphasis> Anxiety, restlessness, confusion, stupor</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Recent chest trauma, such as fractured ribs, penetrating wound</para></listitem>
<listitem><para>Radiation and chemotherapy for malignancy</para></listitem>
<listitem><para>Presence of central intravenous (IV) line</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>History of familial risk factors, such as TB, cancer</para></listitem>
<listitem><para>Recent intrathoracic surgery or lung biopsy</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Temporary assistance with self-care, homemaker and maintenance tasks</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0003s0084ta0087"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST
<?lb?>WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Evaluates organs or structures within the chest and is the initial study of choice in blunt-force chest trauma.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May show injuries (e.g., to chest wall, ribs, heart, or great vessels) if due to trauma. May reveal air and fluid accumulation in the pleural space; may show shift of mediastinal structures.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Thoracic computed tomography (CT):</emphasis> Enhances anatomic views of the chest and locates abnormalities. Early CT may influence therapeutic management.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>CT is more sensitive than x-ray in detecting thoracic injuries, lung contusion, hemothorax, and pneumothorax.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Chest ultrasonography:</emphasis> Noninvasive diagnostic exam that produces images, used to assess the organs and structures within the chest, such as the lungs, mediastinum, and pleural space.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Bedside thoracic ultrasound can rapidly and accurately diagnose pneumothorax without the need for chest x-ray. This can greatly reduce the elapsed time between assessment for and treatment of pneumothorax in an emergency setting (Summers et al, 2016). Ultrasound can detect as little as 5 to 50 mL of pleural fluid and has a 100% sensitivity for effusions greater than 100 mL. May also be used to guide needle insertion for chest tube placement (Daley et al, 2016; Mechem, 2015).</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0003s0087"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Promote or maintain lung reexpansion for adequate oxygenation and ventilation.</para></listitem>
<listitem><para>Minimize or prevent complications.</para></listitem>
<listitem><para>Reduce discomfort and pain.</para></listitem>
<listitem><para>Provide information about disease process, treatment regimen, and prognosis.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0003s0088"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Adequate ventilation and oxygenation maintained.</para></listitem>
<listitem><para>Complications prevented or resolved.</para></listitem>
<listitem><para>Pain absent or controlled.</para></listitem>
<listitem><para>Disease process, prognosis, and therapy needs understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0003s0084note0151"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Breathing Pattern</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Musculoskeletal impairment</para>
<para>Pain; anxiety</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Dyspnea, tachypnea</para>
<para>Alterations in depth of breathing; altered chest excursion</para>
<para>Use of accessory muscles to breathe, nasal flaring</para>
<para>Decreased vital capacity</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Ventilation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Establish a normal and effective respiratory pattern with ABGs within client&rsquo;s normal range.</para>
<para>Be free of cyanosis and other signs or symptoms of hypoxia.</para>
</note>
<note role="none" id="ch0003s0084note0152"><table frame="top" id="ch0003s0084ta0088"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Respiratory Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify etiology or precipitating factors, such as trauma, malignancy, infection, complication of mechanical ventilation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding the cause of lung collapse is necessary for proper chest tube placement and choice of other therapeutic measures.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate respiratory function, noting rapid or shallow respirations, dyspnea, reports of &ldquo;air hunger,&rdquo; development of cyanosis, and changes in vital signs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Respiratory distress and changes in vital signs occur because of physiological stress and pain or may indicate development of shock due to hypoxia or hemorrhage.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor for asynchronous respiratory pattern when using mechanical ventilator. Note changes in airway pressures.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Difficulty breathing with ventilator or increasing airway pressures suggests worsening of condition and development of complications, such as a tension pneumothorax.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate breath sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Breath sounds may be diminished or absent in a lobe, lung segment, or entire lung field (unilateral). Atelectatic area will have no breath sounds, and partially collapsed areas have diminished sounds. Regularly scheduled evaluation also helps determine areas of good air exchange and provides a baseline to evaluate resolution of pneumothorax.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note chest excursion and position of trachea.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Chest excursion is unequal until lung reexpands. Trachea deviates from affected side with tension pneumothorax.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess fremitus.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Voice and tactile fremitus (vibration) is reduced in fluid-filled or consolidated tissue.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Ventilation Assistance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist client with splinting painful area when coughing or during deep breathing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Supporting chest and abdominal muscles makes coughing more effective and less traumatic.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain position of comfort, usually with head of bed elevated. Turn to affected side. Encourage client to sit up as much as possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes maximal inspiration; enhances lung expansion and ventilation in unaffected side.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain a calm attitude, assisting client to &ldquo;take control&rdquo; by using slower, deeper respirations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assists client to deal with the physiological effects of hypoxia, which may be manifested as anxiety or fear.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Tube Care: Chest</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Ascertain type of client&rsquo;s chest drainage system.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This care plan concerns the hospitalized client whose treatment plan includes use of a traditional chest drainage system. Mobile drains are indicated for those clients who are ambulatory and do not require a suction for reinflation of lungs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Once chest tube is inserted:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Seal drainage tubing connection sites securely with lengthwise tape or bands and pad bands with gauze or tape according to established policy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents disconnection and air leaks at connector sites. Padding protects skin from irritation and pressure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anchor thoracic catheter to chest wall and provide extra length of tubing before turning or moving client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents thoracic catheter dislodgment or tubing disconnection and reduces pain and discomfort associated with pulling or jarring of tubing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Secure drainage unit to client&rsquo;s bed or on stand or cart placed in low-traffic area.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintains upright position and reduces risk of accidental tipping and breaking of unit.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor thoracic insertion site, noting condition of skin and presence and characteristics of drainage from around the catheter. Change and reapply sterile occlusive dressing as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides for early recognition and treatment of developing skin or tissue erosion or infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine if dry-seal chest drain or water-seal system is used.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Some chest drains use a mechanical one-way valve in place of a conventional water seal. The one-way valve allows air to escape from the chest and prevents air from entering the chest. Dry suction-control systems regulate suction pressure mechanically rather than with a column of water. Some dry suction systems use a screw-type valve that varies the size of the opening to the vacuum source, thereby limiting the amount of negative pressure that can be transmitted to the chest. These valves narrow the opening of the chest drain to adjust the level of negative pressure; therefore, the total amount of air that can flow out of the chest drain is also limited. Thus, this type of dry suction-control mechanism is impractical for clients with significant pleural air leaks. <emphasis>Note:</emphasis> Dry-seal setups are also used with an automatic control valve (ACV), which provides a one-way valve seal like that achieved with the water-seal system.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>If water-seal system and suction is used:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Check suction-control chamber for correct amount of suction, as determined by water level, wall, or table regulator, at correct setting.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintains prescribed intrapleural negativity, which promotes optimum lung expansion and fluid drainage.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Check fluid level in water-seal chamber; maintain at prescribed level.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Water in a sealed chamber serves as a barrier that prevents atmospheric air from entering the pleural space should the suction source be disconnected and aids in evaluating whether the chest drainage system is functioning appropriately. <emphasis>Note:</emphasis> Underfilling the water-seal chamber leaves it exposed to air, putting client at risk for pneumothorax or tension pneumothorax. Overfilling, a more common mistake, prevents air from easily exiting the pleural space, thus preventing resolution of pneumothorax and possibly creating a tension pneumothorax.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for bubbling in water-seal chamber.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bubbling during expiration reflects venting of pneumothorax (desired action). Bubbling usually decreases as the lung expands or may occur only during expiration or coughing as the pleural space diminishes. Absence of bubbling may indicate complete lung reexpansion (normal) or represent complications, such as obstruction, in the tube.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor water-seal chamber &ldquo;tidaling.&rdquo; Note whether change is transient or permanent.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The water-seal chamber serves as an intrapleural manometer (gauges intrapleural pressure); therefore, fluctuation, or tidaling, reflects pressure differences between inspiration and expiration. Tidaling of 2 to 6 cm during inspiration is normal and may increase briefly during coughing episodes. Continuation of excessive tidal fluctuations may indicate existence of airway obstruction or presence of a large pneumothorax.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide safe transportation if client is sent off unit for diagnostic purposes. Before transporting, check water-seal chamber for correct fluid level; presence or absence of bubbling; and presence, degree, and timing of tidaling. Ascertain whether chest tube can be clamped or disconnected from suction source.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes continuation of optimal evacuation of fluid or air during transport. If client is draining large amounts of chest fluid or air, tube should not be clamped or suction interrupted because of risk of accumulating fluid or air, compromising respiratory status.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor for abnormal or continuous water-seal chamber bubbling.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>With suction applied, continuous water-seal bubbling may indicate a persistent air leak that may be from a large pneumothorax at the chest insertion site (client centered) or chest drainage unit (system centered). <emphasis>Note:</emphasis> Because the assessment of bubbling is variable and subjective, practitioners are favoring electronic drains because assessment of air leak becomes objective and consistent from clinician to clinician (Cerfolio et al, 2010).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine location of air leak (client or system centered) by clamping thoracic catheter just distal to exit from chest.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>If bubbling stops when catheter is clamped at insertion site, leak is client centered at insertion site or within the client.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Place petrolatum gauze or other appropriate material around the insertion as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Usually corrects insertion site air leak.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Clamp tubing in stepwise fashion downward toward drainage unit if air leak continues.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Isolates location of a system-centered air leak. <emphasis>Note:</emphasis> As a rule, clamping for a suspected leak is the only time that chest tube should be clamped.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Position drainage system tubing for optimal function; for example, shorten tubing or coil extra tubing on bed, making sure tubing is not kinked or hanging below entrance to drainage container. Drain accumulated fluid as necessary.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improper position, kinking, or accumulation of clots and fluid in the tubing changes the desired negative pressure and impedes air or fluid evacuation. <emphasis>Note:</emphasis> If a dependent loop in the drainage tube cannot be avoided, lifting and draining it every 15 minutes will maintain adequate drainage in the presence of a hemothorax.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note character and amount of chest tube drainage, whether tube is warm and full of blood and whether bloody fluid level in water-seal bottle is rising.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in evaluating resolution of pneumothorax or development of hemorrhage requiring prompt intervention. <emphasis>Note:</emphasis> Some drainage systems are equipped with an autotransfusion device, which allows for salvage of shed blood.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Follow facility protocol and/or specific physician orders regarding chest tube stripping (&ldquo;milking&rdquo;).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Milking the chest tube is sometimes used when it is deemed necessary to maintain free drainage in the presence of fresh bleeding, large blood clots, or purulent exudates (empyema). Concerns have been expressed over time as to the extreme negative pressure that can be exerted in the chest cavity during tube stripping. Some specialists recommend avoiding tube milking (Carroll, 2013). <emphasis>Note:</emphasis> Medical literature reveals a lack of consensus regarding benefits versus harm of this procedure, and some physicians and hospital policies support chest tube stripping (Halm, 2007; Hogg et al, 2011). However, the sixth edition of the <emphasis>AACN Procedure Manual for Critical Care</emphasis> states, &ldquo;At level C evidence, that stripping and milking of closed chest drainage systems are contraindicated&rdquo; (Pickett, 2011).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>If thoracic catheter is disconnected or dislodged:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for signs of respiratory distress. If possible, reconnect thoracic catheter to tubing and suction, using clean technique. If the catheter is dislodged from the chest, cover insertion site immediately with petrolatum dressing and apply firm pressure. Notify physician at once.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pneumothorax may recur or worsen, compromising respiratory function and requiring prompt intervention to prevent fatal pulmonary and circulatory impairment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>After thoracic catheter is removed:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cover insertion site with sterile occlusive dressing. Observe for signs or symptoms that may indicate recurrence of pneumothorax, such as shortness of breath and reports of pain. Inspect insertion site, noting character of drainage.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early detection of a developing complication, such as recurrence of pneumothorax or presence of infection, is essential.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative:</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with lung reexpansion treatment (e.g., observation without oxygen, administering supplemental oxygen, needle aspiration, one-way valve device, thoracostomy with chest tube placement with chest tube drainage unit [CDU] and with or without suction) as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although numerous treatment options for lung reexpansion are available (depending on the cause, location, and size of the pneumothorax), tube thoracostomy is the definitive treatment for secondary spontaneous pneumothorax and tension pneumothorax (Bascom et al, 2016). The use of water seal alone reduces duration of air leak, chest tube dwell time, and hospital stay (Deng et al, 2010; Hawley et al, 2014).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Obtain postplacement x-rays and review serial chest x-rays.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Placement of tube(s) is determined by the cause of the problem; for example, anterior chest near apex of lung or one tube at the apex and one at posterior fifth to sixth intercostal space. X-rays confirm proper placement and monitor progress of reexpansion of lung.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Ventilation Assistance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor and graph serial ABGs and pulse oximetry. Review vital capacity and tidal volume measurements, where indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assesses status of gas exchange and ventilation and need for continuation or alterations in therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer supplemental oxygen via cannula, mask, or mechanical ventilation, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in reducing work of breathing; promotes relief of respiratory distress and cyanosis associated with hypoxemia.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer analgesics and sedatives, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Given to manage pleuritic pain and reduce anxiety and tachycardia associated with impaired respiratory function, especially when client is on a ventilator.</para></entry></row>
</tbody></tgroup></table></note>
<note id="ch0003s0084note0153"><title><emphasis role="strong">NURSING DIAGNOSIS: readiness for enhanced Knowledge regarding condition, treatment regimen, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Expresses desire to enhance knowledge</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Acute Illness Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of cause of problem (when known).</para>
<para>Identify signs or symptoms requiring medical follow-up.</para>
<para><emphasis role="strong">Knowledge: Treatment Regimen</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Follow therapeutic regimen and demonstrate lifestyle changes, if necessary, to prevent recurrence.</para>
</note>
<note role="none" id="ch0003s0084note0154"><table frame="top" id="ch0003s0084ta0089"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Procedure/Treatment</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review with client purpose and function of CDU, taking note of safety features.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Information on how system works provides reassurance, reducing client anxiety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct client to refrain from lying on or pulling on tubing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of obstructing drainage or inadvertently disconnecting tubing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify changes and situations that should be reported to caregivers, such as change in sound of bubbling, sudden &ldquo;air hunger&rdquo; and chest pain, and disconnection of equipment.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Timely intervention may prevent serious complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review pathology of individual problem.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Information reduces fear of unknown. Provides knowledge base for understanding underlying dynamics of condition and significance of therapeutic interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify likelihood for recurrence or long-term complications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Certain underlying lung diseases, such as severe COPD and malignancies, may increase incidence of recurrence. <emphasis>Note:</emphasis> Incidence of recurrence varies but usually strikes within the first 6 months to 3 years. Daley et al (2016) reported a 5-year recurrence rate of 28% to 32% for primary spontaneous pneumothorax (PSP) and 43% for secondary spontaneous pneumothorax (SSP).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review signs and symptoms requiring immediate medical evaluation, for example, sudden chest pain, dyspnea, air hunger, and progressive respiratory distress.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recurrence of pneumothorax requires medical intervention to prevent and reduce potential complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review significance of good health practices, such as adequate nutrition, rest, and exercise.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintenance of general well-being promotes healing and may prevent or limit recurrences.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Emphasize need for smoking cessation when indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prevents respiratory complications, such as fibrotic changes in lung tissue, and may prevent recurrence of collapsed lung. <emphasis>Note:</emphasis> It is well documented that smoking can increase the risk of spontaneous pneumothorax. However, correlation percentages are unclear. One author recently reported that smoking increases the risk of a first spontaneous pneumothorax by more than 20-fold in men and by nearly 10-fold in women compared with risks in nonsmokers. Substantiating data were not available (Daley et al, 2016).</para></entry></row></tbody></tgroup></table>
</note>
<note id="ch0003s0084note0155">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">risk for Infection</emphasis>&mdash;invasive procedure, traumatized tissue, broken skin, decreased ciliary action</para></listitem>
<listitem><para><emphasis role="bi">ineffective Breathing Pattern</emphasis>&mdash;pain, fatigue, musculoskeletal impairment</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0003s0089"><title><emphasis role="strong">ACUTE LUNG INJURY/ACUTE RESPIRATORY DISTRESS SYNDROME</emphasis></title>
<para>Acute lung injury (ALI) is a syndrome consisting of acute hypoxemic respiratory failure with bilateral pulmonary infiltrates. Acute respiratory distress syndrome (ARDS) is a subtype of ALI and is considered the most severe form of hypoxic lung injury. Some clinicians view these two entities as a continuum with the severity of hypoxemia being the deciding factor. ALI and ARDS are associated with inflammation and edema in the airways that reduce lung compliance, resulting in respiratory failure related to noncardiogenic pulmonary edema. What distinguishes ALI from ARDS is the P/F ratio (see <link linkend="ch0003s0089note0156">Glossary</link>).</para>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology (Pooler, 2009; Saguil &amp; Fargo, 2012; York &amp; Kane, 2012)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Alveolar-capillary leaking (allowing fluids, proteins, and blood cells to enter interstitial space)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Increased interstitial protein levels raises interstitial oncotic pressure and pulls fluid from vascular space, resulting in a relative hypovolemia and edema (third spacing). If fluids, proteins, and blood cells accumulate too rapidly for lymphatic system to clear, noncardiogenic pulmonary edema occurs.</para></listitem>
<listitem><para>Lungs are subjected to increased hyaline membrane formation, development of fibroblasts (possibly leading to interstitial fibrosis), and inactivation of pulmonary surfactant.</para></listitem>
<listitem><para>There are areas within the lungs that are collapsed or consolidated (mainly dependent lobes) and other regions that are open and ventilate in a relatively normal fashion (Chacko &amp; Rani, 2009; Puybasset et al, 2000).</para></listitem>
<listitem><para>Together, these factors worsen gas exchange, decrease lung compliance, produce atelectasis, and increase work of breathing.</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology (National Heart, Lung, and Blood Institute [NHLBI], 2012; York &amp; Kane, 2012)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>ALI/ARDS has been defined as a constellation of clinical criteria (acute onset of bilateral pulmonary infiltrates with hypoxemia without evidence of hydrostatic pulmonary edema) (Johnson &amp; Matthay, 2010). The course of the condition can be described in three overlapping phases (Laycock &amp; Rajah, 2010; Mackay &amp; Al-Haddad, 2009).</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>The <emphasis>acute</emphasis> or <emphasis>exudative</emphasis> phase starts early and lasts up to 7 days from onset. Characterized by the development of hypoxemia, bilateral infiltrates on chest x-ray, and reduction in pulmonary compliance.</para></listitem>
<listitem><para>The <emphasis>subacute</emphasis> or <emphasis>proliferative</emphasis> phase follows. Characterized by persistent hypoxemia, increased dead space, reduced lung compliance, and disruption of capillary function due to microvascular thrombus formation.</para></listitem>
<listitem><para>The <emphasis>chronic</emphasis> or <emphasis>fibrotic</emphasis> phase may start as early as 14 days and lasts for many weeks. Chronicity is the result of widespread pulmonary fibrosis and loss of normal lung structure, declining lung compliance, and increased dead space.</para>
</listitem></orderedlist></listitem>
<listitem><para>The causes of ALI/ARDS are divided into two categories: direct or indirect injuries to the lung.</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Direct injuries</emphasis> include acute bacterial or viral pneumonia, upper airway obstruction, aspiration, near drowning, oxygen toxicity, mechanical ventilation, and toxic inhalation (fumes or smoke).</para></listitem>
<listitem><para><emphasis role="strong">Indirect injuries</emphasis> to the lung include acute pancreatitis; severe infection (sepsis and septic shock), blood transfusions, or severe bleeding from bodily injury; trauma, fractures (multiple and long bone), and fat embolism; burns; cardiopulmonary bypass; drug overdose and medication reactions; and transplantation (bone or lung).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Treatments (Mackay &amp; Al-Haddad, 2009; Powers, 2007; Saguil &amp; Fargo, 2012; York &amp; Kane, 2012)</emphasis></para>
<para>Management requires (1) maintaining airway, (2) providing adequate oxygenation, and (3) supporting hemodynamic function. Supportive therapy includes the following:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="bi">Perfusion:</emphasis> Fluids are needed to replace vascular losses (associated with leaking from capillaries into alveolar spaces) but are given cautiously to avoid fluid overload. Medications include inotropics (e.g., dobutamine) to improve cardiac output and vasopressors (e.g., dopamine) to promote systemic vasoconstriction, which in turn raise blood pressure and enhance organ perfusion.</para></listitem>
<listitem><para><emphasis role="bi">Positioning:</emphasis> Recent studies have supported the use of positioning (including prone position) to improve oxygenation by mobilizing secretions, reducing atelectasis, and improving perfusion in all aspects of the lungs. In addition, kinetic therapy reduces harmful effects of immobilization, such as skin breakdown and ventilator-associated pneumonia (VAP).</para></listitem>
<listitem><para><emphasis role="bi">Protective lung ventilation:</emphasis> Pressure-cycled ventilation is beneficial in management of ARDS in which there is alveolar dysfunction and vulnerability to barotrauma and volutrauma (Mutneja &amp; Tichauer, 2016). Current guidelines include mechanical ventilation with settings that (1) provide low tidal volumes, (2) maintain higher levels of PEEP, (3) reduce FiO<subscript>2</subscript> as possible from 100%, and (4) limit plateau pressures (adapted from NIH, NHLBI, &amp; ARDS, 2014).</para></listitem>
<listitem><para><emphasis role="bi">Protocol weaning:</emphasis> Use of patient-specific weaning protocols can reduce duration of ventilated support and ICU length of stay. Weaning efforts can include (but are not limited to) spontaneous breathing trials.</para></listitem>
<listitem><para><emphasis role="bi">Preventing complications:</emphasis> The lung-injured patient is very ill and often has comorbidities (e.g., traumatic injuries, heart or chronic lung diseases, diabetes, etc.). Having ALI or ARDS adds a whole new level of complication risks (see below).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Complications (Stoppler, n.d.; York &amp; Kane, 2012)</emphasis></para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Early complications (occurring during hospitalization) often include shock; infections (sepsis, pneumonia, VAP); pneumothorax/other ventilator-induced lung injury (VILI), lung scarring; long-term ventilation/difficulty weaning; organ dysfunction/failure (e.g., respiratory muscle disuse hypotrophy; kidney failure/multiple organ failure); fluid overload, stress ulcers; malnutrition; and immobility effects resulting in skin breakdown, blood clots (DVT and PE).</para></listitem>
<listitem><para>Late and ongoing health issues often include shortness of breath (After treatment, some people recover close-to-normal lung function within 6 months. For others, it may take longer. Others have breathing problems for the rest of their lives); persistent fatigue and muscle weakness; anxiety, depression, and other mood disorders; and problems with cognition, including memory, attention, and thinking clearly.</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: In 2016, there were about 200,000 cases of ARDS per year in the United States (American Lung Association, 2016). Survivors of ARDS have diminished functional ability and lower-than-normal quality of life 2 years after hospital discharge, related to health issues (e.g., ongoing pulmonary dysfunction, tracheostomy site complications, problems with joints, and caregiver and financial burdens) (Bakowitz, Bruns, &amp; McCunn, 2012; Laycock &amp; Rajah, 2010). A recent study concerning long-term effects of ARDS concluded that cognitive impairment in ARDS survivors ranges from 70% to 100% at hospital discharge and 20% at 5 years. Mood disorders, including depression and posttraumatic stress disorder (PTSD), are also sustained and prevalent (Herridge et al, 2016).</para></listitem>
<listitem><para>Mortality: Between 30% and 50% of those diagnosed with ARDS die of it (American Lung Association, 2016). Since 2010, the overall mortality rates have been in-hospital (45%), 28/30 days (30%), and 60 days (32%) (M&aacute;ca et al, 2016).</para></listitem>
<listitem><para>Costs: No recent figures were located for direct costs of ARDS in the United States. There were recent publications from Canada, the United Kingdom, and Europe. However, a statistical brief for hospital costs in the United States in 2011 listed two of the primary diagnoses associated with ARDS: septicemia and adult respiratory failure. These costs were listed in mean costs per stay: septicemia $18,000 (an 11.5% increase since 1997) and adult respiratory failure $21,600 (a 6.6% increase since 1997) (Pfuntner et al, 2013).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0003s0089note0156"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Acute lung injury (ALI):</emphasis> Condition characterized by acute severe hypoxia that is not due to left atrial hypertension. ALI is on the lower end of a continuum ending in acute respiratory distress syndrome (ARDS). ALI is defined by a PaO<subscript>2</subscript>/FiO<subscript>2</subscript> ratio of less than 300.</para>
<para><emphasis role="strong">Alveoli:</emphasis> Thin walled sac at end of the airway where gas exchange takes place. In ARDS, infections, injuries, or other conditions cause fluid to build up in the alveoli.</para>
<para><emphasis role="strong">ARDS, or acute respiratory distress syndrome:</emphasis> Rapidly progressing lung condition where low oxygen levels in the blood increase the work of breathing. &ldquo;ARDS is defined by timing (within 1 week of clinical insult or onset of respiratory symptoms); radiographic changes (bilateral opacities not fully explained by effusions, consolidation, or atelectasis); origin of edema (not fully explained by cardiac failure or fluid overload); and severity based on the PaO<subscript>2</subscript>/FiO<subscript>2</subscript> ratio on 5 cm of continuous positive airway pressure (CPAP). The 3 categories are mild (PaO<subscript>2</subscript>/FiO<subscript>2</subscript> 200&ndash;300), moderate (PaO<subscript>2</subscript>/FiO<subscript>2</subscript> 100&ndash;200), and severe (PaO<subscript>2</subscript>/FiO<subscript>2</subscript> &le; 100)&rdquo; (Ranieri et al, 2012).</para>
<para><emphasis role="strong">Atelectasis:</emphasis> A complete or partial collapse of a lung or lobe of a lung leading to reduced or absent gas exchange.</para>
<para><emphasis role="strong">Compliance:</emphasis> Measurement of the relationship between changes in <emphasis role="strong">lung</emphasis> volume and <emphasis role="strong">lung</emphasis> pressure. <emphasis role="strong">Lower levels of compliance</emphasis> make it harder for a person to breathe normally.</para>
<para><emphasis role="strong">High-flow nasal oxygen therapy (HFNOT):</emphasis> Provides warmed, humidified gases at flows of up to 60 L/min, with inspired oxygen (FIO<subscript>2</subscript>) concentrations of up to 100%, and is delivered using a blender connected to a wall outlet, a humidifier, heated tubing, and nasal cannula.</para>
<para><emphasis role="strong">High-flow oxygen therapy (HFOT):</emphasis> Form of respiratory support (often in conjunction with compressed air and humidification) delivered at flow rates higher than that delivered traditionally in oxygen therapy.</para>
<para><emphasis role="strong">Inotropics:</emphasis> Medications that influence the force of muscular contractions.</para>
<para><emphasis role="strong">Oncotic pressure:</emphasis> Osmotic pressure exerted by colloids or plasma proteins (e.g., albumin) on capillary walls.</para>
<para><emphasis role="strong">P/F ratio:</emphasis> Comparison of arterial partial pressure of oxygen (PaO<subscript>2</subscript>) with inspired fractional concentration of oxygen (FiO<subscript>2</subscript>). This ratio compares the amount of oxygen given to patient with the amount of oxygen entering the bloodstream.</para>
<para><emphasis role="strong">Positive end-expiratory pressure (PEEP):</emphasis> A mainstay of therapy for the mechanically ventilated ARDS patient that prevents the patient from completely exhaling and recruits collapsed alveoli, thereby promoting gas exchange</para>
<para><emphasis role="strong">Refractory hypoxemia:</emphasis> Oxygen requirements continue to increase while oxygen saturation remains low.</para>
<para><emphasis role="strong">Ventilation-perfusion (V/Q) mismatch:</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="p179001.jpg"/></imageobject></inlinemediaobject> (ventilation) is the air that reaches the alveoli. Q (perfusion) is the blood that reaches the alveoli via the capillaries. A mismatch is the imbalance between alveolar ventilation and pulmonary capillary blood flow as occurs in ARDS.</para>
</note>
<sect2 id="ch0003s0090"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Acute care facility. The patient may be hospitalized for other concerns (e.g., trauma, surgery, pneumonia) and already be on a ventilator when ALI/ARDS develops.</para>
</sect2>
<sect2 id="ch0003s0091"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0012s0308">Burns</link></para>
<para><link linkend="ch0003s0074">Pneumonia</link></para>
<para><link linkend="ch0003s0084">Pneumothorax/Hemothorax</link></para>
<para><link linkend="ch0003s0094">Respiratory failure/ventilatory assistance</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para>Respiratory acidosis (see Davis<emphasis>Plus</emphasis>)</para>
<para><link linkend="ch0013s0318">Sepsis/septic shock</link></para>
<para><link linkend="ch0014s0348">Surgical intervention</link></para>
<para><link linkend="ch0006s0219">Total nutritional support/enteral feeding</link></para>
<para><link linkend="ch0012s0313">Wound care: complicated or chronic</link></para>
<table frame="top" id="ch0003s0089ta0090"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>***Data are for acute phase.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION
<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Muscle fatigue</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Mental confusion</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>General weakness</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Changes in blood pressure, heart rate/rhythm, and oxygen saturation with activity</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Tachycardia</para></listitem>
<listitem><para>Low blood pressure</para></listitem>
<listitem><para>Cyanosis, mottling (despite supplemental oxygen)</para></listitem>
<listitem><para>Edema (generalized)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Loss of appetite</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Poor skin turgor, dry and flaky skin</para></listitem>
<listitem><para>Muscle wasting and loss of subcutaneous fat</para></listitem>
<listitem><para>Acute oliguria</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Chest pain with inspiration</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Guarding of affected area</para></listitem>
<listitem><para>Distraction behaviors, restlessness</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Shortness of breath (worsening to severe)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Increased respiratory rate; tachypnea; audible labored breathing</para></listitem>
<listitem><para>Dry cough (first 24 to 48 hours)</para></listitem>
<listitem><para>Breath sounds: Crackles</para></listitem>
<listitem><para>Ventilation-perfusion mismatch</para></listitem>
<listitem><para>Oxygenation problems despite delivery of higher-than-normal oxygen concentration</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Risks for direct lung injury (common triggers for ALI):</emphasis></para>
<itemizedlist mark="&bull;">
<listitem><para>Pneumonia, aspiration of gastric contents; lung surgery or chest trauma with lung contusion</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Risks for direct lung injury (less common triggers for ALI):</emphasis></para>
<itemizedlist mark="&bull;">
<listitem><para>Fat/amniotic fluid embolism, high altitude, near drowning, inhalation injury, reperfusion injury</para></listitem>
<listitem><para>History of smoking</para></listitem>
<listitem><para>History of oxygen use for a preexisting lung condition</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Conditions with risk for indirect injuries to lung (common triggers for ALI):</emphasis></para>
<itemizedlist mark="&bull;">
<listitem><para>Sepsis; severe trauma with shock and multiple fluid transfusions</para></listitem></itemizedlist>
<para><emphasis role="bi">Conditions with risk for indirect injuries to lung (less common triggers for ALI):</emphasis></para>
<itemizedlist mark="&bull;">
<listitem><para>Burns; acute pancreatitis</para></listitem>
<listitem><para>Recent high-risk surgery; cardiopulmonary bypass</para></listitem>
<listitem><para>Blood transfusions</para></listitem>
<listitem><para>Drug overdose (especially heroin, barbiturates)</para></listitem>
<listitem><para>Disseminated intravascular coagulation (DIC)</para></listitem>
<listitem><para>Chronic alcoholism; alcohol abuse</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Temperature &gt;100.9&deg;F (38.3&deg;C) or &lt;96.8&deg;F (36&deg;C)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Person living with sequelae of ARDS</para></listitem>
<listitem><para>General debilitation and poor health status</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Assistance with or alteration in drug therapy</para></listitem>
<listitem><para>Assistance in self-care and homemaker and maintenance tasks</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0003s0089ta0091"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST
<?lb?>WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry>
</row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis>Note:</emphasis> Many different diagnostic studies may be done, depending on cause for ARDS and client condition. (Refer to individual care plans as indicated for additional diagnostic studies.)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS:</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Arterial blood gas (ABG):</emphasis> Measures the arterial blood oxygen level.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>ABGs may initially show respiratory alkalosis (due to tachypnea) shifting to respiratory and metabolic acidosis (due to tissue hypoxia and anaerobic metabolism).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Evaluates organs and structures within the chest for evidence of disease.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Infiltrates are bilateral and diffuse or patchy, involving at least three quadrants, and cannot be explained as by pleural effusion, atelectasis, or nodules. <emphasis>Note:</emphasis> The geographic distribution of patchy &ldquo;ground-glass&rdquo; densities, together with areas of lobular sparing and lower-lobe consolidation, are radiologic hallmarks of ARDS (Phua et al, 2009).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Chest computed tomography (CT) scan:</emphasis> Uses x-rays and computer to make detailed pictures of structures inside of the body.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May reveal areas of dense consolidation, <emphasis role="strong">air</emphasis>-filled bronchi (dark) being made visible by the opacification of surrounding alveoli (gray/white), patchy areas of &ldquo;ground glass&rdquo; opacification, and areas of relatively normal appearance.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0003s0092"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Achieve and maintain adequate ventilation and oxygenation.</para></listitem>
<listitem><para>Prevent spread of infection.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0003s0093"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Respiratory function adequate to meet individual need.</para></listitem>
<listitem><para>Complications prevented.</para></listitem>
<listitem><para>Lifestyle and behavior changes adopted to prevent spread of infection.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0003s0089note0157"><title><emphasis role="strong">NURSING DIAGNOSIS: impaired Gas Exchange</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Alveolar-capillary membrane changes [such as in acute respiratory distress]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Abnormal breathing pattern (e.g., rate, rhythm, depth); nasal flaring</para>
<para>Dyspnea, abnormal skin color (e.g., pale, dusky)</para>
<para>Tachycardia; dysrhythmias</para>
<para>Restlessness; confusion; irritability</para>
<para>Abnormal arterial blood gases (ABGs)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Gas Exchange</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate improved ventilation and oxygenation of tissues by ABGs within client&rsquo;s acceptable range and absence of symptoms of respiratory distress.</para>
<para>Participate in treatment regimen (e.g., breathing exercises, effective coughing, use of oxygen) within level of ability or situation.</para>
</note>
<note role="none" id="ch0003s0089note0158"><table frame="top" id="ch0003s0089ta0092"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Respiratory Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess respiratory rate, depth, and ease.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Manifestations of respiratory distress are dependent on, and indicative of, the degree of lung involvement and underlying general health status.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe color of skin, mucous membranes, and nailbeds, noting presence of peripheral cyanosis (nailbeds) or central cyanosis (circumoral).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cyanosis of nailbeds may represent vasoconstriction or the body&rsquo;s response to fever or chills; however, cyanosis of earlobes, mucous membranes, and skin around the mouth (&ldquo;warm membranes&rdquo;) is indicative of systemic hypoxemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess mental status, including awareness, thought processes, and appropriateness of responses.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Restlessness, irritation, and confusion are early signs of hypoxia. Deteriorating awareness, somnolence, and loss of consciousness are late signs of worsening hypoxemia, decreased cerebral oxygenation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess anxiety, noting reports of great concern/fear and inability to breathe, and observe for increasing breathlessness, tachycardia restlessness, irritability, and confusion.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anxiety can be a manifestation of physiological responses to hypoxia as well as psychological concerns. Refer to Care Plan: <link linkend="ch0003s0094">Respiratory Failure/Ventilatory Assistance</link>, ND: <link linkend="ch0003s0079note0145">Anxiety [specify level]</link>.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor heart rate and rhythm.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia is usually present because of fever and dehydration but may represent a response to hypoxemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevate head and support client in position of comfort for breathing as ventilation support measures permit. Provide frequent position changes, including prone position or place in kinetic bed, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Patient position affects perfusion and oxygenation of lungs where patchy areas of ventilation/perfusion mismatch are occurring. These measures promote maximal inspiration, reduce atelectasis, and can enhance removal of secretions to improve ventilation and reduce lung inflammation. Prone positioning requires special beds (e.g., Stryker frame, or other prone positioner) or multiple people to perform safe repositioning.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for deterioration in condition, noting hypotension (accompanied with falling oxygen saturation and pH), pallor, cyanosis, changes in level of consciousness, severe dyspnea, and restlessness.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>ALI is on a continuum, with full ARDS being at the most severe end. Shock and advancing respiratory distress require immediate medical attention and additional interventions. The patient usually requires intubation and mechanical ventilation, and transfer to critical care.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor pulse oximetry continuously and ABGs as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies problems, such as changes in O<subscript>2</subscript> saturation associated with activity, or accelerating hypoxemia, respiratory acidosis, and ventilatory failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Oxygen Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer oxygen therapy by appropriate means (e.g., nasal prongs, mask, and other noninvasive ventilation [NIV] methods).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The purpose of oxygen therapy is to maintain PaO<subscript>2</subscript> above 60 mm Hg, or greater than 90% O<subscript>2</subscript> saturation. Oxygen is administered by the method that provides appropriate delivery within the client&rsquo;s tolerance. <emphasis>Note:</emphasis> Early research concerning the use of NIV in patients with severe acute respiratory syndrome (SARS) reported that 70% could avoid intubation (Cheung et al, 2004).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>High-flow nasal oxygen therapy (HFNOT)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>HFNOT is being used in selected patients with early ARDS to postpone or potentially reduce the need for intubation and mechanical ventilation. HFNOT provides effective humidification and warming of gases, which allows more effective clearance of secretions, decreases atelectasis, and prevents airway surface dehydration. Research has shown that patients with acute hypoxemic respiratory failure (as occurs in ARDS) experience improved work of breathing and comfort with HFNOT compared with traditional noninvasive ventilation methods (Ashraf-Kasan &amp; Kumar, 2017; Roca et al, 2010).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prepare for and transfer to critical care unit if indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Intubation and mechanical ventilation are required in the event of severe respiratory insufficiency. The principle of ventilation in patients with ALI is to correct hypoxemia and maintain adequate gas exchange until the cellular damage resolves. In ARDS, mechanical ventilation is typically delivered as positive-pressure ventilation with PEEP via an endotracheal tube. <emphasis>Note:</emphasis> The National Heart, Lung, and Blood Institute&rsquo;s Acute Respiratory Distress Syndrome Clinical Trials Network tidal volume study (ARDSNET, 2000) showed a significant reduction in mortality by utilizing low-volume and low-peak-pressure ventilation. (Refer to CP: <link linkend="ch0003s0094">Respiratory Failure/Ventilatory Assistance</link> for additional mechanical ventilation interventions.)</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0089note0159"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for imbalanced Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By:</emphasis></para>
<para>Alveolar-capillary membrane changes</para>
<para>Compromised regulatory mechanisms; decreased plasma proteins</para>
<para>Active fluid volume loss (e.g., third spacing)</para>
<para>[Hypotonic dehydration; malnutrition]</para>
<para>Sepsis; trauma; treatment regimen</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate adequate fluid balance as evidenced by stable vital signs, palpable pulses of good quality; normal skin turgor, moist mucous membranes; individually appropriate urinary output; lack of excessive weight fluctuation (loss or gain); no edema present.</para>
</note>
<note role="none" id="ch0003s0089note0160"><table frame="top" id="ch0003s0089ta0093"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Fluid Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note the presence of overt (ALI or ARDS) condition and underlying contributing condition(s) (e.g., sepsis, burns, COPD, pneumonia, kidney failure).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determines potential fluid fluctuations and points toward appropriate assessments and treatments.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note current treatment modalities, including (1) major invasive procedures (e.g., surgery, intubation/mechanical ventilation); (2) use or overuse of certain medications (e.g., heparin, diuretics); and (3) multiple IV infusions and/or transfusions (may not be a complete listing).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These modalities can cause or exacerbate fluid imbalances and contribute to complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Be aware of client&rsquo;s age and functional level (e.g., frail, debilitated) and mental status (e.g., alert, somnolent).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information regarding the client&rsquo;s risk for creating or responding to hydration issues, as well as ability to tolerate fluctuations in fluid volume.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor vital signs, noting and documenting changes. Investigate possible reasons for changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Blood pressure, heart, and respiratory rate often increase whether either fluid excess or deficit is present.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor invasive hemodynamic parameters (e.g., central venous pressure [CVP], pulmonary artery pressure [PAP], pulmonary capillary wedge pressure [PCWP]), where available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pressures may be high because of excessive fluid volume or low if hypovolemia or cardiovascular shock is present.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Calculate 24-hour fluid balance, noting intake more than output or vice versa.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To ensure accurate picture of fluid status and point toward appropriate interventions to achieve fluid balance:</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measure and record intake: Include all sources (e.g., oral, IV solutions; antibiotic/other additive IVs; enteral/parenteral feedings).</para>
<para>Measure and record output: Include all sources (e.g., tubes, drainage devices [urinary, gastric, wound, chest tubes], bleeding from any source; measured stools, or weighed diapers/continence pads, etc.).</para>
<para>Measure/document urine output hourly or as needed. Report urine output &lt;30 mL/hr or output &lt;400 mL/24 hours.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh daily or as needed and evaluate changes as they relate to fluid status.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Detecting trends in weight fluctuations in a timely manner allows for prompt interventions, when needed.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess for dry skin and mucous membranes; delayed capillary refill (especially when accompanied by low blood pressure and elevated heart rate).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Signs of dehydration indicating fluid deficit.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess for and monitor edema (generalized, peripheral, dependent; eyelids); note distended neck veins; adventitious breath sounds (especially when accompanied by elevated blood pressure, heart and respiratory rate).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Signs of fluid excess.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor skin and pressure points continuously. (Refer to ND: <link linkend="ch0003s0089note0161">risk for Disuse Syndrome</link>, following.)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Edematous tissues and patient&rsquo;s malnourished and debilitated status increase risk for skin/tissue breakdown.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review nutritional issues (e.g., intake of sodium, potassium, protein).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Imbalances in these factors are associated with fluid imbalances. <emphasis>Note:</emphasis> A malnourished patient (common in ARDS) can experience significant fluid shifts and electrolyte changes after nutritional support is initiated.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer IV fluids as indicated, using pumps to deliver fluids accurately, and at desired rates to prevent either underinfusion or overinfusion.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Distinguishing between <emphasis role="bi">initial fluid resuscitation</emphasis> and <emphasis role="bi">ongoing fluid therapy</emphasis> is important. In the early phase of ARDS, an associated septic state is usually responsible for hypovolemia. On the other hand, ARDS is characterized by pulmonary edema (caused by an increase in pulmonary capillary permeability) (Mackay &amp; Al-Haddad, 2009; Roch et al, 2011). Patients with hemodynamic failure (shock) must receive early fluid resuscitation, while pulmonary (and generalized) edema may require fluid restriction (and use of diuretics or dialysis). Thus, liberal and conservative fluid strategies are complementary and should follow each other in time in the same patient (Mikkelsen et al, 2012). <emphasis>Note:</emphasis> Studies have reported that conservative fluid management (with the goal to obtain zero fluid balance) significantly increases the number of days without mechanical ventilation (Weidemann et al, 2006).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review laboratory data and chest x-ray (ongoing).</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>To determine changes associated with both fluid and electrolyte status.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0089note0161"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for Disuse Syndrome</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced by:</emphasis></para>
<para>Alteration in level of consciousness</para>
<para>Immobility [unavoidable musculoskeletal inactivity; mechanical ventilation; critically ill condition/shock state; hypoxemia; debilitation; malnutrition]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Risk Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain or regain optimal level of cognitive, neurosensory, and musculoskeletal functioning.</para>
<para>Demonstrate adequate peripheral perfusion with skin warm and dry; palpable peripheral pulses.</para>
<para>Display intact tissues or achieve timely wound healing.</para>
<para>Maintain or reestablish effective elimination patterns.</para>
<para>Express sense of control over present situation and potential outcome.</para>
<para>Be free of preventable complications.</para>
</note>
<note role="none" id="ch0003s0089note0162"><table frame="top" id="ch0003s0089ta0094"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Bed Rest Care</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify underlying conditions/pathology in addition to ALI (e.g., trauma, critical illness; chronic disease conditions, neurological conditions, malnutrition).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These conditions cause or exacerbate problems associated with inactivity and immobility such as reduced strength and endurance; impaired sitting, standing, walking; pressure ulcers; impaired urinary and bowel function; blood clots; and impairments in mental and emotional functioning (interventions and rationale in this ND adapted from Doenges, Moorhouse, &amp; Murr, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note specific and potential concerns relating to client&rsquo;s age and preexisting cognitive, mobility, and functional status.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Age-related physiological changes (along with limitation imposed by current illness) predispose older adults to deconditioning and functional decline.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine if current condition is likely to involve a long-term illness/recovery time, and evaluate client&rsquo;s risk for complications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The patient with ALI/ARDS may be in intensive care and hospitalized for a long time, resulting in a higher risk of physical and psychological complications. The patient&rsquo;s coping abilities and willingness to participate in activities can be affected by whether limitations imposed by current condition are likely to be short-term or long-term.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess and document (ongoing) patient&rsquo;s functional status, including cognition, vision and hearing, social support; psychological well-being; abilities in performance of activities of daily living.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides a comparative baseline that is helpful in evaluating status of condition/underlying disease process, response to treatment, as well as in identifying preventative interventions or necessary services.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor patient&rsquo;s responses to current illness, noting presence of anxiety, depression, withdrawal, problems with thinking and attention.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Studies suggest these patients are at high risk for significant long-term, brain-related morbidity manifested by neurocognitive and neuropsychological impairments, decline in neuromuscular and functional abilities, and diminished quality of life (Biehl et al, 2015; Hopkins et al, 2005).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide individually appropriate preventive or corrective interventions:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis>Musculoskeletal</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Implement safety precautions in care environment (e.g., bed in lowest possible position, use of bedrails and mobility aids, adequate personnel and equipment for turning/sitting/standing/transfers; family or care provider presence with client).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Patient is at high risk due to (1) prolonged bed rest/immobility, (2) activity intolerance associated with hypoxia, (3) neurosensory and cognitive impairments, (4) use of multiple medications, (5) generalized weakness (debilitation) associated with nutrition status and disease process, and (6) reduced balance, muscle strength, and endurance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Initiate and maximize mobility at earliest opportunity (e.g., advancing from passive to active ROM, turning and sitting in bed, and performing personal grooming skills to standing and walking with assistance and equipment).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improves perfusion to all organs and systems; may prevent loss of or help maintain muscle strength and tone. Care providers may be reluctant to mobilize patient for fear that he or she will &ldquo;go downhill&rdquo; while up, experience falls or other injury, or disconnect lines, airways, and other life-support equipment. However, recent and ongoing research suggests that patients who are mobilized earlier come off ventilators sooner, leave ICU and the hospital earlier, and may have fewer short-term (at 12 months) complications (Denehy, Lanphere, &amp; Needham, 2017; Patel et al, 2014; Sharma &amp; Bendas, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis>Sensory/perception</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Orient patient as needed to situation, time, place, and person. Provide cues for orientation (e.g., clock, calendar, verbal reminders, chats about current events, family presence).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Disturbances in sensory stimulation/interpretation and thought processes are associated with immobility, current disease process, treatments, and medication effects. Sensory stimulation helps in recovery of orientation and other cognitive processes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide uninterrupted sleep and rest periods, as well as appropriate level of environmental stimulation (e.g., music, TV/radio, personal possessions, day/night lighting, visitors).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes improvement of both physiological and psychological effects associated with serious illness and treatment environment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Avoid use of restraints if possible. Use the least restrictive type of restraint when applied, and monitor restrained client closely.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use of restraints can exacerbate patient&rsquo;s disorientation and confusion and are used only as a last resort when the risk of injury to the patient or others is high (Springer, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis>Skin</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect skin and bony prominences at admission and frequently, documenting changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides baseline for ongoing assessments and response to interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide skin care routinely in addition to perineal care prn, washing with mild cleanser and drying well. Apply lotion to dry skin or protectant ointment to perineal area.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Clean, moisturized skin is less prone to break down. Prompt peri care minimizes contact with skin irritants (urine, stool, excessive moisture), reducing risk of skin breakdown and pressure ulcer formation in coccyx area.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reposition frequently, including weight shifts when in seated position.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances circulation to compromised tissues, reducing risk of breakdown/pressure injury.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review nutritional status, noting dietary components (e.g., protein, calories, fats, vitamins, minerals, electrolytes).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improved nutrition aids the body in healing and promotes healthier skin and tissues. <emphasis>Note:</emphasis> Client may receive enteral or parenteral feedings during critical phase. (Refer to Care Plan: Total Nutritional Support for further assessments and interventions.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis>Elimination</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe elimination patterns (bowel and bladder), noting changes and potential problems.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides baseline for ongoing assessments and response to interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Implement bowel management program, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The critically ill patient receiving multiple treatments and medications that impact bowel function may require specific medications/enema, etc.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis>Vascular (tissue perfusion)</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess cognition and mental status (ongoing).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes may be associated with underlying disease process (e.g., sepsis, trauma, shock state), mental or emotional state, and status of cerebral oxygenation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Check for calf tenderness, redness, and/or swelling. Document and report these signs, when present.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of deep vein thrombosis, requiring prompt intervention to resolve clotting problem and prevent lung complications (pulmonary embolus).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis>Powerlessness</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate for presence of (or potential for) factors with negative impact on recovery of physical, emotional, and behavioral health.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The current situation and treatment environment can cause feelings of powerlessness. In addition, patient&rsquo;s premorbid state, age, relationship status, and lack of support system/resources can further exacerbate these feelings, resulting in withdrawal or depression.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Involve patient in care decisions, as possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances sense of control and promotes independence.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promote interactions and normalization of activities (to extent possible within treatment environment) with family/SO, friends, and peers.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stimulates the body to produce chemical substances that increase feelings of well-being, alertness, and normalcy in social interactions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide lateral tilting bed or pressure-reducing surfaces (e.g., air/water mattress bed, gel-filled cushions, foam padding).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces static pressure on fragile tissues.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Institute peripheral vascular support measures (e.g., sequential compression devices [SCDs], elastic hose).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances venous return circulation and leg edema, reduces risk of deep vein thrombosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications as indicated, e.g., lorazepam (Ativan); enoxaparin (Lovenox); heparin</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be required for prevention or treatment of various complications, including agitation, DVT.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Collaborate with other health team members in providing rehabilitative therapies, nutritional support, wound care, and mental health counseling as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To achieve maximal gains in physical functioning and psychosocial well-being.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Refer for support and resources, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>ALI/ARDS survivors deal with long-term neurocognitive, emotional, social, and financial effects of critical illness. Client/SO/caregiver may need or desire counseling, support/resources, special equipment, and medications postdischarge.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0089note0163">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Self-Care deficit, [specify]</emphasis>&mdash;fatigue, weakness, neuromuscular or musculoskeletal impairment; impaired mobility; anxiety</para></listitem>
<listitem><para><emphasis role="bi">risk for caregiver Role Strain</emphasis>&mdash;illness severity of care receiver; care receiver discharged home with significant needs; caregiver health impairment; extended duration of caregiving required; caregiving task complexity; excessive caregiving activities; insufficient caregiver respite</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of healthcare system or therapeutic regimen; decisional or family conflict; insufficient social support; economically disadvantaged</para></listitem>
<listitem><para><emphasis role="bi">risk for Frail Elderly Syndrome</emphasis>&mdash;chronic illness, prolonged hospitalization; activity intolerance, decreased energy; alteration in cognitive functioning; malnutrition; anxiety, depression; sensory deficit; impaired balance or mobility; insufficient social support; social vulnerability (e.g., disempowerment, decreased life control)</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0003s0094"><title><emphasis role="strong">RESPIRATORY FAILURE/VENTILATORY ASSISTANCE</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis>&mdash;impairment of respiratory function affecting O<subscript>2</subscript> uptake and CO<subscript>2</subscript> elimination, requiring mechanical assist to support or replace spontaneous breathing. Respiratory failure may be acute or chronic and is associated with:</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Inability to maintain adequate oxygenation (hypoxemia)</para></listitem>
<listitem><para>Inability to maintain adequate ventilation due to apnea or alveolar hypoventilation, causing a rise in PaCO<subscript>2</subscript> and a fall in serum pH (respiratory acidosis)</para></listitem>
<listitem><para>Inability to continue the work of breathing (respiratory muscle weakness or failure)</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Types (Kaymar &amp; Sharma, 2016; Melanson, 2017)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Type 1. Hypoxemia (PO<subscript>2</subscript> &lt;50 mm Hg on room air). These disorders interfere with the lung&rsquo;s ability to oxygenate blood as it flows through the pulmonary vasculature, such as might occur with disconnection with oxygen source, hypoventilation, high-altitude sickness, V/Q mismatch, or shunting.</para></listitem>
<listitem><para>Type 2 (hypercapnic/ventilatory). Acute respiratory acidosis such as might occur with acute exacerbation of chronic emphysema or asthma; increased CO<subscript>2</subscript> production as might occur with sepsis, fever, burns.</para></listitem>
<listitem><para>Type 3 (perioperative). Subset of type 1 but is a common phenomenon. Related causes include atelectasis associated with supine position, airway secretions, upper abdominal incision.</para></listitem>
<listitem><para>Type 4 (shock) associated with hypoperfusion. Shock may be hypovolemic, cardiogenic, or septic.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiologies (Kaymar &amp; Sharma, 2016; Melanson, 2017)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Central nervous system (CNS) impairment (e.g., drug effects or overdose; cervical spinal cord injury; brain injury with increased ICP, stroke; central alveolar hypoventilation)</para></listitem>
<listitem><para>Neuromuscular conditions affecting respiratory muscle function (e.g., polio, botulism, tetanus, multiple sclerosis [MS], myasthenia gravis [MG], Guillain-Barre syndrome [GBS])</para></listitem>
<listitem><para>Chest wall trauma or deformities (e.g., thoracic/lung trauma, pneumothorax, kyphoscoliosis, obesity-hypoventilation syndrome)</para></listitem>
<listitem><para>Lung injury (e.g., pulmonary endothelial and epithelial damage and subsequent increased permeability, such as occurs with acute respiratory distress syndrome [ARDS])</para></listitem>
<listitem><para>Upper airway conditions (e.g., obstruction [foreign object, tumor/mass], bronchospasm, infections)</para></listitem>
<listitem><para>Lower airway conditions (e.g., pneumonia/other lung infections, congestive heart failure)</para></listitem>
<listitem><para>Lung parenchyma (e.g., infections, interstitial lung disease [autoimmune or rheumatologic diseases; occupational and organic exposures, radiation; pulmonary fibrosis])</para></listitem>
<listitem><para>Cardiovascular system (e.g., pulmonary edema, cardiopulmonary shock/arrest)</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Treatment of Respiratory Failure</emphasis></para>
<para>The goal in management of respiratory failure is to reverse hypoxia. Noninvasive ventilation may be considered in patients with mild to moderate acute respiratory failure. Ventilatory support via a nasal or full-face mask is increasingly being used for patients with chronic respiratory failure (see <link linkend="ch0003s0094note0164">Glossary</link> below for NIV).</para>
<para>However, in patients with severe hypoxemia, intubation and mechanical ventilation are usually required to increase PaO<subscript>2</subscript> and to lower PaCO<subscript>2</subscript> and to rest the respiratory muscles. Endotracheal intubation provides the link between the patient and the ventilator. The mode of ventilation and ventilator settings is determined by the patient&rsquo;s lung mechanics, underlying disease process, gas exchange, and response to mechanical ventilation.</para>
</listitem>
<listitem><para><emphasis role="strong">Mechanical Ventilators</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>While ventilator modes have classically been divided into pressure or volume controlled, a more modern approach describes ventilatory modes based on three characteristics: the <emphasis role="strong">trigger</emphasis> (flow versus pressure), the <emphasis role="strong">limit</emphasis> (what determines the size of the breath), and the <emphasis role="strong">cycle</emphasis> (what ends the breath). For example, in both volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV), time is the cycle, with the difference being in how the time to the end of expiration is determined.</para></listitem>
<listitem><para>Common modes of ventilation (Parker, 2012; Miller, 2013; Open Anesthesia, 2017)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Assist control (AC): Provides a breath with either a preset volume for ventilator-initiated breaths or peak pressure every time client takes a breath. One of the most common modes, AC is used for patients who require the most support from the ventilator.</para></listitem>
<listitem><para>Synchronized intermittent mandatory ventilation (SIMV): The ventilator synchronizes machine breath delivery with the patient&rsquo;s spontaneous breath efforts. This mode is a combination of set mandatory machine breaths synchronized with the patient&rsquo;s own spontaneous breaths. The rationale behind using SIMV instead of AC is to help work the patient&rsquo;s respiratory muscles by providing periods of reduced support.</para></listitem>
<listitem><para>Pressure-controlled ventilation (PCV): Type of mandatory breathing that can be used in either AC or SIMV modes and targets a specific pressure during inspiration. In this mode, the clinician sets a specific time for inspiration.</para></listitem>
<listitem><para>Pressure-supported ventilation (PSV or PS): This type of spontaneous breathing support can be used in either CPAP or SIMV modes and targets a set inspiratory pressure. Inspiration ends as the lung gets full and the delivered flow decreases to a specific value set by the clinician. The patient controls the respiratory rate and inspiratory time, as well as the flow rate and tidal volume.</para></listitem>
<listitem><para>Positive end-expiratory pressure (PEEP): An adjunct to mechanical ventilation that uses elevated pressure during the expiratory phase to increase functional residual capacity lung surface area available for gas exchange. This helps prevent small airway collapse.</para></listitem>
<listitem><para>Airway pressure release ventilation (APRV): A variation of CPAP that releases pressure temporarily on exhalation. APRV uses an inverse I:E ratio (i.e., the expiratory [E] phase is longer than the inspiratory [I] phase) to sustain higher airway pressures. Patient can spontaneously ventilate at both low and high pressures, although typically more ventilation occurs at high pressure. This mode has been shown to improve oxygenation in patients who are otherwise difficult to oxygenate.</para></listitem>
<listitem><para>Continuous positive airway pressure (CPAP): This mode allows the patient to breathe at a continuous, elevated airway pressure that can improve oxygenation (PEEP/CPAP) and reduce the patient&rsquo;s work of breathing.</para>
</listitem></orderedlist></listitem>
<listitem><para>Ventilator Settings</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>FiO<subscript>2</subscript>: Measure of oxygen delivered during inspiration.</para></listitem>
<listitem><para>Rate: Number of breaths delivered by ventilator per minute.</para></listitem>
<listitem><para>Tidal volume: Volume of gas delivered with each breath.</para></listitem>
<listitem><para>Sensitivity: Alerts ventilator when to recognize the start of spontaneous breathing effort.</para></listitem>
<listitem><para>Peak flow: The flow rate used to deliver each breath.</para></listitem>
<listitem><para>Inspiratory and expiratory times: Time to deliver one complete respiratory cycle. Typically, expiratory time is three times longer than inspiratory time.</para></listitem>
<listitem><para>Cycling: Way the ventilator ends the inspiratory phase and allows the patient to exhale. Cycling may be volume cycled, pressure cycled, or flow cycled.</para></listitem>
<listitem><para>Limit: Restricts the volume, pressure, or time that gas is delivered during inspiratory phase.</para>
</listitem></orderedlist></listitem>
<listitem><para>Complications</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Associated with endotracheal (ET) tube: Tissue damage to lips, tongue, throat; mucous plugs impairing ventilation and obstruction caused by client biting tube; auto PEEP; sinusitis or otitis; cuff herniation (rare).</para></listitem>
<listitem><para>Associated with the ventilator: Infection, hemodynamic instability from positive-pressure ventilation, barotraumas, gastrointestinal (GI) bleeding due to stress ulcer.</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: Acute respiratory failure requiring mechanical ventilation accounts for approximately 30% of admissions to intensive care units (ICUs) (Esteban et al, 2002).</para></listitem>
<listitem><para>Mortality: The mortality associated with respiratory failure varies according to the etiology. Younger patients (&lt;60 years) have better survival rates than older patients. For ARDS, mortality is approximately 40% to 45%; this figure has not changed significantly over the years (Phua et al, 2009). Significant mortality also occurs in patients with hypercapnic respiratory failure because they have a chronic respiratory disorder and other comorbidities (such as cardiopulmonary, renal, hepatic, or neurologic disease) (Kaymar &amp; Sharma, 2016). A meta-analysis of 39 studies of patients on prolonged mechanical ventilation reported a 1-year mortality of approximately 60% (Demuth et al, 2015).</para></listitem>
<listitem><para>Cost: A large-scale study (of 905,035 patients) who required mechanical ventilation between 2008 and 2011 (but did not have ventilator-associated pneumonia) reported that the average per person cost of hospitalization was $44,888. Patients who developed VAP had a significantly higher cost of hospitalization ($98,386 vs. $44,098, <emphasis>P</emphasis> &lt; .001) (Soni et al, 2014).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0003s0094note0164"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Acute respiratory failure:</emphasis> A short-term condition, occurring suddenly, and treated as a medical emergency.</para>
<para><emphasis role="strong">Barotrauma:</emphasis> Injury to the lungs, airways, or chest wall due to local overinflation caused by high distending pressure in the intrapulmonary airways.</para>
<para><emphasis role="strong">Capnography:</emphasis> Measures the concentration or <emphasis role="strong">partial pressure</emphasis> of <emphasis role="strong">carbon dioxide</emphasis> (CO<subscript>2</subscript>) in respiratory gases and the adequacy of patient ventilation. Capnographs typically provide a numerical value for end-tidal CO<subscript>2</subscript> (ETCO<subscript>2</subscript>) and a graphic representation of exhaled CO<subscript>2</subscript> in respiratory gases over time.</para>
<para><emphasis role="strong">Chronic respiratory failure:</emphasis> Develops over time and requires long-term treatment.</para>
<para><emphasis role="strong">Endotracheal (ET) tube:</emphasis> Tube inserted through the mouth into the trachea to facilitate passage of air into and out of the lungs.</para>
<para><emphasis role="strong">FiO<subscript>2</subscript> (fraction of inspired oxygen):</emphasis> Fraction or percentage of oxygen in the space being measured.</para>
<para><emphasis role="strong">Hypercapnic respiratory failure:</emphasis> Characterized by PaCO<subscript>2</subscript> higher than 50 mm Hg.</para>
<para><emphasis role="strong">Hyperventilation:</emphasis> Fast rate of respiration, which results in loss of carbon dioxide from the blood.</para>
<para><emphasis role="strong">Hypoventilation:</emphasis> High partial pressure of alveolar CO<subscript>2</subscript> (PaCO<subscript>2</subscript>).</para>
<para><emphasis role="strong">Hypoxemia:</emphasis> Low oxygen levels in the blood, common in patients with hypercapnic respiratory failure breathing room air.</para>
<para><emphasis role="strong">Hypoxemic respiratory failure:</emphasis> Characterized by a PaO<subscript>2</subscript> lower than 60 mm Hg with a normal PaCO<subscript>2</subscript> and is the most common form of respiratory failure.</para>
<para><emphasis role="strong">Noninvasive ventilation (NIV):</emphasis> Administration of ventilatory support without using an endotracheal or tracheostomy tube. Use of NIV has significantly increased over the past two decades and is now an essential tool in management of both acute and chronic respiratory failure. NIV modes include positive- or negative-pressure ventilation and high-flow nasal oxygenation (Soo Hoo, 2016).</para>
<para><emphasis role="strong">PaCO<subscript>2</subscript>:</emphasis> Arterial carbon dioxide tension.</para>
<para><emphasis role="strong">PaO<subscript>2</subscript>:</emphasis> Arterial oxygen tension.</para>
<para><emphasis role="strong">Positive-pressure ventilation:</emphasis> Increases pressure in airway, thus forcing air into lungs.</para>
<para><emphasis role="strong">Pressure-cycled ventilator:</emphasis> Gas pressure limit is predetermined.</para>
<para><emphasis role="strong">Respiratory failure:</emphasis> Syndrome in which the respiratory system fails in one or both of its gas exchange functions: oxygenation and carbon dioxide elimination. Respiratory failure can be classified as hypoxemic (low blood oxygen levels) or hypercapnic (high carbon dioxide levels). Respiratory failure may result from either a reduction in ventilatory capacity or an increase in ventilatory demand (or both) (see below).</para>
<para><emphasis role="strong">Ventilation:</emphasis> Ability to remove CO<subscript>2</subscript> through the lungs.</para>
<para><emphasis role="strong">Ventilatory capacity:</emphasis> Maximal spontaneous ventilation that can be maintained without development of respiratory muscle fatigue.</para>
<para><emphasis role="strong">Ventilatory demand:</emphasis> Spontaneous minute ventilation that results in a stable PaCO<subscript>2</subscript>.</para>
<para><emphasis role="strong">Volume cycle ventilator:</emphasis> Volume of gas (tidal volume) is predetermined and delivered.</para>
</note>
<sect2 id="ch0003s0095"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>The focus of this plan of care is the client with invasive mechanical ventilation who remains on a ventilator, whether in an acute or postacute care setting. The expectation is that most clients will be weaned before discharge. However, some clients are either unsuccessful at weaning or are not candidates for weaning. For these clients, portions of this plan of care would need to be modified for the discharge care setting, whether it be an extended-care facility or home.</para>
</sect2>
<sect2 id="ch0003s0096"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0003s0089">Acute lung injury/acute respiratory distress syndrome</link></para>
<para><link linkend="ch0002s0053">Cardiac surgery</link></para>
<para><link linkend="ch0003s0069">Chronic obstructive pulmonary disease (COPD) and asthma</link></para>
<para><link linkend="ch0004s0107">Craniocerebral trauma (acute rehabilitative phase)</link></para>
<para><link linkend="ch0003s0084">Pneumothorax/hemothorax</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0004s0129">Spinal cord injury</link></para>
<para><link linkend="ch0006s0219">Total nutritional support</link></para>
<table frame="top" id="ch0003s0094ta0095"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE: RESPIRATORY FAILURE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Gathered data depend on the underlying pathophysiology and reason for ventilatory support.</para>
<para>***Refer to the appropriate plan of care.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION
<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY OBSERVE</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Generalized weakness and fatigue</para></listitem>
<listitem><para>Shortness of breath at rest or with exertion</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Tachycardia, hypertension, and diaphoresis (stress response)</para></listitem>
<listitem><para>Peripheral or central cyanosis</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Dizziness</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Altered level of consciousness (e.g., drowsy, lethargic, somnolent, comatose)</para></listitem>
<listitem><para>Altered cognitive status (e.g., confused, agitated)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Shortness of breath, inability to breathe</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Increased work breathing, including tachypnea, use of accessory muscles, nasal flaring; intercostal indrawing, suprasternal or supraclavicular retractions</para></listitem>
<listitem><para>Abnormal arterial blood gas results or decreased oxygen saturation</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>History of chronic lung conditions (e.g., COPD, recurrent pneumonia, cystic fibrosis, chest injury, stroke, muscular dystrophy)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Coughing up mucus, wheezing (with chronic respiratory failure)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>(If client is ventilator dependent) may require changes in physical layout of home; acquisition of equipment and supplies; provision of a backup power source; instruction of significant other (SO) and caregivers; provision for continuation of plan of care; assistance with transportation; coordination of resources and support systems</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0003s0094ta0096"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST
<?lb?>WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Procedure used to evaluate organs and structures within the chest.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Chest x-ray results vary depending on type of respiratory failure (acute or chronic), for example:</para>
<para>May be clear and associated with hypoxemia and normocapnia such as might occur with pulmonary embolus, shock</para>
<para>May be diffusely white (opacified) with hypoxemia and normocapnia such as might occur with ARDS, noncardiogenic PE, CHF, pulmonary fibrosis</para>
<para>May show localized infiltrates as might occur with pneumonia, atelectasis</para>
<para>May be clear with hypercapnia such as might occur with COPD, asthma; overdoses; neuromuscular weakness respiratory conditions (Melanson, 2017)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PULMONARY FUNCTION STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine the ability of the lungs to exchange oxygen and carbon dioxide and include, but are not limited to, the following:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Vital capacity (VC):</emphasis> The total amount of air that can be exhaled after a maximum inspiration; the sum of the inspiratory reserve volume, the tidal volume, and the expiratory reserve volume.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduced in restrictive chest or lung conditions</para>
<para>Normal or increased in COPD</para>
<para>Normal to decreased in neuromuscular diseases, such as Guillain-Barr&eacute; syndrome</para>
<para>Decreased in conditions limiting thoracic movement, such as kyphoscoliosis. <emphasis>Note:</emphasis> Negative inspiratory force (NIF) can be substituted for VC to determine whether client can initiate a breath.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Forced vital capacity (FVC):</emphasis> Total amount of air that can forcibly be blown out after full inspiration.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduced in restrictive conditions and in asthma and is normal to reduced in COPD.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Tidal volume (V<subscript>T</subscript>):</emphasis> Specific volume of air that is drawn into and then expired out of the lungs.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be decreased in both restrictive and obstructive processes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Minute ventilation (V<subscript>E</subscript>):</emphasis> Measures volume of air inhaled and exhaled in 1 minute of normal breathing.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This reflects muscle endurance and is a major determinant of work of breathing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Peak inspiratory pressure (PIP):</emphasis> Measures respiratory muscle strength pressure needed to provide each breath.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Normal values should roughly equal the residual volume. Target PIP is below 30 cm H<subscript>2</subscript>O. <emphasis>Note:</emphasis> High PIP may indicate a kinked tube, a need for suctioning, bronchospasm, or a lung problem, such as pulmonary edema or pneumothorax (Parker, 2012).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Forced expiratory volume (FEV<subscript>1</subscript>):</emphasis> Measures amount of air in liters that a person can forcibly blow out in 1 second. Along with FVC, it is considered one of the primary indicators of lung function.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Usually decreased in obstructive and restrictive lung disorders.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">STUDIES THAT MONITOR STATUS AND DETERMINE READINESS FOR WEANING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Arterial blood gases (ABGs):</emphasis> Assesses status of oxygenation, ventilation, and acid-base balance via arterial blood.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>ABG results help determine settings for the ventilator, such as partial pressure of arterial oxygen (PaO<subscript>2</subscript>), arterial saturation (SaO<subscript>2</subscript>), and partial pressure of arterial carbon dioxide (PaCO<subscript>2</subscript>).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Procedure used to evaluate organs and structures within the chest.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitors resolution and progression of underlying condition, such as ARDS, atelectasis, and pneumonia.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Nutritional assessment:</emphasis> Assesses albumin, prealbumin, serum transferrin, complete blood count (CBC), electrolytes, lipid profile, iron tests, blood urea nitrogen (BUN)/creatinine (Cr), glucose, and so on.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Done to identify nutritional imbalances that might prolong time on ventilator or interfere with successful weaning.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0003s0097"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Promote adequate ventilation and oxygenation.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Provide emotional support for client and SO.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0003s0098"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Respiratory function maximized and adequate to meet individual needs.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Effective means of communication established.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood, including home ventilatory support if indicated.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0003s0094note0165"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Breathing Pattern/impaired spontaneous Ventilation</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Neuromuscular or neurological impairment</para>
<para>Respiratory muscle fatigue; musculoskeletal impairment</para>
<para>Hyperventilation/hyperventilation syndrome [alteration of client&rsquo;s normal O<subscript>2</subscript>:CO<subscript>2</subscript> ratio]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Decreased minute volume, vital capacity, tidal volume</para>
<para>Dyspnea; increased use of accessory muscles</para>
<para>Tachypnea or bradypnea or cessation of respirations when off the ventilator</para>
<para>Decreased PO<subscript>2</subscript> and SaO<subscript>2</subscript>, increased PCO<subscript>2</subscript></para>
<para>Increased restlessness, apprehension, metabolic rate</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Ventilation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Reestablish and maintain effective respiratory pattern via ventilator with absence of retractions and use of accessory muscles, cyanosis, or other signs of hypoxia; ABGs and oxygen saturation within acceptable range.</para>
<para>Participate in efforts to wean (as appropriate) within individual ability.</para>
<para><emphasis role="strong">Caregiver Will</emphasis></para>
<para>Demonstrate behaviors necessary to maintain client&rsquo;s respiratory function.</para>
</note>
<note role="none" id="ch0003s0094note0166"><table frame="top" id="ch0003s0094ta0097"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Mechanical Ventilation Management: Invasive</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Investigate etiology of respiratory failure.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding the underlying cause of client&rsquo;s particular ventilatory problem is essential to the care of client, for example, decisions about future capabilities and ventilation needs and most appropriate type of ventilatory support.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe overall breathing pattern. Note respiratory rate, distinguishing between spontaneous respirations and ventilator breaths.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client on a ventilator can experience hyperventilation, hypoventilation, or dyspnea and &ldquo;air hunger&rdquo; and attempt to correct deficiency by overbreathing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate chest periodically, noting presence or absence and equality of breath sounds, adventitious breath sounds, and symmetry of chest movement.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information regarding airflow through the tracheobronchial tree and the presence or absence of fluid, mucous obstruction. <emphasis>Note:</emphasis> Frequent crackles or rhonchi that do not clear with coughing or suctioning may indicate developing complications, such as atelectasis, pneumonia, acute bronchospasm, and pulmonary edema. Changes in chest symmetry may indicate improper placement of the ET tube or development of barotrauma.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Count client&rsquo;s respirations for 1 full minute and compare with desired respirations and ventilator set rate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Respirations vary depending on problem requiring ventilatory assistance; for example, client may be totally ventilator dependent or be able to take breath(s) on own between ventilator-delivered breaths. Rapid client respirations can produce respiratory alkalosis and prevent desired volume from being delivered by ventilator. Slow client respirations and hypoventilation increase PaCO<subscript>2</subscript> levels and may cause acidosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Verify that client&rsquo;s respirations are in phase with the ventilator.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adjustments may be required in flow, tidal volume, respiratory rate, and dead space of the ventilator, or client may need sedation to synchronize respirations and reduce work of breathing and energy expenditure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Position client by elevating head of bed or chair if possible; place in prone position, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevating the client&rsquo;s head and helping client get out of bed while still on the ventilator is both physically&mdash;helps decrease risk of aspiration&mdash;and psychologically beneficial. <emphasis>Note:</emphasis> Large randomized trials and recent meta-analyses show that prone position, when performed early and in sufficient duration, may improve survival in patients with severe ARDS and in patients with restrictive lung conditions ventilated with small tidal volumes. Prone positioning seems to act beneficially, improving hemodynamics, gas exchange, and respiratory mechanics. There are contraindications (e.g., unstable vertebral fractures, difficult airway management, recent thoracic surgery) and care difficulties (e.g., patient&rsquo;s size and number of lines, lack of sufficient personnel to perform care interventions, or safe and rapid repositioning when needed) (Koulouras et al, 2016.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Inflate tracheal or ET tube cuff properly, using minimal leak and occlusive technique. Check cuff inflation every 4 to 8 hours and whenever cuff is deflated and reinflated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The cuff must be properly inflated to ensure adequate ventilation and delivery of desired tidal volume and to decrease risk of aspiration. <emphasis>Note:</emphasis> In long-term clients, the cuff may be deflated most of the time or a noncuffed tracheostomy tube used if the client&rsquo;s airway is protected.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Check tubing for obstruction, such as kinking or accumulation of water. Drain tubing as indicated, avoiding draining toward client or back into the reservoir.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Kinks in tubing prevent adequate volume delivery and increase airway pressure. Condensation in tubing prevents proper gas distribution and predisposes to bacterial growth.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Check ventilator alarms for proper functioning. Do not turn off alarms, even for suctioning. Remove from ventilator and ventilate manually if source of ventilator alarm cannot be quickly identified and rectified. Ascertain that alarms can be heard in the nurses&rsquo; station.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ventilators have a series of visual and audible alarms, such as oxygen, low volume or apnea, high pressure, and inspiratory/expiratory (I:E) ratio. Turning off or failure to reset alarms places client at risk for unobserved ventilator failure or respiratory distress or arrest.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Keep resuscitation bag at bedside and ventilate manually whenever indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides or restores adequate ventilation when client or equipment problems require client to be temporarily removed from the ventilator.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist client in &ldquo;taking control&rdquo; of breathing if weaning is attempted or ventilatory support is interrupted during procedure or activity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Coaching client to take slower, deeper breaths; practice abdominal or pursed-lip breathing; assume position of comfort; and use relaxation techniques can be helpful in maximizing respiratory function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess ventilator settings routinely and readjust, as indicated:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Controls or settings are adjusted according to client&rsquo;s primary disease and results of diagnostic testing to maintain parameters within appropriate limits.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note operating mode of ventilation (e.g., AC, pressure support [PS]).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client&rsquo;s respiratory requirements, presence or absence of an underlying disease process, and the extent to which client can participate in ventilatory effort determine parameters of each setting. PS has advantages for client on long-term ventilation because it allows client to strengthen pulmonary musculature without compromising oxygenation and ventilation during the weaning process.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe oxygen concentration percentage (FiO<subscript>2</subscript>), verify that oxygen line is in proper outlet or tank, and monitor in-line oxygen analyzer or perform periodic oxygen analysis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>FiO<subscript>2</subscript> is adjusted (21% to 100%) to maintain an acceptable oxygen percentage and saturation (e.g., 90%) for client&rsquo;s condition.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe end-tidal CO<subscript>2</subscript> (ETCO<subscript>2</subscript>) values.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measures the amount of exhaled CO<subscript>2</subscript> with each breath and is displayed graphically to spot CO<subscript>2</subscript> exchange problems early before they show up on ABGs. In some cases, a slightly higher level of CO<subscript>2</subscript> can be beneficial, such as for the client with long-standing emphysema. In this instance, elevated PCO<subscript>2</subscript> is accepted without correction, leading to the term &ldquo;permissive hypercapnia&rdquo; (Byrd &amp; Roy, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess set respiratory frequency (f).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Respiratory rate of 10 to 15 per minute may be appropriate except for client with COPD and CO<subscript>2</subscript> retention. In these individuals, rate and volume should be adjusted to achieve personal baseline PaCO<subscript>2</subscript>, not necessarily a &ldquo;normal&rdquo; PaCO<subscript>2</subscript>.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess V<subscript>T</subscript>. Verify proper function of spirometer, bellows, or computer readout of delivered volume; note alterations from desired volume delivery.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitors amount of air inspired and expired. Changes may indicate alteration in lung compliance or leakage through machine or around tube cuff. <emphasis>Note:</emphasis> For the client without preexisting lung disease, the V<subscript>T</subscript> and rate are traditionally selected by using V<subscript>T</subscript> of 8 to 10 mL/kg delivered 12 times per minute in the AC mode. For clients with COPD, the V<subscript>T</subscript> and rate are slightly reduced to 10 mL/kg at 10 breaths per minute to prevent overinflation and hyperventilation. Many clinicians now use a smaller V<subscript>T</subscript> (6 to 8 mL/kg), especially in clients with ARDS and sometimes in obstructive and restrictive lung disease, to reduce air-trapping and mechanical stress on the lung.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Flow rate</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Speed with which the V<subscript>T</subscript> is delivered is usually about 50 L/min but is variable in order to maintain I:E ratio appropriate for specific situation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pressure limit</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Regulates the amount of pressure the volume-cycled ventilator can generate to deliver the preset V<subscript>T</subscript> with usual setting at 10 to 20 cm H<subscript>2</subscript>O above the client&rsquo;s peak inspiratory pressure. Airway pressure should remain relatively constant. Increased pressure alarm reading reflects (1) increased airway resistance as may occur with bronchospasm, (2) retained secretions, and (3) decreased lung compliance as may occur with obstruction of the ET tube, development of atelectasis, ARDS, pulmonary edema, worsening COPD, or pneumothorax. Low airway pressure alarms may be triggered by pathophysiological conditions causing hypoventilation, such as disconnection from ventilator, low ET cuff pressure, ET tube displaced above the vocal cords, and client &ldquo;overbreathing&rdquo; or out of phase with the ventilator.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor I:E ratio.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Expiratory phase is usually twice the length of the inspiratory rate but may be longer to compensate for air-trapping to improve gas exchange in the client with COPD.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Set sigh rate, when used.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Clinicians once recommended that periodic machine breaths that were 1.5 to 2 times the preset V<subscript>T</subscript> be given six to eight times per hour. At present, accounting for sighs is not recommended if the client is receiving V<subscript>T</subscript> of 8 to 10 mL/kg or if PEEP is required. When a low V<subscript>T</subscript> is used, sighs are preset at 1.5 to 2 times the V<subscript>T</subscript> and delivered six to eight times per hour if the peak and plateau pressures are within acceptable limits (Byrd &amp; Roy, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note inspired humidity and temperature; use heat moisture exchanger (HME), as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Usual warming and humidifying function of nasopharynx is bypassed with intubation. Dehydration can dry up normal pulmonary fluids, cause secretions to thicken, and increase risk of infection. Temperature should be maintained at about body temperature to reduce risk of damage to cilia and hyperthermia reactions. The introduction of a heated wire circuit to the traditional system significantly reduces the problem of &ldquo;rainout&rdquo; or condensation in the tubing.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor serial ABGs and pulse oximetry.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Adjustments to ventilator settings may be required, depending on client&rsquo;s response and trends in gas exchange parameters.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0094note0167"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Airway Clearance</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Presence of artificial airway</para>
<para>Neuromuscular dysfunction</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Changes in respiratory rate</para>
<para>Ineffective/absent cough</para>
<para>Adventitious breath sounds</para>
<para>Restlessness</para>
<para>Cyanosis</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Airway Patency</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain patent airway with breath sounds clear.</para>
<para>Be free of aspiration.</para>
<para><emphasis role="strong">Caregiver Will</emphasis></para>
<para>Identify potential complications and initiate appropriate actions.</para>
</note>
<note role="none" id="ch0003s0094note0168"><table frame="top" id="ch0003s0094ta0098"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Artificial Airway Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess airway patency.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Obstruction may be caused by accumulation of secretions, mucous plugs, hemorrhage, bronchospasm, and problems with the position of tracheostomy or ET tube.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate chest movement and auscultate for bilateral breath sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Symmetrical chest movement with breath sounds throughout lung fields indicates proper tube placement and unobstructed airflow. Lower airway obstruction, such as pneumonia or atelectasis, produces changes in breath sounds, such as rhonchi and wheezing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor ET tube placement. Note lip line marking and compare with desired placement. Secure tube carefully with tape or tube holder. Obtain assistance when retaping or repositioning tube.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The ET tube may slip into the right main-stem bronchus, thereby obstructing airflow to the left lung and putting client at risk for a tension pneumothorax.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note excessive coughing, increased dyspnea (using a 0 to 10 [or similar] scale), high-pressure alarm sounding on ventilator, visible secretions in endotracheal or tracheostomy tube, and increased rhonchi.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The intubated client often has an ineffective cough reflex, or client may have neuromuscular or neurosensory impairment, altering ability to cough. Client is usually dependent on suctioning to remove secretions. <emphasis>Note:</emphasis> Research supports use of a dyspnea rating scale (like those used to measure pain) to more accurately quantify and measure changes in dyspnea as experienced by client.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suction as needed when client is coughing or experiencing respiratory distress, limiting duration of suction to no more than 15 seconds. Choose appropriate suction catheter. Hyperventilate before and after each catheter pass, using 100% oxygen if appropriate, using vent rather than Ambu bag, which has an increased risk of barotrauma. Suction continuously during withdrawal.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suctioning should not be routine, and duration should be limited to reduce hazard of hypoxia. Suction catheter diameter should be less than 50% of the internal diameter of the ET or tracheostomy tube for prevention of hypoxia. Hyperoxygenation with ventilator sigh on 100% oxygen may be desired to reduce atelectasis and to reduce accidental hypoxia. <emphasis>Note:</emphasis> Instilling normal saline (NS) is no longer recommended, although it persists in practice. Reasons to abstain from NS use vary but include complications such as infection and harmful hemodynamic changes (Caporros &amp; Forbes, 2014).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use inline catheter suction when available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps maintain oxygen saturation and PEEP when used.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reposition or turn periodically.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes drainage of secretions and ventilation to all lung segments, reducing risk of atelectasis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage the client to drink fluids (if swallowing is possible) and provide fluids within individual capability.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps liquefy secretions, enhancing expectoration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide chest physiotherapy as indicated, such as postural drainage and percussion.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes ventilation of all lung segments and aids drainage of secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer intravenous (IV) and aerosol bronchodilators as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes ventilation and removal of secretions.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Assist with fiber-optic bronchoscopy, if indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be performed to remove secretions and mucous plugs.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0094note0169"><title><emphasis role="strong">NURSING DIAGNOSIS: impaired verbal Communication</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Physical barrier (e.g., tracheostomy intubation)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Inability to speak</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Communication: Expressive</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Establish method of communication in which needs can be understood.</para>
</note>
<note role="none" id="ch0003s0094note0170"><table frame="top" id="ch0003s0094ta0099"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Communication Enhancement: Speech Deficit</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess client&rsquo;s ability to communicate by alternative means.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reasons for long-term ventilatory support are various; client may be alert and be adept at writing (such as chronic COPD with inability to be weaned) or may be lethargic, comatose, or paralyzed. Method of communicating with client is therefore highly individualized. <emphasis>Note:</emphasis> The inability to talk while intubated is a primary cause of feelings of fear.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establish means of communication, for example, maintain eye contact; ask yes/no questions; provide magic slate, paper and pencil, computer, cell phone (if client can text); picture or alphabet board; use sign language as appropriate; and validate meaning of attempted communications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Eye contact assures client of interest in communicating; if client can move head, blink eyes, or is comfortable with simple gestures, a great deal can be done with yes/no questions. Texting, word-processing, writing, or pointing to letter boards is often tiring to client, who can then become frustrated with the process. Use of picture boards that express a concept (e.g., &ldquo;need pain shot&rdquo;) or routine needs (e.g., &ldquo;need bedpan&rdquo;) may simplify communication. Family members and other caregivers may be able to assist and interpret needs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Consider form of communication when placing IV.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>IV positioned in hand or wrist may limit ability to write or sign.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Place call light or bell within reach, making certain client is alert and physically capable of using it. Answer call light or bell immediately. Anticipate needs. Tell client that nurse is immediately available should assistance be required.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ventilator-dependent client may be better able to relax, feel safe (not abandoned), and breathe with the ventilator knowing that nurse is vigilant and needs will be met.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Place note at central call station informing staff that client is unable to speak.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alerts all staff members to respond to client at the bedside instead of over the intercom.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage family and SO to talk with client, providing information about family and daily happenings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>SO may feel self-conscious in one-sided conversation, but knowledge that he or she is assisting client to regain or maintain contact with reality and enabling client to feel part of family unit can reduce feelings of awkwardness.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Evaluate need for or appropriateness of talking tracheostomy tube.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Client with adequate cognitive and muscular skills may have the ability to manipulate talking tracheostomy tube.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0094note0171"><title><emphasis role="strong">NURSING DIAGNOSIS: Anxiety [specify level]</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Situational crises; threat to self-concept</para>
<para>Threat of death</para>
<para>Change in health, economic status, or role functioning</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Increased muscle/facial tension</para>
<para>Insomnia, restlessness</para>
<para>Hypervigilance</para>
<para>Alteration in attention, concentration; confusion</para>
<para>Fear, awareness of physiological symptoms</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Anxiety Self-Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Communicate awareness of feelings and healthy ways to deal with them.</para>
<para>Demonstrate problem-solving skills or behaviors to cope with current situation.</para>
<para><emphasis role="strong">Anxiety Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report that anxiety is reduced to manageable level.</para>
<para>Appear relaxed and sleeping or resting appropriately.</para>
</note>
<note role="none" id="ch0003s0094note0172"><table frame="top" id="ch0003s0094ta0100"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Anxiety Reduction</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify client&rsquo;s perception of threat represented by situation. Determine current respiratory status and adequacy of ventilation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Defines scope of individual problem separate from physiological causes and influences choice of interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe and monitor physical responses, such as restlessness, changes in vital signs, and repetitive movements. Note congruency of verbal/nonverbal communication.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in evaluating extent or degree of concerns, especially when compared with &ldquo;verbal&rdquo; comments.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client and SO to acknowledge and express fears.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides opportunity for dealing with concerns, clarifies reality of fears, and reduces anxiety to a more manageable level.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Acknowledge the anxiety and fear of the situation. Avoid meaningless reassurance that everything will be all right.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Validates the reality of the situation without minimizing the emotional impact. Provides opportunity for client and SO to accept and begin to deal with what has happened, reducing anxiety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify and review with client and SO the safety precautions being taken, such as backup power and oxygen supplies and emergency equipment at hand for suctioning. Discuss or review the meanings of alarm system.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides reassurance to help allay unnecessary anxiety, reduce concerns of the unknown, and preplan for response in emergency situation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note reactions of SO. Provide opportunity for discussion of personal feelings, concerns, and future expectations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Family members have individual responses to what is happening, and their anxiety may be communicated to client, intensifying these emotions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify previous coping strengths of client and SO and current areas of control and ability.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Focuses attention on own capabilities, increasing sense of control.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Demonstrate and encourage use of relaxation techniques, such as guided imagery and progressive relaxation. Provide music therapy and biofeedback as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides active management of situation to reduce feelings of helplessness.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide and encourage sedentary diversional activities within individual capabilities, such as handicrafts, writing, and television.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although handicapped by dependence on ventilator, activities that are normal or desired by the individual should be encouraged to enhance quality of life.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to support individuals, groups, and therapy, as needed.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be necessary to provide additional assistance if client and SO are not managing anxiety or when client is &ldquo;identified with the machine.&rdquo;</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0094note0173"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for impaired Oral Mucous Membrane</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Mechanical factors&mdash;tubes [ET, NG]</para>
<para>Decreased salivation</para>
<para>Ineffective oral hygiene</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Tissue Integrity: Skin and Mucous Membrane</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report or demonstrate a decrease in symptoms.</para>
<para><emphasis role="strong">Caregiver Will</emphasis></para>
<para>Identify specific interventions to promote healthy oral mucosa as appropriate.</para>
</note>
<note role="none" id="ch0003s0094note0174"><table frame="top" id="ch0003s0094ta0101"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Oral Health Maintenance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suction mouth prior to oral care, as well as prn per nursing assessment and facility protocol.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Oral care stimulates saliva production, thereby increasing the amount of secretions present in the mouth and back of throat. Suctioning the mouth before and after oral care reduces the accumulation of excess secretions above the cuff of the endotracheal tube, where aspiration often occurs (a risk factor for ventilator-associated pneumonia [VAP]) (Sole et al, 2011). (Refer to CP: <link linkend="ch0003s0074">Pneumonia</link>, ND: <link linkend="ch0003s0099note0185">risk for Infection [spread]</link> for additional information.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Routinely inspect oral cavity, teeth, gums for sores, lesions, and bleeding.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early identification of problems provides opportunity for appropriate intervention and preventive measures.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer mouth care routinely per protocol and as needed, especially in client with an oral intubation tube; for example, cleanse mouth with water, saline, or preferred alcohol-free mouthwash.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents drying and ulceration of mucous membrane and reduces medium for bacterial growth. Promotes comfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Brush teeth with suction toothbrush, pediatric soft toothbrush, or WaterPik&trade;. Use swab instead of toothbrush on edentulous patient.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Brushing helps remove plaque and debris. Use of a power suction toothbrush helps in accessing hard-to-reach areas while reducing secretion accumulation and minimizing mucosal irritation (Booker et al, 2013).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Apply water-based lip balm and oral lubricant solution.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintains moisture and prevents drying of mucosal surfaces. <emphasis>Note:</emphasis> Dry, cracked mucosa causes discomfort and provides a portal of entry for bacteria.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Change position of ET tube and airway on a regular and prn (as necessary) schedule as appropriate.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Reduces risk of lip and oral mucous membrane ulceration.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0094note0175"><title><emphasis role="strong">NURSING DIAGNOSIS: imbalanced Nutrition: less than body requirements</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Inability to ingest/digest food</para>
<para>[Increased metabolic demands]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Weight loss; poor muscle tone; [decreased subcutaneous fat or muscle mass]</para>
<para>[Hypo-] or hyperactive bowel sounds</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Nutritional Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate progressive weight gain toward goal with normalization of laboratory values.</para>
</note>
<note role="none" id="ch0003s0094note0176"><table frame="top" id="ch0003s0094ta0102"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Nutrition Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate ability to eat.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client with a tracheostomy tube may be able to eat, but client with ET tube must have enteral or parenteral nutrition.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe and monitor for generalized muscle wasting and loss of subcutaneous fat.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These symptoms are indicative of depletion of muscle energy and can reduce respiratory muscle function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Weigh, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Significant and recent weight loss (7% to 10% of body weight) and poor nutritional intake provide clues regarding catabolism, muscle glycogen stores, and ventilatory drive sensitivity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer fluid intake of at least 2500 mL/d within cardiac tolerance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents dehydration that can be exacerbated by increased insensible losses (ventilator or diaphoresis, hypermetabolic state) and reduces risk of constipation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess GI function: presence and quality of bowel sounds and changes in abdominal girth, nausea, and vomiting. Observe and document changes in bowel movements, such as diarrhea and constipation. Test all stools for occult blood.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A functioning GI system is essential for the proper utilization of enteral feedings. <emphasis>Note:</emphasis> Mechanically ventilated clients are at risk of developing abdominal distention (trapped air or ileus) and gastric bleeding (stress ulcers).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Refer to dietitian to adjust nutrients to meet respiratory needs, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>High intake of carbohydrates, protein, and calories may be desired or needed during ventilation to improve respiratory muscle function. Carbohydrates may be reduced and fat somewhat increased just before weaning attempts to prevent excessive CO<subscript>2</subscript> production and reduced respiratory drive.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer tube feeding or hyperalimentation, as needed. (Refer to CP: <link linkend="ch0006s0219">Total Nutritional Support: Parenteral/Enteral Feeding</link>.)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides adequate nutrients to meet individual needs when oral intake is insufficient or not appropriate.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Monitor laboratory studies as indicated, such as prealbumin, serum transferrin, BUN/Cr, and glucose.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provides information about adequacy of nutritional support or need for change.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0094note0177"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for Infection</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>[Inadequate primary defenses]&mdash;traumatized lung tissue, decrease in ciliary action, stasis of body fluids</para>
<para>[Inadequate secondary defenses]&mdash;immunosuppression</para>
<para>Chronic illness, malnutrition</para>
<para>[Increased exposure to pathogens:] Invasive procedure&mdash;intubation; exposure to multiple healthcare workers</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Risk Control: Infectious Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
<para>Be free of signs/symptoms of infection.</para>
<para><emphasis role="strong">Client/Caregiver Will</emphasis></para>
<para>Identify individual risk factors.</para>
<para>Demonstrate interventions to promote safe environment.</para>
</note>
<note role="none" id="ch0003s0094note0178"><table frame="top" id="ch0003s0094ta0103"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Pneumonia Prevention</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note risk factors for occurrence of infection.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Intubation interferes with the normal defense mechanisms that keep microorganisms out of the lungs. ET tubes, especially cuffed ones, interfere with the mucociliary transport system that helps clear airway secretions. Secretions that accumulate below and above the ET tube cuff are an ideal growth medium for pathogens. The ET tube also prevents normal closure of the epiglottis, resulting in an incomplete seal of the laryngeal structures that normally protect the lungs. This can contribute to aspiration, which often leads to ventilator-associated pneumonia (VAP) (Damas et al, 2015). The reported incidence of VAP varies according to different studies but is reportedly occurring in 10% to 28% of individuals receiving mechanical ventilation (Amanullah &amp; Posner, 2015). Other factors include prolonged mechanical ventilation, trauma, general debilitation, malnutrition, age, and invasive procedures. Awareness of individual risk factors provides opportunity to limit effects and helps prevent VAP.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe color, odor, and characteristics of sputum. Note drainage around tracheostomy tube.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Yellow or green, purulent odorous sputum or drainage is indicative of infection; thick, tenacious sputum suggests dehydration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Engage in proper hand washing or alcohol-based hand rubs, wear gloves when handling respiratory secretions and equipment contaminated with respiratory secretions; maintain sterile techniques when performing arterial punctures (for ABGs) and when suctioning using open system; use closed-system ET tube whenever possible, to allow for continuous removal of secretions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These factors may be the simplest but are the most important keys to prevention of hospital-acquired infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Restrict the number of times the ventilator tubes are open, and provide clean nebulizer and tubing changes per protocol.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Research indicates that frequent changes of ventilator tubings have not been shown to reduce the risk of VAP and are currently not recommended. Current recommendations are to change tubings when soiled or when causing the ventilator to malfunction (Amanullah &amp; Posner, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate breath sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Presence of rhonchi and wheezes suggests retained secretions requiring expectoration or suctioning.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor for elevation of temperature.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fever may signal onset of infection, although if client is immunosuppressed, fever may not present.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keep head of bed elevated (if not prohibited by medical conditions such as spinal cord injury) to &gt;30 degrees.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Positioning of the intubated patient is believed to be relevant in the development of VAP. The 45-degree semi-recumbent position is widely recommended, but recent data suggest that the lateral position may be superior to prevent VAP (Coppadoro, Bittner, &amp; Berra, 2012; Niel-Weise et al, 2011).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide or instruct client and SO in proper oral care and secretion disposal, such as disposing of tissues and soiled tracheostomy dressings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of pneumonia associated with aspiration of oral bacteria, as well as transmission of fluid-borne organisms.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor and screen visitors. Avoid contact with persons with respiratory infections.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Individual is already compromised and is at increased risk with exposure to infections.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide respiratory isolation when indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Depending on specific diagnosis, client may require protection from others or must prevent transmission of infection, for example, influenza or tuberculosis (TB) to others.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain adequate hydration and nutrition. Encourage fluids to 2500 mL/d within cardiac tolerance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps improve general resistance to disease and reduces risk of infection from static secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid gastric distention. Check pH of secretions, if indicated. Avoid antacids, as well.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps identify presence of gastric secretions in respiratory tract and permits early intervention for VAP associated with gastric reflux and aspiration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage self-care and activities to limit of tolerance. Assist with graded exercise program.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improves general well-being and muscle strength and may stimulate immune system recovery. <emphasis>Note:</emphasis> Many studies are being conducted addressing benefits and adverse effects of early mobility for the patient on a ventilator. In addition to no severe negative effects, many benefits have been correlated with early mobility. Studies have demonstrated that intensive care unit (ICU) patients who participate in early rehabilitation have (1) improved muscle strength, (2) a significant reduction in the duration of mechanical ventilation, and (3) demonstrable decrease in patients&rsquo; ICU and hospital lengths of stay (Agency for Healthcare Research and Quality [AHRQ], 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor laboratory tests (e.g., WBCs with differential).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Leukocytosis may indicate presence and severity of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate period chest x-rays.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Infiltrates may signal presence of pneumonia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Obtain sputum cultures as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be needed to identify pathogens and appropriate antimicrobials. <emphasis>Note:</emphasis> Microorganisms implicated in VAP that occurs in the first 48 hours after intubation are those of the upper airway (<emphasis>Haemophilus influenzae</emphasis> and <emphasis>Streptococcus pneumoniae</emphasis>). After this early period, gram-negative bacilli (e.g., <emphasis>Pseudomonas aeruginosa, Escherichia coli,</emphasis> and <emphasis>Acinetobacter, Proteus,</emphasis> and <emphasis>Klebsiella</emphasis>) are more predominant. <emphasis>Staphylococcus aureus,</emphasis> especially methicillin-resistant <emphasis>S. aureus</emphasis> (MRSA), typically becomes a major agent after 7 days of mechanical ventilation (Byrd &amp; Roy, 2017).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer broad-spectrum antimicrobials, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>If infection does occur, one or more agents may be used, depending on identified pathogen(s).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0094note0179"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for dysfunctional Ventilatory Weaning Response</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Physiological factors: Inadequate nutrition; pain, [muscle weakness or fatigue], alteration in sleep pattern</para>
<para>Psychological factors: Uncertainty about ability to wean; anxiety, fear; [unprepared for weaning attempt]</para>
<para>Situational factors: Environmental barrier (e.g., distractions, low nurse to patient ratio, unfamiliar healthcare staff); history of ventilator dependence &gt;4 days; history of multiple unsuccessful weaning attempts</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Mechanical Ventilation Weaning Response: Adult</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Actively participate in the weaning process.</para>
<para>Reestablish independent respiration with ABGs within acceptable range and free of signs of respiratory failure.</para>
<para><emphasis role="strong">Activity Tolerance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate increased tolerance for activity and participate in self-care within level of ability.</para>
</note>
<note role="none" id="ch0003s0094note0180"><table frame="top" id="ch0003s0094ta0104"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Mechanical Ventilatory Weaning</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess physical factors involved in weaning as follows:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stable heart rate/rhythm, blood pressure (BP), and clear breath sounds</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The heart must work harder to meet increased energy needs associated with weaning. Weaning may be deferred if tachycardia, pulmonary crackles, or hypertension are present.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fever</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increase of 1&deg;F (0.6&deg;C) in body temperature raises metabolic rate and oxygen demands by 7%.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nutritional status and muscle strength</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Weaning is hard work. Client not only must be able to withstand the stress of weaning but also must have the stamina to breathe spontaneously for extended periods.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine psychological readiness.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Weaning provokes anxiety for client regarding concerns about ability to breathe on own and long-term need of ventilator.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Explain weaning techniques, for example, spontaneous breathing trial (SBT), T-piece, pressure support ventilation (PSV), and spontaneous intermittent maximal ventilation (SIMV). Discuss individual plan and expectations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assists client to prepare for weaning process, helps limit fear of unknown, promotes cooperation, and enhances likelihood of a successful outcome. <emphasis>Note:</emphasis> Current guidelines recommend SBT as the preferred method of weaning as it withdraws ventilatory support while oxygenation is continued. The simplest form of SBT is the T-piece trial. In PSV weaning, all breaths are spontaneous and combined with enough pressure support to ensure that each breath is a reasonable tidal volume. Findings from randomized trials suggest that SIMV weaning delays extubation compared with PSV and SBT and that it should not be the primary mode of weaning in most clients (Byrd &amp; Roy, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide undisturbed rest and sleep periods. Avoid stressful procedures or situations and nonessential activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maximizes energy for weaning process; limits fatigue and oxygen consumption. <emphasis>Note:</emphasis> It takes approximately 12 to 14 hours of respiratory rest to rejuvenate tired respiratory muscles. For clients on AC, raising the rate to 20 breaths per minute can also provide respiratory rest.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate and document client&rsquo;s progress. Note restlessness; changes in BP, heart rate, and respiratory rate; use of accessory muscles; discoordinated breathing with ventilator; increased concentration on breathing (mild dysfunction); client&rsquo;s concerns about possible machine malfunction; inability to cooperate or respond to coaching; and color changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators that client may require slower weaning and an opportunity to stabilize or may need to stop or revise program.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Recognize and provide encouragement for client&rsquo;s efforts.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Positive feedback provides reassurance and support for continuation of weaning process.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor cardiopulmonary response to activity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Excessive oxygen consumption and demand increase the possibility of failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Consult with dietitian and nutritional support team for adjustments in composition of diet.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduction of carbohydrates and fats may be required to prevent excessive production of CO<subscript>2</subscript>, which could alter respiratory drive.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor CBC, serum albumin and prealbumin, transferrin, total iron-binding capacity, and electrolytes, especially potassium, calcium, and phosphorus.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Verifies that nutrition is adequate to meet energy requirements for weaning.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review chest x-ray and ABGs.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Chest x-rays should show clear lungs or marked improvement in pulmonary congestion or infiltrates. ABGs should document satisfactory oxygenation on an FiO<subscript>2</subscript> of 40% or less.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0094note0181"><title><emphasis role="strong">NURSING DIAGNOSIS: deficient Knowledge (Specify)</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Alteration in cognitive functioning or memory</para>
<para>Insufficient information; insufficient knowledge of resources</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports the problem</para>
<para>Inaccurate follow-through of instruction or performance of a procedure</para>
<para>Inappropriate behaviors&mdash;agitated, apathetic</para>
<para>Development of preventable complications</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client/SO/Caregiver Will</emphasis></para>
<para><emphasis role="strong">Health-Seeking Behavior</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Participate in learning process.</para>
<para>Exhibit increased interest, shown by verbal or nonverbal cues.</para>
<para>Assume responsibility for own learning and begin to look for information and to ask questions.</para>
<para><emphasis role="strong">Knowledge: Treatment Regimen</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Indicate understanding of mechanical ventilation therapy.</para>
<para>Demonstrate behaviors or new skills to meet individual needs and prevent complications.</para>
</note>
<note role="none" id="ch0003s0094note0182"><table frame="top" id="ch0003s0094ta0105"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Learning Facilitation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine ability and willingness to learn.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Physical condition may preclude client involvement in care before and after discharge. SO/caregiver may feel inadequate, afraid of machinery, and have reservations about ability to learn or deal with overall situation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Schedule teaching sessions for quiet, nonstressful times when all participants are well rested.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances learners&rsquo; ability to focus on and absorb content provided.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Arrange information in logical sequence, progressing from simple to more complex material at learners&rsquo; pace.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Allows learners to build on information learned in previous sessions; is less threatening and overwhelming.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Knowledge: Disease Process</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide material in multiple formats, such as books and pamphlets, audiovisuals, hands-on demonstrations, and take-home instruction sheets, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Uses multiple senses to stimulate learning and retention of information. Provides resources for review following discharge.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss specific condition requiring ventilatory support, what measures are being tried for weaning, and short- and long-term goals of treatment.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides knowledge base to aid client and SO in making informed decisions. Weaning efforts may continue for several weeks (extended period of time). Dependence is evidenced by repeatedly increased PCO<subscript>2</subscript> and decline in PaO<subscript>2</subscript> during weaning attempts, presence of dyspnea, anxiety, tachycardia, perspiration, and cyanosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client and SO to evaluate impact of ventilatory dependence on their lifestyle and what changes they are willing or unwilling to make. Problem-solve solutions to issues raised.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Quality of life must be resolved by the ventilator-dependent client and caregivers who need to understand that home ventilatory support is a 24-hour job that affects everyone.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promote participation in self-care and diversional activities and socialization, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Refocuses attention toward more normal life activities, increases endurance, and helps prevent depersonalization.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review issues of general well-being: role of nutrition, assistance with feeding and meal preparation, graded exercise and specific restrictions, and rest periods alternated with activity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances recuperation and ensures that individual needs will be met.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend that SO and caregivers learn cardiopulmonary resuscitation (CPR).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides sense of security about ability to handle emergency situations that might arise until help can be obtained.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Schedule team conference. Establish in-hospital training for caregivers if client is to be discharged home on ventilator.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Team approach is needed to coordinate client&rsquo;s care and teaching program to meet individual needs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct caregiver and client in hand-washing techniques, use of sterile technique for suctioning, tracheostomy or stoma care, and chest physiotherapy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of infection and promotes optimal respiratory function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide demonstration and &ldquo;hands-on&rdquo; sessions, as well as written material, about specific type of ventilator to be used, including function and care of equipment.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances familiarity, reducing anxiety and promoting confidence in implementation of new tasks and skills.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss what and when to report to the healthcare provider, for example, signs of respiratory distress and infection.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps reduce general anxiety while promoting timely and appropriate evaluation and intervention to prevent complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ascertain that all needed equipment is in place and that safety concerns have been addressed, such as alternative power source (generator, batteries), backup equipment, and client call and alarm system.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Predischarge preparations can ease the transfer process. Planning for potential problems increases sense of security for client and SO.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Contact community or hospital-based services.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suppliers of home equipment, physical therapy, care providers, emergency power provider, and social services, such as financial assistance, aid in procuring equipment and personnel and facilitate transition to home.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to vocational or occupational therapist.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Some ventilator-dependent clients are able to resume vocations either while on the ventilator or during the day (while ventilator dependent at night).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0094note0183">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<para>If client is discharged on ventilator, the client&rsquo;s needs and concerns remain the same as noted in this plan of care, in addition to the following:</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Self-Care deficit</emphasis>&mdash;musculoskeletal/neuromuscular impairment, weakness, fatigue, pain, environmental barriers</para></listitem>
<listitem><para><emphasis role="bi">interrupted Family Processes</emphasis>&mdash;situational crisis, shift in family roles, shift in health status of a family member</para></listitem>
<listitem><para><emphasis role="bi">risk for Relocation Stress Syndrome</emphasis>&mdash;reports powerlessness, decreased health status, lack of predeparture counseling, moderate to high degree of environmental change</para></listitem>
<listitem><para><emphasis role="bi">risk for caregiver Role Strain</emphasis>&mdash;discharge of family member with significant home-care needs, presence of situational stressors that normally affect families (economic vulnerability, changes in roles and responsibilities), duration of caregiving required, inexperience with caregiving</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0003s0099"><title><emphasis role="strong">PULMONARY TUBERCULOSIS (TB)</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Bacterial infection by <emphasis>Mycobacterium tuberculosis</emphasis> (Mtb) bacilli</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Primarily affects the lungs (85%; Herchline &amp; Amorosa, 2016), although it can invade other body systems.</para></listitem>
<listitem><para>Airborne droplets are inhaled, with the droplet nuclei deposited within the alveoli of the lung.</para>
</listitem></orderedlist></listitem>
<listitem><para>Primary infection is followed by a latent or dormant phase or by active disease in some individuals.</para></listitem>
<listitem><para>When the immune system weakens, dormant TB organisms can reactivate and multiply (reactivation TB).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Classifications</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Latent: Body&rsquo;s immune system has encapsulated the bacteria into tiny capsules called tubercles, infection not transmissible to others.</para></listitem>
<listitem><para>Active: Infection is spreading in the body and can be transmitted to others.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Following exposure, the bacilli may (1) be killed by the immune system, (2) multiply and cause primary TB, (3) become dormant and remain asymptomatic, or (4) proliferate after a latency period (reactivation disease) (Herchline &amp; Amorosa, 2016).</para></listitem>
<listitem><para>Multidrug-resistant tuberculosis (MDR-TB)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Primary: Caused by person-to-person transmission of a drug-resistant organism</para></listitem>
<listitem><para>Secondary: Usually the result of nonadherence to therapy or inappropriate treatment</para></listitem>
<listitem><para>On the rise especially in large cities, in those previously treated with antitubercular drugs, or in those who failed to follow or complete a drug regimen</para></listitem>
<listitem><para>Can progress from diagnosis to death in as little as 4 to 6 weeks</para>
</listitem></orderedlist></listitem>
<listitem><para>Risk factors: Individuals with weakened immune systems (higher among persons with HIV infection); chronic conditions such as diabetes, kidney disease, some forms of cancer, IV drug use; advanced age, malnutrition; impoverished populations, homelessness, shelter dwelling, incarceration; as well as among people who have traveled or lived in countries in which TB is endemic (e.g., Africa, eastern Europe, Asia, Russia, Latin America, Caribbean Islands).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: In 2015, in the United States, 9557 TB cases were reported to CDC, representing a 1.6% increase from 2014. In 2015, a total of 66.4% of reported TB cases in the United States occurred among foreign-born persons (CDC, 2015b). In 2014, an estimated 1.2 million (12%) of the 9.6 million people who developed TB worldwide were HIV positive (World Health Organization [WHO], 2015).</para></listitem>
<listitem><para>Mortality: There were 493 deaths in the United States from TB in 2014, the most recent year for which these data are available (CDC, 2015b and 2016b). Although the global TB death rate dropped 47% between 1990 and 2014, there were still 1.8 million TB-related deaths worldwide in 2015 (WHO, 2015). TB is a leading killer of HIV-positive people: in 2015, 35% of HIV deaths were due to TB (WHO, 2017).</para></listitem>
<listitem><para>Costs: The average direct per person cost of treating multidrug-resistant TB (MDR-TB) is $134,000 (rising to $430,000 for extensively drug-resistant TB [XDR-TB]) compared with $17,000 for drug-susceptible TB. Outpatient medications accounted for about 40% of costs, averaging $53,300 for MDR-TB and $164,000 for XDR-TB (Kelly, 2014).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0003s0099note0184"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Acid-fast bacilli (AFB):</emphasis> Rod-shaped bacteria that can be seen and counted under the microscope on a specially stained sputum sample on a glass slide, called an AFB smear. The most common AFB are members of the genus <emphasis>Mycobacterium.</emphasis></para>
<para><emphasis role="strong">BCG (Bacille Calmette-Guerin):</emphasis> Vaccine for TB used in many countries with a high prevalence of TB, to prevent childhood tuberculous meningitis and miliary (skin rash) disease. BCG is not generally used in adults in the United States because of the variable effectiveness of the vaccine against adult pulmonary TB and the vaccine&rsquo;s potential interference with tuberculin skin test reactivity. However, the client should be asked whether he or she has been vaccinated upon admission to care (worked with clients with active disease; may have lived in, traveled to, or immigrated from countries with high incidence of TB) (CDC, 2016c).</para>
<para><emphasis role="strong">Cavitation:</emphasis> The formation of cavities in a body tissue or an organ, especially those formed in the lung, because of TB. In cavitary disease, breath sounds are high-pitched and hollow (like blowing over the end of an empty bottle).</para>
<para><emphasis role="strong">Directly observed treatment (DOT):</emphasis> Healthcare worker observes client taking antitubercular medications. DOT provides a mechanism for early detection of adverse medication reactions or nonadherence with medication regimen in high-risk clients or environments, such as jails, homeless shelters, and crowded worksites, among others.</para>
<para><emphasis role="strong">Extensively drug-resistant TB (XDR-TB):</emphasis> A rare type of MDR-TB that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin, or capreomycin). XDR-TB needs up to 2 years of extensive treatment and is the most challenging to treat (CDC, 2016b).</para>
<para><emphasis role="strong">Fremitus:</emphasis> Sensation felt by a hand placed on the chest that vibrates during speech.</para>
<para><emphasis role="strong">Latent TB:</emphasis> Persons with latent TB are infected with <emphasis>M. tuberculosis</emphasis> but do not have TB disease. The only sign of TB infection is a positive reaction to the tuberculin skin test or TB blood test. Persons with latent TB infection are not infectious and cannot spread TB infection to others. Without treatment, about 5% to 10% of infected persons will develop TB disease at some time in their lives (CDC, 2014).</para>
<para><emphasis role="strong">Multidrug-resistant tuberculosis (MDR-TB):</emphasis> A form of TB caused by bacteria that do not respond to, at least, isoniazid and rifampicin, the two most powerful, first-line (or standard) anti-TB drugs.</para>
<para><emphasis role="strong">Tubular breath sounds:</emphasis> Low-pitched and sticky and occur over areas of consolidation.</para>
<para><emphasis role="strong">Whispered pectoriloquies:</emphasis> Transmission of the voice sound through the pulmonary structures so that it is unusually audible on auscultation of the chest, indicating either consolidation of the lung parenchyma or the presence of a large cavity.</para>
</note>
<sect2 id="ch0003s0100"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Most clients are treated in community clinics but may be hospitalized for diagnostic evaluation or initiation of therapy, adverse drug reactions, or severe illness or debilitation.</para>
<para>****This plan of care is intended to reflect care of the <emphasis role="strong">hospitalized</emphasis> person or long-term care resident with active (rather than latent) TB.</para>
</sect2>
<sect2 id="ch0003s0101"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0003s0074">Pneumonia</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<table frame="top" id="ch0003s0099ta0106"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec namest="1" nameend="2" spanname="1-2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Data depend on stage of disease and degree of involvement.</para></entry>
</row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION
<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Generalized weakness and fatigue</para></listitem>
<listitem><para>Shortness of breath with exertion</para></listitem>
<listitem><para>Difficulty sleeping, with evening or night fever, chills</para></listitem>
<listitem><para>Soaking night sweats</para></listitem>
<listitem><para>Nightmares</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Tachycardia, tachypnea/dyspnea on exertion</para></listitem>
<listitem><para>Muscle wasting, pain, and stiffness (advanced stages)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Recent or long-standing stress factors</para></listitem>
<listitem><para>Financial concerns, poverty</para></listitem>
<listitem><para>Feelings of helplessness and hopelessness</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Denial (especially during early stages)</para></listitem>
<listitem><para>Anxiety, apprehension, irritability</para></listitem>
<listitem><para>Inattention, marked irritability, change in mentation (advanced stages)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Loss of appetite</para></listitem>
<listitem><para>Nausea, vomiting</para></listitem>
<listitem><para>Weight loss</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Muscle wasting and loss of subcutaneous fat</para></listitem>
<listitem><para>Poor skin turgor, dry and flaky skin</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Chest pain aggravated by recurrent cough</para></listitem>
<listitem><para>Discomfort when coughing or breathing</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Guarding of affected area</para></listitem>
<listitem><para>Distraction behaviors, restlessness</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Shortness of breath</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Respirations:</emphasis> Increased respiratory rate (associated with fever, extensive disease, or fibrosis of the lung parenchyma and pleura)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>History of TB or exposure to infected individual</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Breath sounds:</emphasis> Diminished bilaterally or unilaterally (pleural effusion or pneumothorax); tubular breath sounds and/or whispered pectoriloquies over large lesions; crackles may be noted over apex of lungs during quick inspiration after a short cough (posttussive crackles)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Persistent cough, productive or nonproductive</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Sputum characteristics:</emphasis> May be green, or purulent, mucoid, or blood-tinged</para></listitem>
<listitem><para>Asymmetry in respiratory excursion (pleural effusion)</para></listitem>
<listitem><para>Dullness to percussion and decreased fremitus (pleural fluid or pleural thickening)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Presence of immunosuppressed conditions, such as AIDS, cancer</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Low-grade fever or acute febrile illness</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Positive HIV test; HIV infection</para></listitem>
<listitem><para>Visit to, immigration from, or close contact with persons in areas with high prevalence of TB, such as Southeast Asia, sub-Saharan Africa, and the countries of the former Soviet Union</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Enlarged lymph nodes in neck</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SOCIAL INTERACTION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Feelings of isolation and rejection because of communicable disease</para></listitem>
<listitem><para>Change in usual patterns of responsibility or change in physical capacity to resume role</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Familial history of TB</para></listitem>
<listitem><para>Person living with HIV</para></listitem>
<listitem><para>General debilitation and poor health status</para></listitem>
<listitem><para>Use or abuse of substances such as intravenous (IV) drugs, cocaine, and crack</para></listitem>
<listitem><para>Failure to improve or reactivation of TB</para></listitem>
<listitem><para>Nonparticipation in therapy</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Assistance with or alteration in drug therapy</para></listitem>
<listitem><para>Temporary assistance in self-care and homemaker and maintenance tasks</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0003s0099ta0107"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST
<?lb?>WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Acid-fast bacilli (AFB) sputum smear:</emphasis> Rapid screening test to detect mycobacteria.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This is a relatively quick way to determine if an infection may be due to one of the mycobacteria (such as tuberculosis). AFB smears can provide presumptive results within a few hours and are valuable in helping to make decisions about treatment while culture results are pending (Lab Tests Online, 2014).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Sputum TB culture:</emphasis> Acid-fast bacilli (AFB) are rod-shaped bacteria identified through sputum culture and smear.
<?lb?><emphasis>M. tuberculosis</emphasis> is the most prevalent species of mycobacteria and the most infectious.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Culture for AFB is the most specific test for TB and allows direct identification and determination of susceptibility of the causative organism. Though this test is more sensitive than an AFB smear, <emphasis>Mycobacteria</emphasis> grow more slowly than other types of bacteria, so positive identification may take days to several weeks. Negative results (no mycobacterial growth) can take up to 6 to 8 weeks to confirm. <emphasis>Note:</emphasis> Positive cultures should be followed by drug susceptibility testing (Herchline &amp; Amorosa, 2016; Lab Tests Online, 2014).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Molecular diagnostic tools for TB (e.g., restriction fragment length polymorphism, real-time PCR, DNA sequencing, and DNA strip assays):</emphasis> Sputum sample assay that can rapidly detect TB and simultaneously detect drug resistance.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Innovations in TB testing in recent years provide for rapid, sensitive, and specific diagnosis of <emphasis>M. tuberculosis</emphasis> in clinical specimens, as well as the status of its drug sensitivity. These tests have improved diagnostic accuracy, shortened time to diagnosis and treatment, and reduced unnecessary treatment (Herchline &amp; Amorosa, 2016; Sharma et al, 2013).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">TB screening skin tests (TST), such as purified protein derivative (PPD) administered by single-needle intradermal injection (Mantoux test):</emphasis> Determine past or present exposure to TB and whether the client (immigrant, traveler) has received BCG vaccine (common in countries where TB is prevalent).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A positive reaction&mdash;area of induration 10 mm or greater, occurring 48 to 72 hours after intradermal injection of the antigen&mdash;indicates past infection and the presence of antibodies but is not necessarily indicative of active disease. Positive results develop 2 to 10 weeks after exposure. A significant reaction in a client who is clinically ill means that active TB is a possibility. A significant reaction in healthy persons usually signifies dormant TB or an infection caused by a different mycobacterium. <emphasis>Note:</emphasis> BCG vaccination may cause a false-positive reaction to the TST, which may complicate decisions about prescribing treatment. Blood tests to detect TB infection, unlike the TST, are not affected by prior BCG vaccination and are less likely to give a false-positive result (see <link linkend="ch0004s0104note0196">Glossary</link>) (CDC, 2016c).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">TB screening blood tests: Interferon-gamma release assays (IGRAs),</emphasis>&nbsp;<emphasis role="strong">e.g.,</emphasis>&nbsp;<emphasis role="bi">QuantiFERON&reg;-TB Gold In-Tube test (QFT-GIT) and T-SPOT&reg; TB test (T-Spot)</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>An IGRA may be used in place of (but not in addition to) a TST in all situations in which the CDC recommends tuberculin skin testing as an aid in diagnosing <emphasis>M. tuberculosis</emphasis> infection. Blood testing requires only one visit to the lab, is typically more accurate than a skin test, and results are available within 24 hours.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Human immunodeficiency virus (HIV) serology</emphasis> (e.g., combination HIV antibody and HIV antigen test): Screening test for HIV, available only as a blood test.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The CDC recommends that HIV serology testing be done in all patients diagnosed with TB whose HIV status is unknown. <emphasis>Note:</emphasis> Among 8366 persons with TB disease who had a documented HIV test result in 2015, 6% were coinfected with HIV (CDC, 2017b).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Blood cultures:</emphasis> A test designed to detect if microorganisms (such as bacteria and fungi) are present in blood. A blood culture is done when a person has symptoms of a blood infection (bacteremia).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Help to establish the diagnosis of active TB. However, mycobacterial bacteremia is detectable using blood cultures only if specialized systems (with mycobacteria-specific, radioisotope tagging) are used; these bacilli have specific nutrient growth requirements not met by routine culture systems (Herchline &amp; Amorosa, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Rapid drug susceptibility testing:</emphasis> Recommended at the time of TB diagnosis to quickly detect if infected patient is resistant to one or more antitubercular drugs.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Timely diagnosis of drug resistance can ensure that infected patient is not placed on ineffective drug therapies and can minimize risks of spreading infection to others (York &amp; Kane, 2013).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Evaluates organs and structures within the chest for evidence of disease.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May show small, patchy infiltrations of early lesions in the upper-lung field, calcium deposits of healed primary lesions, or fluid of an effusion. Changes indicating more advanced TB may include cavitation, scar tissue, and fibrotic areas. <emphasis>Note:</emphasis> Chest radiographic findings may be normal in as many as 15% of patients with primary pulmonary tuberculosis (Catanzano, 2016).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Computed tomography (CT) scan:</emphasis> Uses computer-processed combinations of many x-ray images taken from different angles to produce cross-sectional images of the body.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>CT is the examination of choice for evaluating the tracheobronchial tree and may be helpful in evaluating parenchymal involvement and bronchogenic spread of infection. Concerning characterization of the infection as active or not, CT is more sensitive than chest x-ray (Catanzano, 2016).</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0003s0102"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Achieve and maintain adequate ventilation and oxygenation.</para></listitem>
<listitem><para>Prevent spread of infection.</para></listitem>
<listitem><para>Support behaviors and tasks to maintain health.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0003s0103"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Respiratory function adequate to meet individual need.</para></listitem>
<listitem><para>Complications prevented.</para></listitem>
<listitem><para>Lifestyle and behavior changes adopted to prevent spread of infection.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0003s0099note0185"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for Infection [spread]</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Inadequate primary defenses&mdash;decreased ciliary action, stasis of body fluids</para>
<para>[Tissue destruction; extension of infection]</para>
<para>Inadequate secondary defenses&mdash;suppressed inflammatory response</para>
<para>Malnutrition</para>
<para>Increased environmental exposure to pathogens</para>
<para>[Deficient knowledge to avoid exposure to pathogens]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Risk Control: Infectious Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify interventions to prevent or reduce risk of spread of infection.</para>
<para>Demonstrate techniques and initiate lifestyle changes to promote safe environment.</para>
</note>
<note role="none" id="ch0003s0099note0186"><table frame="top" id="ch0003s0099ta0108"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Infection Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis>For hospitalized client/resident suspected of or diagnosed with active TB:</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This list does not encompass all isolation precautions that might be implemented but is intended as a basic guide for nursing care in the hospital setting (adapted from Knechel, 2009; Siegel et al, 2007; York &amp; Kane, 2013):</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Implement/maintain patient and healthcare personnel isolation precautions:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Most hospitalized patients are in a compromised immune state and at higher risk of exposure to infectious diseases than when in the community. This factor necessitates isolation of the patient (with suspected or known active TB disease) from other patients. In addition, the patient with latent TB (immunocompromised due to other factors, e.g., uncontrolled diabetes, sepsis, chemotherapy, ventilator-associated pneumonia [VAP], malnutrition) is at high risk of activation or reactivation of TB.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Meticulous handwashing by all persons before and after examining and providing hands-on care to patient and when handling respiratory secretions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Healthcare personnel use high-level particulate respirator mask when in patient room.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Patient wears surgical mask when visitors present or if leaving room.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct and remind patient to cough, sneeze, and expectorate into tissue and to refrain from spitting.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review proper disposal of tissue and provide disposal container.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use closed system suctioning if patient on mechanical ventilation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis>Implement environmental isolation procedures:</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Single-patient room</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Negative pressure relative to surrounding area with 6 to 12 air exchanges per hour if available</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Air exhausted to outdoors or recirculated through air purifier system</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Door closed at all times</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Signage on door; visitor screening and limitation, per facility protocol</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cleaning and disinfection of patient-care areas for frequently touched surfaces (e.g., bedrails, bedside tables, commodes, doorknobs, sinks, surfaces, and equipment in close proximity to the patient)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify others at risk, such as household members, close associates, and friends.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Those exposed may require a course of drug therapy to prevent development of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct client to cough, sneeze, and expectorate into tissue and to refrain from spitting. Review proper disposal of tissue and good hand washing techniques. Request return demonstration.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Behaviors necessary to prevent spread of droplet/airborne infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review necessity of infection control measures, such as temporary respiratory isolation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May help client understand need for protecting others while acknowledging client&rsquo;s sense of isolation and social stigma associated with communicable diseases.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor temperature, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Febrile reactions are indicators of continuing presence of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer anti-infective agents, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The goals for treatment of TB are to cure the individual and to minimize transmission to other persons. It is essential that treatment be tailored and supervision be based on each client&rsquo;s clinical and social circumstances. Directly observed treatment (DOT) may be the most effective way to maximize the completion of therapy in certain situations/selected populations.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Primary drugs: isoniazid (INH, Liniazid), rifampin (RIF, Rifadin, Rimactane), pyrazinamide (PZA, Tebrazid), and ethambutol (Etbi, Myambutol)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>There are 10 drugs currently approved by the U.S. Food and Drug Administration (FDA) for treating TB. Of the approved drugs, these first-line medications are highly effective for susceptible TB (CDC, 2016d). In active TB, these four drugs will be given together for the initial phase (first 2 months) of therapy, followed by a choice of options (usually two drugs based on drug sensitivity testing for the continuation phase [usually 4 to 7 months]). Extended therapy for up to 24 months is indicated for reactivation cases, extrapulmonary reactivated TB, or in the presence of other medical problems, such as diabetes mellitus or silicosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Other FDA-approved agents include cycloserine (Seromycin), ethionamide (Trecator), para-aminosalicylic acid (PAS), amikacin (Amikan)/kanamycin (Kantrex), streptomycin (Streptomycin), levofloxacin (Levoquin)/moxifloxacin (Aveflox), and capreomycin (Capastat).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These second-line drugs are used in combination with other antitubercular agents, often when client is unable to tolerate typical TB drugs or when client has drug-resistant TB.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rifabutin (Mucobutin)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Therapeutic agent for atypical mycobacterium typically used in client with advanced HIV disease with TB.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bedaquiline (Sirturo)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Approved specifically for treatment of multidrug-resistant (MDR)-TB as part of combination therapy (Walker, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, such as the following:</para></entry>
<entry rowsep="0" morerows="1" colsep="0" valign="top">
<para>Client who has three consecutive negative sputum smears over a 3- to 5-month period, is adhering to drug regimen, and is asymptomatic will be classified as a nontransmitter.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top"/>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sputum smear results</para></entry>
</row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Liver function studies, such as aspartate aminotransferase (AST), alanine aminotransferase (ALT)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The most common serious adverse effect of drug therapy&mdash;particularly RIF, but possibly others as well&mdash;is drug-induced hepatitis.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Notify local health department.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Required by law and should be reported within 1 week of diagnosis. Helpful in identifying contacts to reduce spread of infection. Treatment course is long and usually handled in the community, with public health nurse monitoring.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0099note0187"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Airway Clearance</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Physiological: Infection</para>
<para>Excessive mucus; exudates in the alveoli; retained secretions</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Change in respiratory rate, rhythm</para>
<para>Ineffective cough</para>
<para>Diminished/adventitious breath sounds&mdash;[rhonchi, wheezes, stridor]</para>
<para>Dyspnea</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Airway Patency</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain patent airway.</para>
<para>Expectorate secretions without assistance.</para>
<para>Demonstrate behaviors to improve or maintain airway clearance.</para>
<para>Participate in treatment regimen, within the level of ability and situation.</para>
<para>Identify potential complications and initiate appropriate actions.</para>
</note>
<note role="none" id="ch0003s0099note0188"><table frame="top" id="ch0003s0099ta0109"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Airway Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess respiratory function, such as breath sounds, rate, rhythm, and depth, and use of accessory muscles.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diminished breath sounds may reflect atelectasis. Rhonchi and wheezes indicate accumulation of secretions and inability to clear airways, which may lead to use of accessory muscles and increased work of breathing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note ability to expectorate mucus and cough effectively; document character and amount of sputum and presence of hemoptysis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Expectoration may be difficult when secretions are thick, cloudy, and sometimes bloody because of infection or inadequate hydration. Blood-tinged or frankly bloody sputum results from tissue breakdown in the lungs and may require further evaluation and intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Place client in semi- or high-Fowler&rsquo;s position. Assist client with coughing and deep-breathing exercises.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Positioning helps maximize lung expansion and decreases respiratory effort. Maximal ventilation may open atelectatic areas and promote movement of secretions into larger airways for expectoration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Clear secretions from mouth and trachea; suction as necessary.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents obstruction and aspiration. Suctioning may be necessary if client is unable to expectorate secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain fluid intake of at least 2500 mL/d unless contraindicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>High fluid intake helps thin secretions, making them easier to expectorate.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Humidify inspired oxygen.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents drying of mucous membranes and helps thin secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bronchodilators, such as oxtriphylline (Choledyl) and theophylline (Theo-Dur)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases lumen size of the tracheobronchial tree, thus decreasing resistance to airflow and improving oxygen delivery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Corticosteroids (prednisone)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be useful in the presence of extensive involvement with profound hypoxemia and when inflammatory response is life-threatening.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Be prepared for and assist with emergency intubation.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Intubation may be necessary in rare cases of bronchogenic TB accompanied by laryngeal edema or acute pulmonary bleeding.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0099note0189"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for impaired Gas Exchange</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Ventilation-perfusion imbalance</para>
<para>Alveolar-capillary membrane changes</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Gas Exchange</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report absence of or decreased dyspnea.</para>
<para>Demonstrate improved ventilation and adequate oxygenation of tissues by ABGs within acceptable ranges and absence of symptoms of respiratory distress.</para>
</note>
<note role="none" id="ch0003s0099note0190"><table frame="top" id="ch0003s0099ta0110"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Respiratory Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess for dyspnea (using 0 to 10 [or similar] scale), tachypnea, abnormal breath sounds, increased respiratory effort, limited chest wall expansion, and fatigue.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pulmonary TB can cause a wide range of effects in the lungs, ranging from a small patch of bronchopneumonia to diffuse intense inflammation, caseous necrosis, pleural effusion, and extensive fibrosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate change in level of mentation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Accumulation of secretions and airway compromise can impair oxygenation of vital organs and tissues, often reflected in change in mental status.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note cyanosis or change in skin color, including mucous membranes and nailbeds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Respiratory effects can range from mild dyspnea to profound respiratory distress. <emphasis>Note:</emphasis> Using a scale to evaluate dyspnea helps clarify degree of difficulty and changes in condition.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Demonstrate and encourage pursed-lip breathing during exhalation, especially for clients with fibrosis or parenchymal destruction.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Creates resistance against outflowing air to prevent collapse of the airways, thereby helping to distribute air throughout the lungs and relieve or reduce shortness of breath.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promote bedrest, or limit activity and assist with self-care activities as necessary.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reducing oxygen consumption and demand during periods of respiratory compromise may reduce severity of symptoms.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor serial ABGs and pulse oximetry.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased oxygen content (PaO<subscript>2</subscript>) and saturation or increased PaCO<subscript>2</subscript> indicates need for change in therapeutic regimen.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provide supplemental oxygen as appropriate.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Aids in correcting the hypoxemia that may occur secondary to decreased ventilation and diminished alveolar lung surface.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0099note0191"><title><emphasis role="strong">NURSING DIAGNOSIS: imbalanced Nutrition: less than body requirements</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>[Fatigue]</para>
<para>Biological factors&mdash;frequent cough and sputum production; dyspnea; [nausea]</para>
<para>Inability to ingest or digest food; inability to absorb nutrients</para>
<para>Economically disadvantaged</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Body weight 20% or more below ideal weight range; [decreased subcutaneous fat or muscle mass]; insufficient muscle tone</para>
<para>Reported lack of interest in food, altered taste sensation</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Nutritional Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate progressive weight gain toward goal with normalization of laboratory values and be free of signs of malnutrition.</para>
<para>Initiate behaviors or lifestyle changes to regain and to maintain appropriate weight.</para>
</note>
<note role="none" id="ch0003s0099note0192"><table frame="top" id="ch0003s0099ta0111"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Nutrition Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify client at risk for malnutrition and issues that may affect client&rsquo;s dietary plan whether in community or acute care setting.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Many factors are in play when considering malnutrition in persons with TB. Risk factors may include (1) poverty (e.g., lack of health insurance, low quality of health services, lack of resources for food purchase or preparation, homelessness), (2) client&rsquo;s age and chronic illness status (institutional living/incarceration), (3) geographical inaccessibility (e.g., limited access to supermarkets; lack of transportation) or psychological inaccessibility (e.g., client suffering with stigma of disease), and (4) certain cultural aspects, including language and conceptions about nutrition (e.g., personal food preferences, price, convenience, cooking skills) and the health-disease process.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Document client&rsquo;s nutritional status on admission, noting skin turgor, current weight and degree of weight loss, integrity of oral mucosa, ability to swallow, presence of bowel tones, and history of nausea, vomiting, or diarrhea.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in defining extent of issues affecting nutritional intake and suggesting appropriate choice of interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine client&rsquo;s ability and willingness to address nutritional issues. Ascertain client&rsquo;s usual dietary pattern and likes and dislikes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps to identify specific needs or strengths. Consideration of individual preferences may improve dietary intake.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor intake and output (I&amp;O) and weight periodically.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in measuring effectiveness of nutritional and fluid support.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate anorexia, nausea, and vomiting. Note possible correlation to medications. Monitor frequency, volume, and consistency of stools.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Affects dietary choices and can identify areas for problem-solving to enhance intake of nutrients.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage and provide for frequent rest periods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps conserve energy, especially when metabolic requirements are increased by fever.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide oral care before and after respiratory treatments.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces bad taste left from sputum or medications used for respiratory treatments that can stimulate the vomiting center.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage small, frequent meals or snacks with foods high in protein and carbohydrates.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maximizes nutrient intake without undue energy expenditure from eating large meals.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage SO to bring foods from home and to share meals with client unless not feasible or contraindicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Creates a more normal social environment during mealtime and helps meet personal and cultural preferences.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Refer to dietitian/nutritionist for adjustments in dietary composition.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can aid in planning a diet with nutrients adequate to meet client&rsquo;s metabolic requirements, dietary preferences, and financial resources.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Consult with respiratory therapy to schedule treatments 1 to 2 hours before or after meals.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May help reduce the incidence of nausea and vomiting associated with medications or the effects of respiratory treatments on a full stomach.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor laboratory studies, such as blood urea nitrogen (BUN), serum protein, and prealbumin and albumin.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Low values reflect malnutrition and indicate need for change in therapeutic regimen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer antipyretics, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fever increases metabolic needs and therefore calorie consumption.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer antiemetics (e.g., odansetron [Zofran]; promethazine [Phenergan]), as appropriate.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Treating nausea associated with many antitubercular drugs may help client with food aversion/intolerance, thereby improving nutritional status.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0099note0193"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for ineffective Health Management</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By:</emphasis></para>
<para>Complexity of therapeutic regimen or healthcare system</para>
<para>Insufficient knowledge of therapeutic regimen; decisional conflicts</para>
<para>Economically disadvantaged; insufficient social support; family pattern of healthcare</para>
<para>Perceived seriousness of condition, susceptibility, benefit, or barrier</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Management: Chronic Disease</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize acceptance of need and desire to change actions to achieve agreed-upon health goals.</para>
<para>Initiate behaviors or lifestyle changes to improve general well-being and reduce risk of reactivation or transmission of TB.</para>
<para>Identify symptoms requiring evaluation and intervention.</para>
<para>Describe a plan for receiving adequate follow-up care.</para>
</note>
<note role="none" id="ch0003s0099note0194"><table frame="top" id="ch0003s0099ta0112"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Learning Facilitation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess client&rsquo;s ability and willingness to learn (noting level of fear, concern, fatigue, participation level), best environment in which client can learn, how much content the client can learn, best media and language to teach the client, and determine who should be included.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Learning depends on emotional and physical readiness and is achieved at an individual pace.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide instruction and specific written or audio/visual information for client to refer to (such as schedule for medications and follow-up sputum testing for documenting response to therapy).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Take-home information relieves client of the burden of having to remember large amounts of information. Repetition strengthens learning.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client and SO to verbalize fears and concerns. Answer questions factually. Note prolonged use of denial.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides opportunity to correct misconceptions that may alleviate anxiety. Prolonged denial may affect coping with and managing the tasks necessary to regain health.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review pathology of disease&mdash;active or inactive phases, dissemination of infection through bronchi to adjacent tissues or via bloodstream and lymphatic system to other organs&mdash;and potential spread of infection to others via airborne droplets during coughing, sneezing, spitting, talking, laughing, and singing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowledge may reduce risk of transmission or reactivation. Understanding of how the disease is passed and awareness of transmission possibilities help client and significant other (SO) take steps to prevent infection of others.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify individual risk factors for reactivation of tuberculosis, such as lowered resistance associated with alcoholism, malnutrition, intestinal bypass surgery, use of immunosuppressant drugs, presence of diabetes mellitus or cancer, or postpartum.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowledge about these factors helps client alter lifestyle and avoid or reduce incidence of disease reactivation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify symptoms that should be reported to healthcare provider, such as hemoptysis, chest pain, fever, difficulty breathing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Complications associated with active pulmonary tuberculosis (and possibly reactivation TB) include (and are not limited to) drug-resistant TB, cavitation, abscess formation, destructive emphysema, spontaneous pneumothorax, pleurisy, and extrapulmonary TB affecting many other organ systems.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review necessity of follow-up and periodic retesting of sputum for the duration of therapy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in monitoring the effects of medications and client&rsquo;s response to therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain medication dosage, frequency of administration, expected action, and the reason for long treatment period. Review potential interactions with other drugs and substances. Emphasize reportable side effects (e.g., hearing loss, vertigo).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances cooperation with therapeutic regimen and may prevent client from discontinuing medication before cure is truly effected. DOT is the treatment of choice when client is unable or unwilling to take medications as prescribed. <emphasis>Note:</emphasis> Clients with HIV infection and TB are particularly susceptible to drug interactions because they are typically taking numerous antiretroviral medications, some of which react with antituberculosis medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss potential side effects of treatment, such as dry mouth, gastrointestinal (GI) upset, constipation, visual disturbances, headache, and orthostatic hypertension, and problem-solve solutions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>It is important that antituberculosis drugs not be discontinued because of &ldquo;nuisance&rdquo; side effects. Problem-solving, such as taking medication with food and changing the hour of dosing, may reduce discomfort associated with therapy and enhance cooperation with regimen. Severe reactions must be reported to physician.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of uninterrupted drug therapy. Evaluate client&rsquo;s potential for cooperation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Contagious period may last only 2 to 3 days after initiation of drug regimen, but in the presence of cavitation or moderately advanced disease, risk of spread of infection may continue up to 3 months. Compliance with multidrug regimens for prolonged periods is difficult; therefore, DOT should be considered.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize need to abstain from alcohol while on drugs such as INH or cycloserine (may not be complete listing). Discuss safe alcohol intake with physician and client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>When some antitubercular drugs and alcohol are combined, there can be adverse side effects and drug interactions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage abstaining from smoking.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although smoking does not stimulate recurrence of TB, it does increase the likelihood of respiratory dysfunction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss importance of maintaining high-protein and carbohydrate diet and adequate fluid intake. (Refer to ND: <link linkend="ch0003s0099note0191">imbalanced Nutrition: less than body requirements</link>.)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Meeting the body&rsquo;s metabolic and fluid requirements helps minimize fatigue and promotes recovery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify and reinforce concerns, such as treatment failure, drug-resistant TB, and relapse.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Treatment failure most often occurs because client is not adhering to treatment regimen but can also be due to drug resistance, malabsorption of drugs, laboratory error, and extreme biological variation in response. Most relapses or recurrence of positive cultures or radiographic deterioration occur 6 to 12 months after completion of therapy. Continuous monitoring by healthcare providers can identify these concerns early and alter the plan accordingly.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to public health agency as appropriate.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>DOT by community nurses is often the most effective way to ensure client adherence to therapy. Monitoring may include pill counts and urine dipstick testing for presence of antitubercular drug. Clients with MDR-TB may be monitored with monthly sputum specimens for AFB smear and culture. <emphasis>Note:</emphasis> In some states, there are legal means for involuntary confinement for care if efforts to ensure client adherence are ineffective.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0003s0099note0195">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS</emphasis> following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, economic difficulties, family patterns of healthcare, perceived seriousness and benefits</para></listitem>
<listitem><para><emphasis role="bi">risk for Infection (secondary)</emphasis>&mdash;decrease in ciliary action, stasis of body fluids (secretions), suppressed inflammatory response, tissue destruction, chronic disease, malnutrition, increased environmental exposure</para></listitem>
<listitem><para><emphasis role="bi">Fatigue</emphasis>&mdash;disease states, malnutrition, discomfort</para></listitem>
<listitem><para><emphasis role="bi">ineffective family Therapeutic Regimen Management</emphasis>&mdash;complexity of therapeutic regimen, decisional conflicts, economic difficulties, family conflict</para></listitem></itemizedlist>
</note>
</sect2></sect1>
</chapter>